|
|
|
Scientific Literature, diabetes
-
Aarnisalo J, Treszl A, Svec P, Marttila J, Oling V, Simell O, Knip M, Korner A, Madacsy L, Vasarhelyi B, Ilonen J, Hermann R. Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant.
J. Autoimmun. 31: 13-21 (2008).
-
Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J. Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes.
Diabetologia 51: 769-772 (2008).
*
-
Aarsetoey H, Ponitz V, Grundt H, Staines H, Harris WS, Nilsen DW. (n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome.
J. Nutr. 139: 507-513 (2009).
*
-
Abahusain MA, Al-Nahedh NN. The biochemical status of vitamin A and alpha-tocopherol during different stages of renal disease and its relationship to diabetes.
Saudi J. Kidney Dis. Transpl. 13: 18-23 (2002).
-
Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, Trischitta V. Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Nat. Clin. Pract. Endocrinol. Metab. 2: 694-701 (2006).
*
-
Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, Radha V, Deepa R, Mohan V. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes.
Diabetes 54: 1207-1213 (2005).
*
-
Abbas Z, Jafri W, Rasool S, Abid S, Hameed I. Mucormycosis in patients with complicated cirrhosis.
Singapore Med. J. 48: 69-73 (2007).
*
-
Abbott J, Hart A, Morton AM, Dey P, Conway SP, Webb AK. Can health-related quality of life predict survival in adults with cystic fibrosis?
Am. J. Respir. Crit. Care Med. 179: 54-58 (2009).
*
-
Abdel Aziz AM, Lehman GA. Current treatment options for chronic pancreatitis.
Curr. Treat. Options Gastroenterol. 10: 355-368 (2007).
-
Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis.
J. Clin. Gastroenterol. 20: 127-130 (1995).
-
Abdelmalek MF, Liu C, Shuster J, Nelson DR, Asal NR. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.
Clin. Gastroenterol. Hepatol. 4: 1162-1169 (2006).
-
Abderrahmani A, Chevre JC, Otabe S, Chikri M, Hani EH, Vaxillaire M, Hinokio Y, Horikawa Y, Bell GI, Froguel P. Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians.
Diabetes 49: 306-308 (2000).
*
-
Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S. Effect of linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Int. Immunopharmacol. 5: 231-239 (2005).
-
Abdullah MA. Epidemiology of type I diabetes mellitus among Arab children.
Saudi Med. J. 26: 911-917 (2005).
-
Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, Nakashima K, Takagi N, Baba H, Hasegawa Y, Shimokata K. NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis.
J. Infect. 46: 215-220 (2003).
-
Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H, Sakamaki H, Kawasaki E, Awata T, Yamaguchi Y, Eguchi K. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes.
Diabetes Res. Clin. Pract. 46: 169-175 (1999).
-
Abebe F, Mustafa T, Nerland AH, Bjune GA. Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.
Clin. Exp. Immunol. 143: 180-192 (2006).
*
-
Abiru N, Kawasaki E, Eguch K. Current knowledge of Japanese type 1 diabetic syndrome.
Diabetes Metab. Res. Rev. 18: 357-366 (2002).
*
-
Ablamunits V, Bisikirska BC, Herold KC. Human regulatory CD8 T cells.
Ann. N. Y. Acad. Sci. 1150: 234-238 (2008).
*
-
Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, Rumpold H, Gerdov M, Mannhalter C, Prager R, Irsigler K, Wagner OF. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
Exp. Clin. Endocrinol. Diabetes 115: 38-41 (2007).
-
Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease.
Hepatology 40: 475-483 (2004).
*
-
Abreu MT, Yang H. Is genetic testing in IBD ready for prime time?
Am. J. Gastroenterol. 99: 316-318 (2004).
*
-
Abu-Zekry M, Kryszak D, Diab M, Catassi C, Fasano A. Prevalence of celiac disease in Egyptian children disputes the East-West agriculture-dependent spread of the disease.
J. Pediatr. Gastroenterol. Nutr. 47: 136-140 (2008).
-
Acevedo-Suarez CA, Hulbert C, Woodward EJ, Thomas JW. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.
J. Immunol. 174: 827-833 (2005).
*
-
Acha-Orbea H. Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
Res. Immunol. 142: 487-490 (1991).
-
Achenbach P, Fuchtenbusch M. Modulating the autoimmune response in type 1 diabetes: a report on the 64th Scientific Sessions of the ADA, June 2004, Orlando, FL, USA.
Rev. Diabet. Stud. 1: 137-140 (2004).
*
-
Ackerman NB, Kronmueller J. The importance of candida as an infectious agent.
Surg. Gynecol. Obstet. 140: 65-68 (1975).
-
Adam SJ, Counter CM. A method to generate genetically defined tumors in pigs.
Methods Enzymol. 439: 39-51 (2008).
-
Adamiec J, Oficjalska-Mlynczak J. Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy.
Przegl. Lek. 64: 389-392 (2007).
-
Adamiec R, Gacka M, Dobosz T, Szymaniec S, Bednarska-Chabowska D, Sadakierska-Chudy A. Stimulation of the peroxisome proliferator-activated receptor gamma (PPARgamma) and the expression of selected blood monocyte cytokine genes in diabetic macroangiopathy.
Atherosclerosis 194: e108-e115 (2007).
-
Adamiec-Mroczek J, Oficjalska-Mlynczak J. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes - role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.
Graefes. Arch. Clin. Exp. Ophthalmol. 246: 1665-1670 (2008).
*
-
Adams LA, Feldstein A, Lindor KD, Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
Hepatology 39: 909-914 (2004).
*
-
Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
Am. J. Gastroenterol. 104: 861-867 (2009).
-
Adams M, Williams A, Fell J. Exercise in the fight against thrombosis: friend or foe?
Semin. Thromb. Hemost. 35: 261-268 (2009).
-
Adams PC. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?
Mol. Genet. Metab. 71: 81-86 (2000).
*
-
Adamson KA, Cheetham TD, Kendall-Taylor P, Seckl JR, Pearce SH. The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus.
Int. J. Immunogenet. 34: 17-21 (2007).
*
-
Addolorato G, Russell M, Albano E, Haber PS, Wands JR, Leggio L. Understanding and treating patients with alcoholic cirrhosis: an update.
Alcohol Clin. Exp. Res. Apr 21 [Epub ahead of print] (2009).
-
Addous A, Mohamed AS, Ismail G, Al-Hashemy A. Post-transplant diabetes mellitus in kidney transplant recipients with special reference to association with HLA antigens.
Saudi J. Kidney Dis. Transpl. 11: 559-562 (2000).
-
Adibi SA. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease.
Am. J. Physiol. Gastrointest. Liver Physiol. 285: G779-G788 (2003).
*
-
Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J. Overproduction of large VLDL particles is driven by increased liver fat content in man.
Diabetologia 49: 755-765 (2006).
*
-
Adler AI, Gunn E, Haworth CS, Bilton D. Characteristics of adults with and without cystic fibrosis-related diabetes.
Diabet. Med. 24: 1143-1148 (2007).
*
-
Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D. Genetic determinants and epidemiology of cystic fibrosis-related diabetes - results from a British cohort of children and adults.
Diabetes Care 31: 1789-1794 (2008).
*
-
Adorini L. New trends in clinical and experimental immunosuppression - fourth international conference.
IDrugs 3: 496-498 (2000).
-
Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system.
Nat. Clin. Pract. Rheumatol. 4: 404-412 (2008).
-
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
Prostate 68: 740-747 (2008).
-
Aganna E, Aksentijevich I, Hitman GA, Kastner DL, Hoepelman AI, Posma FD, Zweers EJ, McDermott MF. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance.
Eur. J. Hum. Genet. 9: 63-66 (2001).
*
-
Aganna E, Hawkins PN, Ozen S, Pettersson T, Bybee A, McKee SA, Lachmann HJ, Karenko L, Ranki A, Bakkaloglu A, Besbas N, Topaloglu R, Hoffman HM, Hitman GA, Woo P, McDermott MF. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis.
Genes Immun. 5: 289-293 (2004).
*
-
Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Clin. Gastroenterol. Hepatol. 5: 1276-1281 (2007).
-
Agardh D, Bjorck S, Agardh CD, Lidfeldt J. Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women.
Scand. J. Gastroenterol. 44: 571-578 (2009).
*
-
Agardh D, Lynch K, Brundin C, Ivarsson SA, Lernmark A, Cilio CM. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease.
Clin. Exp. Immunol. 144: 67-75 (2006).
*
-
Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis.
J. Hepatol. 32: 538-541 (2000).
*
-
Agarwal N, Sharma BC. Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH).
Hepatol. Res. 33: 92-96 (2005).
-
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword.
Nat. Rev. Immunol. 3: 745-756 (2003).
*
-
Aggarwal BB, Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning.
Ann. N. Y. Acad. Sci. 1030: 434-441 (2004).
*
-
Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link?
Biochem. Pharmacol. 72: 1605-1621 (2006).
*
-
Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H. TNF blockade: an inflammatory issue.
Ernst Schering Res. Found. Workshop 56: 161-186 (2006).
-
Agostoni C, Decsi T, Fewtrell M, Goulet O, Kolacek S, Koletzko B, Michaelsen KF, Moreno L, Puntis J, Rigo J, Shamir R, Szajewska H, Turck D, van Goudoever J; ESPGHAN Committee on Nutrition:. Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition.
J. Pediatr. Gastroenterol. Nutr. 46: 99-110 (2008).
*
-
Agostoni C, Shamir R. For debate: can a change in policy of complementary infant feeding reduce the risk for type 1 diabetes and celiac disease?
Pediatr. Endocrinol. Rev. 6: 2-4 (2008).
-
Agrawal RP, Rathore A, Joshi A, Changal H, Kochar DK. Prevalence of celiac disease in type 1 diabetes mellitus in North West Rajasthan, India.
Diabetes Res. Clin. Pract. 79: e15-e16 (2008).
-
Agrawal S, Dimitrova N, Prasthani N, Udayakumar K, Sailakshmi S, Sriram S, Manjusha N, Sengupta U. T2D-Db: an integrated platform to study the molecular basis of type 2 diabetes.
BMC Genomics 9: 320 (2008).
*
-
Agte VV, Tarwadi KV. Combination of diabetes and cataract worsens the oxidative stress and micronutrient status in Indians.
Nutrition 24: 617-624 (2008).
*
-
Aguirre AL, Center SA, Randolph JF, Yeager AE, Keegan AM, Harvey HJ, Erb HN. Gallbladder disease in Shetland sheepdogs: 38 cases (1995-2005).
J. Am. Vet. Med. Assoc. 231: 79-88 (2007).
-
Agyei-Frempong MT, Titty FV, Owiredu WK, Eghan BA. The prevalence of autoimmune diabetes among diabetes mellitus patients in Kumasi, Ghana.
Pak. J. Biol. Sci. 11: 2320-2325 (2008).
-
Ahima RS. The natural history of nonalcoholic fatty liver disease: insights from children and mice.
Gastroenterology 135: 1860-1862 (2008).
*
-
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K, Khullar M. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
DNA Cell Biol. 28: 141-150 (2009).
-
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, Bhansali A, Khullar M. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians.
Mol. Cell. Biochem. 314: 9-17 (2008).
*
-
Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ. Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetes.
Am. J. Ther. 14: 49-62 (2007).
-
Ahmed I, Nasreen S, Bhatti R. Alopecia areata in children.
J. Coll. Physicians Surg. Pak. 17: 587-590 (2007).
-
Ahmed RA, Murao K, Imachi H, Yu X, Li J, Wong NC, Ishida T. Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes.
Endocrine 35: 233-242 (2009).
-
Ahmed S, Ihara K, Bassuny WM, Kuromaru R, Kohno H, Miyako K, Matsuura N, Iwata I, Nagafuchi S, Hara T. Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population.
Genes Immun. 3: 96-101 (2002).
*
-
Ahmed W, Ziouzenkova O, Brown J, Devchand P, Francis S, Kadakia M, Kanda T, Orasanu G, Sharlach M, Zandbergen F, Plutzky J. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
J. Intern. Med. 262: 184-198 (2007).
*
-
Ahn JH, Shin MS, Jung SH, Kang SK, Kim KR, Rhee SD, Jung WH, Yang SD, Kim SJ, Woo JR, Lee JH, Cheon HG, Kim SS. Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonists.
J. Med. Chem. 49: 4781-4784 (2006).
*
-
Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals.
Ann. N. Y. Acad. Sci. 1056: 218-233 (2005).
*
-
Ahrens ET, Morel PA. In vivo imaging of autoimmune disease in model systems.
Curr. Top. Dev. Biol. 70C: 215-238 (2005).
-
Ahuja HS, Szanto A, Nagy L, Davies PJ. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
J. Biol. Regul. Homeost. Agents 17: 29-45 (2003).
-
Airaghi L, Tedeschi A. Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level.
Acta Diabetol. 43: 43-45 (2006).
*
-
Aithal GP. Dangerous liaisons: drug, host and the environment.
J. Hepatol. 46: 995-998 (2007).
*
-
Aittoniemi J, Fotinou C, Craig TJ, de Wet H, Proks P, Ashcroft FM. Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 364: 257-267 (2009).
*
-
Aittoniemi J, Turpeinen H, Tiittanen M, Knip M, Simell O, Ilonen J, Vaarala O. Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children.
Hum. Immunol. 69: 108-111 (2008).
-
Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, Sidobre S, Kronenberg M, Hogaboam CM, Swain MG. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.
J. Immunol. 174: 8027-8037 (2005).
*
-
Ajuebor MN, Carey JA, Swain MG. CCR5 in T cell-mediated liver diseases: what's going on?
J. Immunol. 177: 2039-2045 (2006).
*
-
Aker S, Bantis C, Reis P, Kuhr N, Schwandt C, Grabensee B, Heering P, Ivens K. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
Nephrol. Dial. Transplant. Apr 6 [Epub ahead of print] (2009).
-
Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes.
Am. J. Med. Genet. 115: 18-29 (2002).
-
Akesson K, Carlsson A, Ivarsson SA, Johansson C, Weidby BM, Ludvigsson J, Gustavsson B, Lernmark A, Kockum I. The non-inherited maternal HLA haplotype affects the risk for type 1 diabetes.
Int. J. Immunogenet. 36: 1-8 (2009).
*
-
Akesson L, Gelling RW, Jensen R, Ogimoto K, Fuller JM, Pefley R, Manavi S, Lernmark A, Schwartz MW. Increased lipid oxidation heralds diabetes onset in DR.lyp/lyp rats.
Exp. Clin. Endocrinol. Diabetes 116: 475-480 (2008).
-
Akimoto T, Kobayashi S, Tamura N, Ohsawa T, Kawano T, Tanaka M, Hashimoto H. Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus.
Angiology 56: 601-609 (2005).
-
Akinci A, Cetinkaya E, Aycan Z. Dry eye syndrome in diabetic children.
Eur. J. Ophthalmol. 17: 873-878 (2007).
-
Akinci B, Comlekci A, Tankurt E. Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.
Exp. Clin. Endocrinol. Diabetes 117: 142-145 (2009).
-
Akinmoladun VI, Akadiri OA, Adeleye JO, Lasisi OA. An unusual case of total maxillary sequestration in a diabetic patient.
Afr. J. Med. Med. Sci. 37: 395-398 (2008).
-
Akirav E, Kushner JA, Herold KC. Beta-cell mass and type 1 diabetes: going, going, gone?
Diabetes 57: 2883-2888 (2008).
-
Aksoy DY, Agbaht K, Harmanci O, Karadag O, Aytemir K, Sungur A, Onat AM, Apras S, Yildiz BO, Bayraktar M. Autoimmune polyendocrine syndrome with atrial septal defect.
Am. J. Med. Sci. 335: 157-159 (2008).
-
Al-Attas OS, Al-Daghri NM, Al-Rubeaan KA, da Silva NF, Sabico SL, Kumar S, McTernan PG, Harte AL. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies.
Cardiovasc. Diabetol. 8: 20 (2009).
-
Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Sallam R. Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria.
Diabetes Metab. Res. Rev. 24: 52-58 (2008).
*
-
Al-Harbi EM, Abbassi AJ, Tamim H, al-Jenaidi F, Kooheji M, Kamal M, al-Mahroos S, al-Nasir F, Motala AA, Almawi WY. Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients.
Clin. Diagn. Lab. Immunol. 11: 292-296 (2004).
*
-
Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, Arekat MR, Irani-Hakime N, Najm P, Al-Ola K, Motala AA, Almawi WY. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.
J. Clin. Endocrinol. Metab. 90: 5104-5109 (2005).
*
-
Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, Bull SB, Boright AP, Paterson AD. Multiple variants in vascular endothelial growth factor (VEGF) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study.
Diabetes 56: 2161-2168 (2007).
*
-
Al-Mujaini A, Ganesh A, Al-Zuhaibi S, Al-Dhuhli H, Al-Mashani A, Al-Kindi H, Al-Memari A, Al-Futaisi A, Al-Asmi A. Lymphocytic infundibulo-neurohypophysitis: an unusual cause of recurrent optic neuropathy in a child.
J. AAPOS 13: 207-209 (2009).
-
Alam MA, Husain SA, Narang R, Chauhan SS, Kabra M, Vasisht S. Association of polymorphism in the thermolabile 5,10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease.
Mol. Cell. Biochem. 310: 111-117 (2008).
-
Alanentalo T, Loren CE, Larefalk A, Sharpe J, Holmberg D, Ahlgren U. High-resolution three-dimensional imaging of islet-infiltrate interactions based on optical projection tomography assessments of the intact adult mouse pancreas.
J. Biomed. Opt. 13: 054070 (2008).
-
Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Diabetes 55: 2098-2105 (2006).
*
-
Alaynick WA. Nuclear receptors, mitochondria and lipid metabolism.
Mitochondrion 8: 329-337 (2008).
-
Alba A, Planas R, Clemente X, Carrillo J, Ampudia R, Puertas MC, Pastor X, Tolosa E, Pujol-Borrell R, Verdaguer J, Vives-Pi M. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.
Clin. Exp. Immunol. 151: 467-475 (2008).
*
-
Alba LM, Lindor K. Review article: non-alcoholic fatty liver disease.
Aliment. Pharmacol. Ther. 17: 977-986 (2003).
*
-
Albahrani AI, Usher J, Marks E, Ranganath L, Shenkin A. Atypical presentation of a middle age male with severe hypertriglyceridaemia: a case report.
J. Med. Case Reports 1: 51 (2007).
*
-
Albala BC, Jimenez RB, Perez B F, Liberman GC. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance.
Rev. Med. Chil. 134: 372-379 (2006).
-
Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Perez-Bravo F. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders.
Diabetes Res. Clin. Pract. 77: 245-250 (2007).
-
Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.
Gut 54: 987-993 (2005).
*
-
Albers HM, Kurreeman FA, Stoeken-Rijsbergen G, Brinkman DM, Kamphuis SS, van Rossum MA, Girschick HJ, Wouters C, Saurenmann RK, Hoppenreijs E, Slagboom P, Houwing-Duistermaat JJ, Verduijn W, Huizinga TW, Ten Cate R, Toes RE, Schilham MW. Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis.
Arthritis Rheum. 60: 901-904 (2009).
*
-
Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups.
Am. Heart J. 157: 777-783.e1 (2009).
-
Alberti-Flor JJ, Jeffers L, Schiff ER. Primary sclerosing cholangitis occurring in a patient with systemic lupus erythematosus and diabetes mellitus.
Am. J. Gastroenterol. 79: 889-891 (1984).
-
Alemany-Rodriguez MJ, Aladro Y, Amela-Peris R, Perez-Vieitez MC, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F. Autoimmune diseases and multiple sclerosis.
Rev. Neurol. 40: 594-597 (2005).
-
Alenghat T, Meyers K, Mullican SE, Leitner K, Adeniji-Adele A, Avila J, Bucan M, Ahima RS, Kaestner KH, Lazar MA. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology.
Nature 456: 997-1000 (2008).
*
-
Alenghat T, Yu J, Lazar MA. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor.
EMBO J. 25: 3966-3974 (2006).
*
-
Aleshin S, Grabeklis S, Hanck T, Sergeeva M, Reiser G. PPARgamma positively and PPARalpha negatively control COX-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Mol. Pharmacol. May 29 [Epub ahead of print] (2009).
*
-
Alexander E, Pinto J, Pal GS, Kamath N, Kuruvilla M. Disease concomitance in psoriasis: a clinical study of 61 cases.
Indian J. Dermatol. Venereol. Leprol. 67: 66-68 (2001).
-
Alexander JW, Goodman HR, Succop P, Light JA, Kuo PC, Moser AB, James JH, Woodle ES. Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant.
Exp. Clin. Transplant. 6: 118-126 (2008).
-
Alexandru N, Jardín I, Popov D, Simionescu M, García-Estan J, Salido GM, Rosado JA. Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.
J. Cell. Mol. Med. 12: 2015-2026 (2008).
-
Ali BR. Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells?
Med. Hypotheses 72: 55-57 (2009).
-
Alibek K, Grechanyi L, Klimenko T, Pashkova A. Fifth revolution in medicine: on the role of infections in pathogenesis of aging and chronic diseases.
Lik. Sprava. 1-2: 3-30 (2008).
-
Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy.
Semin. Cell Dev. Biol. 18: 819-826 (2007).
*
-
Alizadeh BZ, Valdigem G, Coenen MJ, Zhernakova A, Franke B, Monsuur A, van Riel PL, Barrera P, Radstake TR, Roep BO, Wijmenga C, Koeleman BP. Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis.
Hum. Mol. Genet. 16: 2552-2559 (2007).
*
-
Allcock RJ, Christiansen FT, Price P. The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15.
Immunogenetics 49: 660-665 (1999).
*
-
Allcock RJ, Windsor L, Gut IG, Kucharzak R, Sobre L, Lechner D, Garnier JG, Baltic S, Christiansen FT, Price P. High-density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging.
Hum. Mutat. 24: 517-525 (2004).
-
Allen DB, MacDonald MJ, Gottschall JL, Hunter JB. Autoimmune thyroid phenomena are not evidence for human lymphocyte antigen-genetic heterogeneity in insulin-dependent diabetes.
Am. J. Med. Genet. 33: 405-408 (1989).
-
Allen S, Huber J, Devendra D. Prevalence of organ-specific autoantibodies in childhood- and adult-onset type 1 diabetes.
Ann. N. Y. Acad. Sci. 1150: 260-262 (2008).
*
-
Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
Diabetes 55: 2523-2533 (2006).
*
-
Allgayer H, Kruis W. PPAR-ligands: a clinically important regulatory system with multiple options in the treatment of diabetes mellitus, inflammatory bowel disease and in the chemoprevention of colon cancer?
Z. Gastroenterol. 41: 1035-1038 (2003).
-
Allotey RA, Mohan V, McDermott MF, Deepa R, Premalatha G, Hassan Z, Cassell PG, North BV, Vaxillaire M, Mein CA, Swan DC, O'Grady E, Ramachandran A, Snehalatha C, Sinnot PJ, Hemmatpour SK, Froguel P, Hitman GA. The EIF2AK3 gene region and type I diabetes in subjects from South India.
Genes Immun. 5: 648-652 (2004).
*
-
Alnajjar A, Chabane Sari D, Abuharfeil N, Hudaib M, Aburjai T. Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people.
Prostaglandins Leukot. Essent. Fatty Acids 74: 347-356 (2006).
*
-
Alnounou M, Munoz SJ. Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf]
Practical Gastroenterology April 2006: 92-100 (2006). *
-
Alonso N, Granada ML, Salinas I, Reverter JL, Flores L, Ojanguren I, Martinez-Caceres EM, Sanmarti A. Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis.
Eur. J. Endocrinol. 157: 763-769 (2007).
*
-
Alonso N, Soldevila B, Sanmarti A, Pujol-Borrell R, Martinez-Caceres E. Regulatory T cells in diabetes and gastritis.
Autoimmun. Rev. 8: 659-662 (2009).
-
Alper CA, Husain Z, Larsen CE, Dubey DP, Stein R, Day C, Baker A, Beyan H, Hawa M, Ola TO, Leslie RD. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes.
J. Autoimmun. 27: 89-95 (2006).
*
-
Alsaadi G, Quirynen M, Komarek A, van Steenberghe D. Impact of local and systemic factors on the incidence of late oral implant loss.
Clin. Oral Implants Res. 19: 670-676 (2008).
-
Alsaadi G, Quirynen M, Komarek A, van Steenberghe D. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection.
J. Clin. Periodontol. 34: 610-617 (2007).
-
Alsaadi G, Quirynen M, Michiles K, Teughels W, Komarek A, van Steenberghe D. Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants.
J. Clin. Periodontol. 35: 51-57 (2008).
-
Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, Al-Saud NA, Aldaghri N, Mohammad S, Meyer BF. Genetic Study of Saudi Diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes.
Diabetes Metab. Res. Rev. 24: 137-140 (2008).
-
Altintas E, Senli MS, Sezgin O. Prevalence of celiac disease among dyspeptic patients: a community-based case-control study.
Turk. J. Gastroenterol. 19: 81-84 (2008).
*
-
Altobelli E, Maccarone M, Petrocelli R, Marziliano C, Giannetti A, Peris K, Chimenti S. Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population.
BMC Public Health 7: 59 (2007).
*
-
Altobelli E, Petrocelli R, Maccarone M, Altomare G, Argenziano G, Giannetti A, Peserico A, Vena GA, Tiberti S, Chimenti S, Peris K. Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption.
Eur. J. Dermatol. 19: 252-256 (2009).
-
Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H. RAR and RXR modulation in cancer and metabolic disease.
Nat. Rev. Drug Discov. 6: 793-810 (2007).
*
-
Alvaro A, Rosales R, Masana L, Vallve JC. Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids.
J. Nutr. Biochem. May 13 [Epub ahead of print] (2009).
*
-
Alver A, Mentese A, Karahan SC, Erem C, Keha EE, Arikan MK, Eminagaoglu MS, Deger O. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease.
Exp. Clin. Endocrinol. Diabetes 115: 287-291 (2007).
-
Alves Cde A, Aguiar RA, Alves AC, Santana MA. Diabetes mellitus in patients with cystic fibrosis.
J. Bras. Pneumol. 33: 213-221 (2007).
*
-
Aly T, Devendra D, Eisenbarth GS. Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.
Am. J. Ther. 12: 481-490 (2005).
-
Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE, Kretowski A, Erlich HA, Fain PR, Rewers MJ, Eisenbarth GS. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex.
Diabetes 57: 770-776 (2008).
*
-
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype.
Diabetes 55: 1265-1269 (2006).
*
-
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
J. Autoimmun. 25: S40-S45 (2005).
-
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS. Extreme genetic risk for type 1A diabetes.
Proc. Natl. Acad. Sci. U.S.A. 103: 14074-14079 (2006).
*
-
Amadori A, Antonelli A, Balteri I, Schreiber A, Bugiani M, De Rose V. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
Respir. Med. 103: 407-413 (2009).
-
Amarapurka DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.
Ann. Hepatol. 5: 30-33 (2006).
*
-
Amarapurkar A, Ghansar T. Fatty liver: experience from western India.
Ann. Hepatol. 6: 37-40 (2007).
*
-
Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, Baijal R, Lala S, Chaudhary D, Deshpande A. Prevalence of non-alcoholic fatty liver disease: population based study.
Ann. Hepatol. 6: 161-163 (2007).
*
-
Amarapurkar DN, Patel ND. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
Trop. Gastroenterol. 25: 130-134 (2004).
-
Amarapurkar DN, Patel ND, Kamani PM. Impact of diabetes mellitus on outcome of HCC.
Ann. Hepatol. 7: 148-151 (2008).
*
-
Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
Diabetes Res. Clin. Pract. 67: 175-179 (2005).
-
Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
Clin. Exp. Dermatol. 31: 746-749 (2006).
*
-
Aminkeng F, Van Autreve JE, Koeleman BP, Quartier E, Van Schravendijk C, Gorus FK, Van der Auwera BJ; Belgian Diabetes Registry. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.
Hum. Immunol. 68: 690-697 (2007).
-
Amirshahrokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Toxicol. Appl. Pharmacol. 232: 119-124 (2008).
*
-
Ammann R. Diagnosis and management of chronic pancreatitis: current knowledge.
Swiss Med. Wkly. 136: 166-174 (2006).
*
-
Amrouche Ch, Jamoussi Kamoun H, Trabelsi N, Blouza Chabchoub S. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
Tunis. Med. 86: 316-318 (2008).
-
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises.
Mol. Pharm. 4: 807-818 (2007).
*
-
Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus.
J. Autoimmun. 26: 208-214 (2006).
-
Anaya JM, Gomez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases?
Clin. Dev. Immunol. 13: 185-195 (2006).
*
-
Andersen G, Burgdorf KS, Sparso T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. AHSG tagSNPs associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 Danish whites.
Diabetes 57: 1427-1432 (2008).
*
-
Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes.
Diabetologia 49: 75-82 (2006).
*
-
Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER. Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications.
Diabetes Care 29: 2660-2663 (2006).
*
-
Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, Moller NP. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage.
FASEB J. 18: 8-30 (2004).
*
-
Andersen K, Pedersen BK. The role of inflammation in vascular insulin resistance with focus on IL-6.
Horm. Metab. Res. 40: 635-639 (2008).
-
Anderson AC, Chandwaskar R, Lee DH, Kuchroo VK. Cutting edge: the Idd3 genetic interval determines regulatory T cell function through CD11b+CD11c- APC.
J. Immunol. 181: 7449-7452 (2008).
-
Anderson CC. Placing regulatory T cells into global theories of immunity: an analysis of Cohn's challenge to integrity (Dembic).
Scand. J. Immunol. 69: 306-309 (2009).
*
-
Anderson DE. TIM-3 as a therapeutic target in human inflammatory diseases.
Expert Opin. Ther. Targets 11: 1005-1009 (2007).
-
Anderson L, Joseph F, Goenka N, Patel V. Isolated thyroxine malabsorption treated with intramuscular thyroxine injections.
Am. J. Med. Sci. 337: 150-152 (2009).
-
Anderson MS. Update in endocrine autoimmunity.
J. Clin. Endocrinol. Metab. 93: 3663-3670 (2008).
-
Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation.
Annu. Rev. Immunol. 23: 447-485 (2005).
*
-
Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance.
Immunity 23: 227-239 (2005).
*
-
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow within the thymus by the aire protein.
Science 298: 1395-1401 (2002).
*
-
Anderson RP. Coeliac disease: current approach and future prospects.
Intern. Med. J. 38: 790-799 (2008).
*
-
Anderson RP. Coeliac disease.
Aust. Fam. Physician 34: 239-242 (2005).
*
-
Andersson G, Svensson AC, Setterblad N, Rask L. Retroelements in the human MHC class II region.
Trends Genet. 14: 109-114 (1998).
*
-
Andreeva-Gateva P. Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism.
Ann. Biol. Clin. (Paris) 61: 295-303 (2003).
-
Andren-Sandberg A, Hardt PD. Second Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases. Castle of Rauischholzhausen of the Justus-Liebig-University, Giessen (Rauischholzhausen), Germany. March 7-8, 2008.
JOP 9: 541-575 (2008).
*
-
Andres E, Dali-Youcef N, Vogel T, Serraj K, Zimmer J. Oral cobalamin (vitamin B) treatment. An update.
Int. J. Lab. Hematol. 31: 1-8 (2009).
-
Andrulionyte L, Kuulasmaa T, Chiasson JL, Laakso M. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Diabetes 56: 1181-1186 (2007).
*
-
Andrulionyte L, Peltola P, Chiasson JL, Laakso M. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Diabetes 55: 2148-2152 (2006).
*
-
Andrulionyte L, Zacharova J, Chiasson JL, Laakso M; for the STOP-NIDDM Study Group. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
Diabetologia 47: 2176-2184 (2004).
*
-
Ang DK, Brodnicki TC, Jordan MA, Wilson WE, Silveira P, Gliddon BL, Baxter AG, van Driel IR. Two genetic loci independently confer susceptibility to autoimmune gastritis.
Int. Immunol. 19: 1135-1144 (2007).
*
-
Ange-van Heugten KD, Burns R, Verstegen MW, Jansen WL, Ferket PR, van Heugten E. Evaluation of diabetes determinants in woolly monkeys (Lagothrix lagotricha).
J. Anim. Physiol. Anim. Nutr. (Berl.) 91: 481-491 (2007).
*
-
Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study.
Eur. J. Epidemiol. 19: 1085-1087 (2004).
*
-
Anghel SI, Wahli W. Fat poetry: a kingdom for PPARgamma.
Cell Res. 17: 486-511 (2007).
*
-
Angulo P. Use of ursodeoxycholic acid in patients with liver disease.
Curr. Gastroenterol. Rep. 4: 37-44 (2002).
-
Angulo P. Current best treatment for non-alcoholic fatty liver disease.
Expert Opin. Pharmacother. 4: 611-623 (2003).
-
Angulo P. Non-alcoholic steatohepatitis.
Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 87-88. October 17 - 19 (2003). *
-
Angulo P. Treatment of nonalcoholic fatty liver disease.
Ann. Hepatol. 1: 12-19 (2002).
*
-
Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
J. Hepatol. 41: 943-949 (2004).
*
-
Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Hepatology 30: 1356-1362 (1999).
*
-
Angulo P, Lindor KD. Primary biliary cirrhosis and primary sclerosing cholangitis.
Clin. Liver Dis. 3: 529-570 (1999).
*
-
Angulo P, Lindor KD. Non-alcoholic fatty liver disease.
J. Gastroenterol. Hepatol. 17 Suppl.: 186S-190S (2002).
*
-
Angulo P, Lindor KD. Treatment of non-alcoholic steatohepatitis.
Best Pract. Res. Clin. Gastroenterol. 16: 797-810 (2002).
*
-
Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: present and emerging therapies.
Semin. Liver Dis. 21: 81-88 (2001).
-
Anheim M, Degos B, Echaniz-Laguna A, Fleury M, Grucker M, Tranchant C. Ataxia associated with gluten sensitivity, myth or reality?
Rev. Neurol. (Paris) 162: 214-221 (2006).
-
Anjos S, Polychronakos C. Mechanisms of genetic susceptibility to type I diabetes: beyond HLA.
Mol. Genet. Metab. 81: 187-195 (2004).
*
-
Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block.
J. Clin. Endocrinol. Metab. 89: 6257-6265 (2004).
*
-
Ansari MJ, Sayegh MH. Costimulation couture: a designer approach to regulating autoimmunity.
J. Clin. Invest. 116: 2080-2083 (2006).
*
-
Ansquer JC, Foucher C, Aubonnet P, Le Malicot K. Fibrates and microvascular complications in diabetes - insight from the FIELD study.
Curr. Pharm. Des. 15: 537-552 (2009).
-
Antal Z, Jarchum I, DiLorenzo TP. HLA class I supertypes in type 1 diabetic children in an urban children's hospital.
Ann. N. Y. Acad. Sci. 1150: 86-89 (2008).
*
-
Antinozzi PA, Garcia-Diaz A, Hu C, Rothman JE. Functional mapping of disease susceptibility loci using cell biology.
Proc. Natl. Acad. Sci. U.S.A. 103: 3698-3703 (2006).
*
-
Antoine HJ, Pall M, Trader BC, Chen YD, Azziz R, Goodarzi MO. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
Fertil. Steril. 87: 862-869 (2007).
*
-
Antolic B, Gersak K, Verdenik I, Novak-Antolic Z. Adverse effects of thyroid dysfunction on pregnancy and pregnancy outcome: epidemiologic study in Slovenia.
J. Matern. Fetal Neonatal Med. 19: 651-654 (2006).
-
Antonelli A, Fallahi P, Ferrari SM, Pupilli C, d'Annunzio G, Lorini R, Vanelli M, Ferrannini E. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study.
Diabet. Med. 25: 1349-1353 (2008).
*
-
Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.
Autoimmun. Rev. 8: 18-23 (2008).
-
Anuradha S, Radha V, Deepa R, Hansen T, Carstensen B, Pedersen O, Mohan V. A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians.
Diabetes Care 28: 2430-2435 (2005).
*
-
Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA, Gershwin ME. NOD mice and autoimmunity.
Autoimmun. Rev. 4: 373-379 (2005).
-
Aoki K, Taniyama M, Nagayama C, Oikawa Y, Shimada A. T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase.
Ann. N. Y. Acad. Sci. 1079: 181-185 (2006).
*
-
Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.
Nature 458: 1180-1184 (2009).
*
-
Appel SJ, Wadas TM, Rosenthal RS, Ovalle F. Latent autoimmune diabetes of adulthood (LADA): an often misdiagnosed type of diabetes mellitus.
J. Am. Acad. Nurse Pract. 21: 156-159 (2009).
-
Aprahamian T, Bonegio RG, Richez C, Yasuda K, Chiang LK, Sato K, Walsh K, Rifkin IR. The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin.
J. Immunol. 182: 340-346 (2009).
-
Arafat HA, Lada E, Katakam AK, Amin N. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Exp. Clin. Endocrinol. Diabetes 114: 555-562 (2006).
-
Arakawa Y, Kobayashi H, Ozaki T, Ariga H, Matsuo Y, Honda T, Arai T, Kurosu Y, Morita K, Konuma H, et al. Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation.
Gan. To. Kagaku. Ryoho. 11: 917-925 (1984).
-
Araki E, Igata M, Motoshima H, Tsuruzoe K. Polymorphisms of PPARs and metabolic disorders.
Nippon Rinsho 63: 617-622 (2005).
-
Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Hirakawa M, Ikeda K, Kumada H. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.
Hepatology 49: 739-744 (2009).
-
Arason GJ. The association of complement with common connective tissue diseases - a review.
Laeknabladid. 94: 371-374 (2008).
-
Arason GJ, Kolka R, Hreidarsson AB, Gudjonsson H, Schneider PM, Fry L, Arnason A. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
Clin. Exp. Immunol. 140: 572-579 (2005).
*
-
Araujo EP, De Souza CT, Ueno M, Cintra DE, Bertolo MB, Carvalheira JB, Saad MJ, Velloso LA. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes.
Endocrinology 148: 5991-5997 (2007).
*
-
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S. Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes.
Pediatr. Diabetes 9: 272-276 (2008).
-
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S. Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents.
Hum. Immunol. 68: 739-743 (2007).
-
Araujo J, da Silva GA, de Melo FM. Serum prevalence of celiac disease in children and adolescents with type 1 diabetes mellitus.
J. Pediatr. (Rio J.) 82: 210-214 (2006).
*
-
Araujo J, Segat L, Guimaraes RL, Brandao LA, Souza PE, Santos S, Soares TS, Falcao EA, Rodrigues F, Carvalho R Jr, de Lima-Filho JL, Arraes LC, Crovella S. Mannose binding lectin gene polymorphisms and associated auto-immune diseases in type 1 diabetes Brazilian patients.
Clin. Immunol. 131: 254-259 (2009).
*
-
Araujo J, Silva GA, Melo FM. Prevalence of celiac disease in children and adolescents with type 1 diabetes - authors' reply.
J. Pediatr. (Rio J.) 82: 401 (2006).
-
Ardesjo B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kampe O, Ekwall O. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
J. Autoimmun. 30: 273-282 (2008).
-
Arefanian H, Tredget EB, Rajotte RV, Korbutt GS, Gill RG, Rayat GR. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
Cell. Transplant. 16: 787-798 (2007).
-
Arfa I, Abid A, Nouira S, Elloumi-Zghal H, Malouche D, Mannai I, Zorgati MM, Ben Alaya N, Rebai A, Zouari B, Ben Ammar S, Ben Rayana MC, Hmida S, Blousa-Chabchoub S, Abdelhak S. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.
J. Renin Angiotensin Aldosterone Syst. 9: 32-36 (2008).
-
Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.
J. Hepatol. May 3 [Epub ahead of print] (2009).
-
Aribi M. Candidate genes implicated in type 1 diabetes susceptibility.
Curr. Diabetes Rev. 4: 110-121 (2008).
-
Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, De Juli E, Danesino C. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.
Eur. J. Cancer 39: 2341-2348 (2003).
*
-
Aridor M. Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases.
Adv. Drug Deliv. Rev. 59: 759-781 (2007).
-
Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.
J. Clin. Invest. 113: 451-463 (2004).
*
-
Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. IKK-beta links inflammation to obesity-induced insulin resistance.
Nat. Med. 11: 191-198 (2005).
*
-
Arkkila PE. Thromboangiitis obliterans (Buerger's disease).
Orphanet J. Rare Dis. 1: 14 (2006).
*
-
Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases.
Blood 99: 2694-2702 (2002).
*
-
Armagan O, Ekim A, Dinc A, Oner C. Ankylosing spondylitis in a patient with Turner syndrome: a case report.
Rheumatol. Int. 27: 1177-1180 (2007).
*
-
Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL. Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome.
Eur. J. Immunogenet. 23: 211-219 (1996).
-
Arnlov J, Zethelius B, Riserus U, Basu S, Berne C, Vessby B, Alfthan G, Helmersson J. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study.
Diabetologia 52: 97-105 (2009).
*
-
Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations.
Ann. Rheum. Dis. 66: 1137-1142 (2007).
*
-
Arredondo M, Jorquera D, Carrasco E, Albala C, Hertrampf E. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with iron status in persons with type 2 diabetes mellitus.
Am. J. Clin. Nutr. 86: 1347-1353 (2007).
*
-
Arroyo A, Perez-Vicente F, Serrano P, Candela F, Sanchez A, Teresa Perez-Vazquez M, Calpena R. Treatment of chronic anal fissure.
Cir. Esp. 78: 68-74 (2005).
-
Arrue I, Saiz A, Ortiz-Romero PL, Rodriguez-Peralto JL. Lupus-like reaction to interferon at the injection site: report of five cases.
J. Cutan. Pathol. 34 Suppl. 1: 18-21 (2007).
-
Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M, Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P, Powell B, et al. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.
Proc. Natl. Acad. Sci. U.S.A. 106: 262-267 (2009).
*
-
Artwohl M, Lindenmair A, Sexl V, Maier C, Rainer G, Freudenthaler A, Huttary N, Wolzt M, Nowotny P, Luger A, Baumgartner-Parzer SM. Different mechanisms of saturated versus polyunsaturated free fatty acid-induced apoptosis in human endothelial cells.
J. Lipid Res. 49: 2627-2640 (2008).
*
-
Artz E, Warren-Ulanch J, Becker D, Greenspan S, Freemark M. Seropositivity to celiac antigens in asymptomatic children with type 1 diabetes mellitus: association with weight, height, and bone mineralization.
Pediatr. Diabetes 9: 277-284 (2008).
-
Asaki T, Aoki T, Hamamoto T, Sugiyama Y, Ohmachi S, Kuwabara K, Murakami K, Todo M. Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
Bioorg. Med. Chem. 16: 981-994 (2008).
*
-
Asano K, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Hiromine Y, Ogihara T. The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese.
Ann. N. Y. Acad. Sci. 1079: 47-50 (2006).
*
-
Asano K, Ikegami H, Fujisawa T, Nishino M, Nojima K, Kawabata Y, Noso S, Hiromine Y, Fukai A, Ogihara T. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.
Hum. Immunol. 68: 384-391 (2007).
-
Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients.
Am. J. Gastroenterol. 103: 2308-2313 (2008).
*
-
Asleh R, Blum S, Kalet-Litman S, Alsheik J, Miller-Lotan R, Asaf R, Rock W, Aviram M, Milman U, Shapira C, Abassi Z, Levy AP. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Diabetes 57: 2794-2800 (2008).
-
Asleh R, Miller-Lotan R, Aviram M, Hayek T, Yulish M, Levy JE, Miller B, Blum S, Milman U, Shapira C, Levy AP. Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.
Circ. Res. 99: 1419-1425 (2006).
*
-
Asnani S, Theuma P, Fonseca VA. PPARgamma agonists and vascular risk factors: potential effects on cardiovascular disease.
Metab. Syndr. Relat. Disord. 1: 23-32 (2003).
-
Aso Y, Matsuura H, Momobayashi A, Inukai Y, Sugawara N, Nakano T, Yamamoto R, Wakabayashi S, Takebayashi K, Inukai T. Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease.
Endocr. J. 53: 377-385 (2006).
*
-
Assisi A, Banzi R, Buonocore C, Capasso F, Muzio VD, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.
Int. Clin. Psychopharmacol. 21: 319-336 (2006).
-
Astapova I, Lee LJ, Morales C, Tauber S, Bilban M, Hollenberg AN. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.
Proc. Natl. Acad. Sci. U.S.A. 105: 19544-19549 (2008).
*
-
Atar D, Dyrberg T, Michelsen B, Karlsen A, Kofod H, Mølvig J, Lernmark A. Site-specific antibodies distinguish single amino acid substitutions in position 57 in HLA-DQ beta-chain alleles associated with insulin-dependent diabetes.
J. Immunol. 143: 533-538 (1989).
-
Atassi MZ, Casali P. Molecular mechanisms of autoimmunity.
Autoimmunity 41: 123-132 (2008).
-
Atherton HJ, Bailey NJ, Zhang W, Taylor J, Major H, Shockcor J, Clarke K, Griffin JL. A combined 1H NMR spectroscopy and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome.
Physiol. Genomics 27: 178-186 (2006).
*
-
Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP. Do we need to consider inflammatory markers when we treat atherosclerotic disease?
Atherosclerosis 200: 1-12 (2008).
-
Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP. Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?
Expert Opin. Investig. Drugs 17: 969-972 (2008).
-
Attali P, Ink O, Pelletier G, Vernier C, Jean F, Moulton L, Etienne JP. Dupuytren's contracture, alcohol consumption, and chronic liver disease.
Arch. Intern. Med. 147: 1065-1067 (1987).
-
Attie AD, Flowers MT, Flowers JB, Groen AK, Kuipers F, Ntambi JM. Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
Novartis Found. Symp. 286: 47-53 (2007).
-
Augarten A, Berman H, Aviram M, Diver-Habber A, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Katznelson D, Szeinberg A, Kerem BS, Theodor L, Paret G, Yahav Y. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
Clin. Exp. Med. 3: 119-123 (2003).
*
-
Augarten A, Kerem BS, Yahav Y, Noiman S, Rivlin Y, Tal A, Blau H, Ben-Tur L, Szeinberg A, Kerem E, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation.
Lancet 342: 25-26 (1993).
-
Augarten A, Tov AB, Madgar I, Barak A, Akons H, Laufer J, Efrati O, Aviram M, Bentur L, Blau H, Paret G, Wilschanski M, Kerem BS, Yahav Y. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Eur. J. Gastroenterol. Hepatol. 20: 164-168 (2008).
-
Augstein P, Heinke P, Salzsieder E, Grimm R, Giebel J, Salzsieder C, Harrison LC. Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (Deltapsim) in the pancreatic beta-cell line NIT-1.
Diab. Vasc. Dis. Res. 5: 198-204 (2008).
-
Aune TM, Maas K, Moore JH, Olsen NJ. Gene expression profiles in human autoimmune disease.
Curr. Pharm. Des. 9: 1905-1917 (2003).
-
Aune TM, Maas K, Parker J, Moore JH, Olsen NJ. Profiles of gene expression in human autoimmune disease.
Cell. Biochem. Biophys. 40: 81-96 (2004).
-
Avagliano L, Grillo C, Prioli MA. Congenital heart disease: a retrospective study of their frequency.
Minerva Ginecol. 57: 171-178 (2005).
-
Awadallah S, Hamad M. A study of haptoglobin phenotypes in patients with chronic renal failure.
Ann. Clin. Biochem. 40: 680-683 (2003).
-
Awadallah S, Hamad M. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent.
Cytobios. 101: 145-150 (2000).
-
Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H. Association of haptoglobin phenotypes with markers of diabetic nephropathy in type 2 diabetes mellitus.
J. Diabetes Complications 22: 384-388 (2008).
-
Awais M, Sato M, Umezawa Y. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.
Biosens. Bioelectron. 22: 2564-2569 (2007).
*
-
Awara WM, El-Sisi AE, El-Refaei M, El-Naa MM, El-Desoky K. Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.
Rev. Diabet. Stud. 2: 146-156 (2005).
*
-
Awasthi A, Murugaiyan G, Kuchroo VK. Interplay between effector Th17 and regulatory T cells.
J. Clin. Immunol. 28: 660-670 (2008).
*
-
Awata T, Kanazawa Y. Genetic markers for insulin-dependent diabetes mellitus in Japanese.
Diabetes Res. Clin. Pract. 24: S83-S87 (1994).
-
Awata T, Kawasaki E, Tanaka S, Ikegami H, Maruyama T, Shimada A, Nakanishi K, Kobayashi T, Iizuka H, Uga M, Kawabata Y, Kanazawa Y, Kurihara S, Osaki M, Katayama S; on behalf of the Japanese Study Group on Type 1 Diabetes Genetics. Association of type 1 diabetes with two loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese.
J. Clin. Endocrinol. Metab. 94: 231-235 (2009).
-
Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, Negishi K, Izumida T, Yoshida Y, Hagura R, Kuzuya N, Kanazawa Y, Katayama S. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.
Diabetes 47: 128-129 (1998).
-
Aycan Z, Berberoglu M, Adiyaman P, Ergur AT, Ensari A, Evliyaoglu O, Siklar Z, Ocal G. Latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and celiac disease.
J. Pediatr. Endocrinol. Metab. 17: 1565-1569 (2004).
-
Aydin E, Demir HD, Ozyurt H, Etikan I. Association of plasma homocysteine and macular edema in type 2 diabetes mellitus.
Eur. J. Ophthalmol. 18: 226-232 (2008).
-
Ayela C, Roquet F, Valera L, Granier C, Nicu L, Pugniere M. Antibody-antigenic peptide interactions monitored by SPR and QCM-D A model for SPR detection of IA-2 autoantibodies in human serum.
Biosens. Bioelectron. 22: 3113-3119 (2007).
-
Aygun C, Uraz S, Damci T, Osar Z, Yumuk V, Akdenizli E, Ilkova H. Celiac disease in an adult Turkish population with type 1 diabetes mellitus.
Dig. Dis. Sci. 50: 1462-1466 (2005).
*
-
Ayse Selimoglu M, Ertekin V, Gursan N, Orbak Z, Esrefoglu M. Brunner's gland hyperplasia in a child with diabetes mellitus and coeliac disease.
Acta Paediatr. 95: 508-510 (2006).
*
-
Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology.
Curr. Opin. Rheumatol. 20: 416-422 (2008).
*
-
Azukizawa S, Kasai M, Takahashi K, Miike T, Kunishiro K, Kanda M, Mukai C, Shirahase H. Synthesis and biological evaluation of (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: a novel series of PPARgamma agonists.
Chem. Pharm. Bull. (Tokyo) 56: 335-345 (2008).
-
Azulay JP. The extent of the clinical manifestations of chronic polyradiculoneuropathy.
Rev. Neurol. (Paris) 162: 518-521 (2006).
-
Babaya N, Nakayama M, Eisenbarth GS. The stages of type 1A diabetes.
Ann. N. Y. Acad. Sci. 1051: 194-204 (2005).
*
-
Baccala R, Theofilopoulos AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity.
Trends Immunol. 26: 5-8 (2005).
*
-
Bach JF. Infections and autoimmune diseases.
J. Autoimmun. 25: S74-S80 (2005).
-
Bach JF. A Toll-like trigger for autoimmune disease.
Nat. Med. 11: 120-121 (2005).
*
-
Bach JF. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
C. R. Biol. 329: 260-262 (2006).
*
-
Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes.
Annu. Rev. Immunol. 19: 131-161 (2001).
*
-
Bach JF, Koutouzov S, van Endert PM. Are there unique autoantigens triggering autoimmune diseases?
Immunol. Rev. 164: 139-155 (1998).
-
Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
J. Autoimmun. 10: 375-386 (1997).
-
Bacher S, Schmitz ML. The NF-kappa B pathway as a potential target for autoimmune disease therapy.
Curr. Pharm. Des. 10: 2827-2837 (2004).
-
Backes JM, Gibson CA, Ruisinger JF, Moriarty PM. Fibrates: what have we learned in the past 40 years?
Pharmacotherapy 27: 412-424 (2007).
-
Bacon BR. Iron overload states.
Clin. Liver Dis. 2: 63-75, vi (1998).
-
Badenhoop K, Boehm BO. Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease.
Exp. Clin. Endocrinol. Diabetes 112: 407-415 (2004).
-
Badenhoop K, Donner H, Pani M, Rau H, Siegmund T, Braun J. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population.
Exp. Clin. Endocrinol. Diabetes 107 Suppl. 3: S89-S92 (1999).
-
Badenhoop K, Kahles H, Seidl C, Kordonouri O, Lopez ER, Walter M, Rosinger S, Ziegler A, Bohm BO; Diabetes Genetics Consortium. MHC-environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth.
Diabetes Obes. Metab. 11 Suppl. 1: 88-91 (2009).
*
-
Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EA, Bottazzo GF. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus.
Diabetologia 32: 445-448 (1989).
-
Badenhoop K, Tonjes RR, Rau H, Donner H, Rieker W, Braun J, Herwig J, Mytilineos J, Kurth R, Usadel KH. Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus.
Hum. Immunol. 50: 103-110 (1996).
-
Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease.
J. Clin. Endocrinol. Metab. 80: 2112-2117 (1995).
*
-
Badii R, Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hamaq AO, Ghoussaini M, Froguel P, Wareham NJ. Lack of association between the Pro(12)Ala polymorphism of the PPAR-gamma2 gene and type 2 diabetes mellitus in the Qatari consanguineous population.
Acta Diabetol. 45: 15-21 (2008).
*
-
Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars.
Science 307: 1909-1914 (2005).
*
-
Baeke F, Etten EV, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities.
Mol. Aspects Med. 29: 376-387 (2008).
-
Baev DV, Caielli S, Ronchi F, Coccia M, Facciotti F, Nichols KE, Falcone M. Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice.
J. Immunol. 181: 869-877 (2008).
-
Baeyens L, Bonne S, Bos T, Rooman I, Peleman C, Lahoutte T, German M, Heimberg H, Bouwens L. Notch signaling as gatekeeper of rat acinar-to-beta cell conversion in vitro.
Gastroenterology 136: 1750-1760.e13 (2009).
*
-
Bagarolli RA, Saad MJ, Saad ST. Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes.
J. Diabetes Complications Apr 21 [Epub ahead of print] (2009).
-
Bagley J, Paez-Cortez J, Tian C, Iacomini J. Gene therapy in type 1 diabetes.
Crit. Rev. Immunol. 28: 301-324 (2008).
-
Bagley J, Tian C, Iacomini J. Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells.
Methods Mol. Biol. 433: 277-286 (2008).
-
Bahr MJ, Ockenga J, Boker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.
Am. J. Physiol. Endocrinol. Metab. 291: E199-E206 (2006).
*
-
Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.
Curr. Diab. Rep. 4: 194-198 (2004).
-
Baier LJ, Permana PA, Traurig M, Dobberfuhl A, Wiedrich C, Sutherland J, Thuillez P, Luczy-Bachman G, Hara M, Horikawa Y, Hinokio Y, Hanson RL, Bogardus C. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.
Diabetes Care 23: 302-304 (2000).
*
-
Bailey CJ. Drugs on the horizon for diabesity.
Curr. Diab. Rep. 5: 353-359 (2005).
-
Bailey MM, Gorman EM, Munson EJ, Berkland C. Pure insulin nanoparticle agglomerates for pulmonary delivery.
Langmuir. 24: 13614-13620 (2008).
-
Bailey SD, Loredo-Osti JC, Lepage P, Faith J, Fontaine J, Desbiens KM, Hudson TJ, Bouchard C, Gaudet D, Perusse L, Vohl MC, Engert JC. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.
Diabetes 55: 2896-2902 (2006).
*
-
Bailliard F, Anderson RH. Tetralogy of Fallot.
Orphanet J. Rare Dis. 4: 2 (2009).
*
-
Baisch JM, Capra JD. Linkage disequilibrium within the HLA complex does not extend into HLA-DP.
Scand. J. Immunol. 37: 499-503 (1993).
-
Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus.
N. Engl. J. Med. 322: 1836-1841 (1990).
-
Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Am. J. Gastroenterol. 104: 1130-1134 (2009).
-
Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, Defronzo RA. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
Diabetologia 50: 1723-1731 (2007).
*
-
Bajwa PJ, Lee JW, Straus DS, Lytle C. Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
Am. J. Physiol. Gastrointest. Liver Physiol. May 14 [Epub ahead of print] (2009).
*
-
Bak H, Lee JW, Ahn HJ, Hwang SM, Choi EH, Lee SH, Ahn SK. An unusual case with membranous lipodystrophy in a hypertensive patient with transepidermal elimination.
Yonsei. Med. J. 47: 428-431 (2006).
*
-
Baker C, Petrich de Marquesini LG, Bishop AJ, Hedges AJ, Dayan CM, Wong FS. Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery.
J. Clin. Immunol. 28: 350-360 (2008).
*
-
Baker N, O'Meara SJ, Scannell M, Maderna P, Godson C. Lipoxin a4: anti-inflammatory and anti-angiogenic impact on endothelial cells.
J. Immunol. 182: 3819-3826 (2009).
-
Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JW, Gudbjornsdottir S, Nystrom L, Agardh CD, Landin-Olsson M, Sundkvist G, Groop LC. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients.
Diabetologia 51: 2224-2232 (2008).
*
-
Bakke AC, Purtzer MZ, Wildin RS. Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX).
Clin. Exp. Immunol. 137: 373-378 (2004).
*
-
Balakrishnan V, Unnikrishnan AG, Thomas V, Choudhuri G, Veeraraju P, Singh SP, Garg P, Pai CG, Devi RN, Bhasin D, Jayanthi V, Premalatha N, Chacko A, Kar P, Rai RR, Rajan R, Subhalal N, Mehta R, Mishra SP, Dwivedi M, Vinayakumar KR, Jain AK, et al. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India.
JOP 9: 593-600 (2008).
*
-
Balakumar P, Rose M, Ganti SS, Krishan P, Singh M. PPAR dual agonists: are they opening Pandora's box?
Pharmacol. Res. 56: 91-98 (2007).
*
-
Balakumar P, Rose M, Singh M. PPAR ligands: are they potential agents for cardiovascular disorders?
Pharmacology 80: 1-10 (2007).
-
Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database.
Hepatology 48: 878-888 (2008).
-
Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosis-prone diabetes mellitus.
Endocr. Rev. 29: 292-302 (2008).
*
-
Balducci-Silano PL, Layrisse ZE. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles.
J. Autoimmun. 8: 425-437 (1995).
-
Balic I, Angel B, Codner E, Carrasco E, Perez-Bravo F. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.
Hum. Immunol. 70: 116-120 (2009).
-
Balistreri WF. Celiac disease and type 1 diabetes: to screen or not to screen?
J. Pediatr. 150: a1 (2007).
*
-
Ballarini A, Lee-Kirsch MA. Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes.
Ann. N. Y. Acad. Sci. 1110: 159-165 (2007).
*
-
Ballotti S, de Martino M. Rotavirus infections and development of type 1 diabetes: an evasive conundrum.
J. Pediatr. Gastroenterol. Nutr. 45: 147-156 (2007).
*
-
Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.
J. Am. Soc. Nephrol. 17: 2333-2340 (2006).
*
-
Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism.
Proc. Natl. Acad. Sci. U.S.A. 105: 13644-13649 (2008).
*
-
Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.
Thyroid 10: 375-380 (2000).
-
Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.
Thyroid 10: 475-480 (2000).
-
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease.
J. Clin. Endocrinol. Metab. 89: 4562-4568 (2004).
*
-
Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease.
Genes Immun. 5: 203-208 (2004).
*
-
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease.
Genes Immun. 4: 586-593 (2003).
*
-
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease.
Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124 (2003).
*
-
Ban Y, Greenberg DA, Concepcion ES, Tomer Y. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease.
Thyroid 12: 1079-1083 (2002).
-
Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population.
J. Clin. Endocrinol. Metab. 85: 4639-4643 (2000).
*
-
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Tomita M, Ban Y. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population.
Autoimmunity 34: 39-43 (2001).
-
Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity.
Pediatr. Endocrinol. Rev. 3: 20-32 (2005).
-
Ban Y, Tomer Y. Susceptibility genes in thyroid autoimmunity.
Clin. Dev. Immunol. 12: 47-58 (2005).
*
-
Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases.
Autoimmunity 36: 367-379 (2003).
-
Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama KI, Ban Y, Hirano T. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population.
Autoimmunity 42: 126-130 (2009).
-
Bando H, Hashimoto N, Hirota Y, Sakaguchi K, Hisa I, Inoue Y, Imanishi Y, Seino S, Kaji H. Severe hypophosphatemic osteomalacia with Fanconi syndrome, renal tubular acidosis, vitamin D deficiency and primary biliary cirrhosis.
Intern. Med. 48: 353-358 (2009).
*
-
Banerjee S, Ghosh US, Dutta S. Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance.
J. Assoc. Physicians India 56: 593-599 (2008).
-
Banga A, Unal R, Tripathi P, Pokrovskaya I, Owens RJ, Kern PA, Ranganathan G. Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids.
Am. J. Physiol. Endocrinol. Metab. 296: E480-E489 (2009).
*
-
Baniasadi V, Narain N, Goswami R, Das SN. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians.
Tissue Antigens 67: 383-389 (2006).
*
-
Banos G, Perez-Torres I, El Hafidi M. Medicinal agents in the metabolic syndrome.
Cardiovasc. Hematol. Agents Med. Chem. 6: 237-252 (2008).
-
Banwell B, Bar-Or A, Cheung R, Kennedy J, Krupp LB, Becker DJ, Dosch HM; Wadsworth Pediatric Multiple Sclerosis Study Group. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
Ann. Neurol. 63: 98-111 (2008).
-
Bao F, Babu SR, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR. Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family.
Ann. N. Y. Acad. Sci. 1005: 348-351 (2003).
*
-
Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
J. Autoimmun. 13: 143-148 (1999).
-
Bao S, Root C, Jagasia S. Type B insulin resistance syndrome associated with systemic lupus erythematosus.
Endocr. Pract. 13: 51-55 (2007).
-
Baptista ML, Koda YK, Mitsunori R, Nisihara, Ioshii SO. Prevalence of celiac disease in Brazilian children and adolescents with type 1 diabetes mellitus.
J. Pediatr. Gastroenterol. Nutr. 41: 621-624 (2005).
*
-
Baranowski M. Biological role of liver X receptors.
J. Physiol. Pharmacol. 59 Suppl. 7: 31-55 (2008).
-
Baranowski M, Blachnio-Zabielska A, Zabielski P, Gorski J. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
Arch. Biochem. Biophys. 477: 86-91 (2008).
*
-
Barbato M, Viola F, Miglietta MR, Argo G, Iulianella VR, Di Giuseppe S, Pippa G, Gentiloni Silverj F, Lo Russo L, Frediani T, Lucarelli S, Multari G, Cardi E. Association between insulin dependent diabetes mellitus and coeliac disease. A study on 175 diabetes patients.
Minerva Gastroenterol. Dietol. 44: 1-5 (1998).
-
Barbe-Tuana FM, Klein D, Ichii H, Berman DM, Coffey L, Kenyon NS, Ricordi C, Pastori RL. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets.
Diabetes 55: 2437-2445 (2006).
*
-
Barbeau WE, Bassaganya-Riera J, Hontecillas R. Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes.
Med. Hypotheses 68: 607-619 (2007).
-
Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Schiattarella C, Siciliano S, Lemme P, Paolisso G. The -8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients.
Atherosclerosis Mar 19 [Epub ahead of print] (2008).
-
Barker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening.
J. Clin. Endocrinol. Metab. 91: 1210-1217 (2006).
*
-
Barker JM, Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions.
Adv. Pediatr. 55: 349-365 (2008).
-
Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS. Two single nucleotide polymorphisms identify highest-risk diabetes human leukocyte antigen genotype: potential for rapid screening.
Diabetes 57: 3152-3155 (2008).
-
Barker JM, Triolo TM, Eisenbarth GS. Response to Comment on: Barker et al. (2008) Two Single Nucleotide Polymorphisms Identify the Highest-Risk Diabetes HLA Genotype: Diabetes 57:3152-3155, 2008.
Diabetes 58: e2 (2009).
-
Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
Diabetes Care 28: 850-855 (2005).
*
-
Barnard ND, Noble EP, Ritchie T, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green AA, Ferdowsian H. D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes.
Nutrition 25: 58-65 (2009).
-
Baroudi Ouederni T, Sanchez-Corona J, Flores Martinez SE, Ben Maiz H, Aounallah Skhiri H, Kammoun Abid H, Benammar-Elgaaied A. The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population.
Clin. Biochem. Mar 27 [Epub ahead of print] (2009).
*
-
Baroudi T, Bouhaha R, Moran-Moguel C, Sanchez-Corona J, Ben Maiz H, Kammoun Abid H, Benammar-Elgaaied A. Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia.
J. Renin Angiotensin Aldosterone Syst. 10: 35-40 (2009).
-
Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.
J. Autoimmun. 27: 166-173 (2006).
-
Barre DE. The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes - a mini-review.
J. Oleo. Sci. 56: 319-325 (2007).
*
-
Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS; The Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
Nat. Genet. May 10 [Epub ahead of print] (2009).
*
-
Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
Nat. Genet. 40: 955-962 (2008).
*
-
Barritt AS 4th, Zacks SL, Rubinas TC, Herfarth HH. Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease: a case series and systematic review of the literature.
Inflamm. Bowel Dis. 14: 1695-1700 (2008).
*
-
Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'rahilly S, Wareham NJ. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
Diabetologia 49: 501-505 (2006).
*
-
Barter P. Managing diabetic dyslipidaemia-beyond LDL-C:HDL-C and triglycerides.
Atheroscler. Suppl. 7: 17-21 (2006).
-
Barth A, Rost M, Kindt A, Peiker G. Serum bile acid profile in women during pregnancy and childbed.
Exp. Clin. Endocrinol. Diabetes 113: 372-375 (2005).
-
Bartholo RM, Zaltman C, Elia C, Cardoso AP, Flores V, Lago P, Cassabian L, Carvalho Dorileo F, Lapa-E-Silva JR. Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease.
Braz. J. Med. Biol. Res. 38: 197-203 (2005).
*
-
Barton A, Eyre S, Ke X, Hinks A, Bowes J, Flynn E, Martin P; YEAR Consortium; BIRAC Consortium, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, Reid DM, Harrison P, Wordsworth P, Thomson W, Worthington J. Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes.
Hum. Mol. Genet. Apr 9 [Epub ahead of print] (2009).
*
-
Barton A, Jury F, Eyre S, Bowes J, Hinks A, Ward D, Worthington J. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.
Arthritis Rheum. 50: 748-752 (2004).
*
-
Barton A, Myerscough A, John S, Gonzalez-Gay M, Ollier W, Worthington J. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis.
Rheumatology (Oxford) 39: 63-66 (2000).
*
-
Bartsch DK, Kress R, Sina-Frey M, Grutzmann R, Gerdes B, Pilarsky C, Heise JW, Schulte KM, Colombo-Benkmann M, Schleicher C, Witzigmann H, Pridohl O, Ghadimi MB, Horstmann O, von Bernstorff W, Jochimsen L, Schmidt J, Eisold S, Estevez-Schwarz L, et al. Prevalence of familial pancreatic cancer in Germany.
Int. J. Cancer 110: 902-906 (2004).
*
-
Bartsocas CS, Gerasimidi-Vazeou A. Genetics of type 1 diabetes mellitus.
Pediatr. Endocrinol. Rev. 3 Suppl. 3: 508-513 (2006).
-
Bas F, Kabatas-Eryilmaz S, Gunoz H, Darendeliler F, Kucukemre B, Bundak R, Saka N. Type 1 diabetes mellitus associated with autoimmune thyroid disease, celiac disease and familial Mediterranean fever: case report.
Turk. J. Pediatr. 51: 183-186 (2009).
-
Basarkar A, Singh J. Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice.
Pharm. Res. 26: 72-81 (2009).
-
Basch E, Bent S, Collins J, Dacey C, Hammerness P, Harrison M, Smith M, Szapary P, Ulbricht C, Vora M, Weissner W. Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration.
J. Soc. Integr. Oncol. 5: 92-105 (2007).
-
Baschal EE, Aly TA, Jasinski JM, Steck AK, Johnson KN, Noble JA, Erlich HA, Eisenbarth GS; Diabetes Genetics Consortium. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes.
Diabetes Obes. Metab. 11 Suppl. 1: 25-30 (2009).
*
-
Baschal EE, Aly TA, Jasinski JM, Steck AK, Noble JA, Erlich HA, Eisenbarth GS; the Type 1 Diabetes Genetics Consortium. Defining multiple common "completely" conserved major histocompatibility complex SNP haplotypes.
Clin. Immunol. May 6 [Epub ahead of print] (2009).
*
-
Basciano H, Miller AE, Naples M, Baker C, Kohen R, Xu E, Su Q, Allister E, Wheeler M, Adeli K. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.
Am. J. Physiol. Endocrinol. Metab. Jun 9 [Epub ahead of print] (2009).
*
-
Bassols J, Ortega FJ, Moreno-Navarrete JM, Peral B, Ricart W, Fernandez-Real JM. Study of the proinflammatory role of human differentiated omental adipocytes.
J. Cell. Biochem. Jun 2 [Epub ahead of print] (2009).
-
Bassuny WM, Ihara K, Matsuura N, Ahmed S, Kohno H, Kuromaru R, Miyako K, Hara T. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes.
Immunogenetics 54: 282-285 (2002).
*
-
Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria.
Rheumatology (Oxford) 46: 683-689 (2007).
*
-
Basu A, Jensen MD, McCann F, Nandy D, Mukhopadhyay D, McConnell JP, Rizza RA. Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes.
Endocr. Pract. 13: 147-152 (2007).
-
Basu SK, Govardhan CP, Jung CW, Margolin AL. Protein crystals for the delivery of biopharmaceuticals.
Expert Opin. Biol. Ther. 4: 301-317 (2004).
-
Batarelo V, Durinovic-Bello I. The sentinel role of CD8 T cells in regulating CD4 T cell responses to proinsulin in beta-islet cell autoimmunity.
Ann. N. Y. Acad. Sci. 1150: 270-272 (2008).
*
-
Battaglia M, Roncarolo MG. In vivo neutralization of inflammatory cytokines might not be necessary for regulatory T-cell immunotherapy.
Nat. Rev. Immunol. Nov 30 [Epub ahead of print] (2007).
*
-
Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes.
Eur. J. Immunogenet. 30: 223-227 (2003).
*
-
Battezzati A, Battezzati PM, Costantini D, Seia M, Zazzeron L, Russo MC, Dacco V, Bertoli S, Crosignani A, Colombo C. Spontaneous hypoglycemia in patients with cystic fibrosis.
Eur. J. Endocrinol. 156: 369-376 (2007).
*
-
Baum H, Staines NA. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease.
Cytokines Cell Mol. Ther. 3: 115-125 (1997).
-
Baxter A, Jordan M, Silveira P, Wilson W, Van Driel I. Genetic control of susceptibility to autoimmune gastritis.
Int. Rev. Immunol. 24: 55-62 (2005).
-
Baxter AG. Immunogenetics and the cause of autoimmune disease.
Autoimmunity 25: 177-189 (1997).
*
-
Beasley RP. Diabetes and hepatocellular carcinoma.
Hepatology 44: 1408-1410 (2006).
*
-
Beauquis J, Homo-Delarche F, Revsin Y, De Nicola AF, Saravia F. Brain alterations in autoimmune and pharmacological models of diabetes mellitus: focus on hypothalamic-pituitary-adrenocortical axis disturbances.
Neuroimmunomodulation 15: 61-67 (2008).
-
Beauquis J, Saravia F, Coulaud J, Roig P, Dardenne M, Homo-Delarche F, De Nicola A. Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse.
Exp. Neurol. 210: 359-367 (2008).
-
Beaven SW, Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
Annu. Rev. Med. 57: 313-329 (2006).
*
-
Becker A, Smulders YM, van Guldener C, Stehouwer CD. Epidemiology of homocysteine as a risk factor in diabetes.
Metab. Syndr. Relat. Disord. 1: 105-120 (2003).
-
Becker D, Enk A, Brauninger W, Knop J. Granuloma anulare disseminatum as a rare side effect of allopurinol.
Hautarzt. 46: 343-345 (1995).
-
Becker H, Weber C, Storch S, Federlin K. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
Clin. Immunol. Immunopathol. 56: 219-225 (1990).
-
Becker J, Delayre-Orthez C, Frossard N, Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Fundam. Clin. Pharmacol. 20: 429-447 (2006).
*
-
Becker KG. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?
Diabetes 48: 1353-1358 (1999).
*
-
Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders.
Med. Hypotheses 62: 309-317 (2004).
-
Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, Trent JM. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.
Proc. Natl. Acad. Sci. U.S.A. 95: 9979-9984 (1998).
*
-
Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus.
Pharmacogenomics J. Apr 21 [Epub ahead of print] (2009).
-
Beeton C, Smith BJ, Sabo JK, Crossley G, Nugent D, Khaytin I, Chi V, Chandy KG, Pennington MW, Norton RS. The D-diastereomer of SHK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
J. Biol. Chem. 283: 988-997 (2008).
*
-
Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, Leehealey CJ, S Andrews B, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Proc. Natl. Acad. Sci. U.S.A. 103: 17414-17419 (2006).
*
-
Befeler AS. New developments in hepatocellular carcinoma.
54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
-
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.
Am. J. Hum. Genet. 75: 330-337 (2004).
*
-
Behl Y, Krothapalli P, Desta T, Roy S, Graves DT. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats.
Diabetes 58: 917-925 (2009).
-
Beilhack GF, Landa RR, Masek MA, Shizuru JA. Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants.
Diabetes 54: 1770-1779 (2005).
*
-
Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels.
Exp. Clin. Endocrinol. Diabetes 115: 221-228 (2007).
-
Bekris LM, Shephard C, Peterson M, Hoehna J, Yserloo BV, Rutledge E, Farin F, Kavanagh TJ, Lernmark A. Glutathione-S-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset.
Autoimmunity 38: 567-575 (2005).
-
Belanger S, Tai LH, Anderson SK, Makrigiannis AP. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.
Genes Immun. 9: 509-521 (2008).
-
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
N. Engl. J. Med. 355: 2297-2307 (2006).
*
-
Bell DS, Allbright E. The multifaceted associations of hepatobiliary disease and diabetes.
Endocr. Pract. 13: 300-312 (2007).
-
Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E. The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects.
Scand. J. Gastroenterol. 35: 1301-1307 (2000).
*
-
Bell J, Rassenti L, Smoot S, Smith K, Newby C, Hohlfeld R, Toyka K, McDevitt H, Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis.
Lancet 1: 1058-1060 (1986).
-
Bell JI. The molecular genetics of HLA-related disorders.
Ciba Found. Symp. 130: 197-214 (1987).
-
Bell JK, Askins J, Hall PR, Davies DR, Segal DM. The dsRNA binding site of human Toll-like receptor 3.
Proc. Natl. Acad. Sci. U.S.A. 103: 8792-8797 (2006).
*
-
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Davies DR, Segal DM. The molecular structure of the TLR3 extracellular domain.
J. Endotoxin Res. 12: 375-378 (2006).
*
-
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, Davies DR. The molecular structure of the Toll-like receptor 3 ligand-binding domain.
Proc. Natl. Acad. Sci. U.S.A. 102: 10976-10980 (2005).
*
-
Belniak E, Stelmasiak Z, Papuc E. Multiple sclerosis and other autoimmune diseases.
Neurol. Neurochir. Pol. 41: 259-266 (2007).
-
Belvisi MG, Hele DJ, Birrell MA. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Eur. J. Pharmacol. 533: 101-109 (2006).
*
-
Ben-Menachem T. Risk factors for cholangiocarcinoma.
Eur. J. Gastroenterol. Hepatol. 19: 615-617 (2007).
*
-
Bending D, De La Pena H, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B, Cooke A. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.
J. Clin. Invest. pii: 37865 (2009).
*
-
Bendlova B, Vejralkova D, Vcelak J, Lukalova P, Burkonova D, Kunelova M, Vrbikova J, Dvorakova K, Vondra K, Vankova M. PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2.
Physiol. Res. 57 Suppl. 1: S77-S90 (2008).
*
-
Benedek G, Brautbar C, Vardi P, Sharon N, Weintrob N, Zung A, Israel S. Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel.
Tissue Antigens 73: 33-38 (2009).
*
-
Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases.
JPEN J. Parenter. Enteral Nutr. 30: 45-51 (2006).
*
-
Bengmark S. Advanced glycation and lipoxidation end products amplifiers of inflammation: the role of food.
JPEN J. Parenter. Enteral Nutr. 31: 430-440 (2007).
*
-
Bengtson MB, Ronning T, Vatn M, Harris J. Irritable bowel syndrome in twins: genes and environment.
Gut 55: 1754-1759 (2006).
*
-
Benn CS, Aaby P. Sex-differential responses to preventive health interventions. Maybe we treat boys and girls differently when we treat them equally? - Secondary publication.
Dan. Med. Bull. 54: 153-154 (2007).
-
Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Franks S, Elliott P, Jarvelin MR, McCarthy MI. No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth.
Diabetologia 51: 82-85 (2008).
*
-
Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, Barnett AH, Bain SC, Todd JA. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus.
J. Autoimmun. 9: 415-421 (1996).
-
Benoist C, Germain RN, Mathis D. A plaidoyer for 'systems immunology'.
Immunol. Rev. 210: 229-234 (2006).
*
-
Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?
Nat. Immunol. 2: 797-801 (2001).
*
-
Bensing S, Brandt L, Tabaroj F, Sjoberg O, Nilsson B, Ekbom A, Blomqvist P, Kampe O. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Clin. Endocrinol. (Oxf.) 69: 697-704 (2008).
*
-
Benten D, Follenzi A, Bhargava KK, Kumaran V, Palestro CJ, Gupta S. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice.
Hepatology 42: 140-148 (2005).
*
-
Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes.
Diabetes 53: 3007-3012 (2004).
*
-
Beranek M, Kolar P, Tschoplova S, Kankova K, Vasku A. Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy.
Diabetes Res. Clin. Pract. 79: 362-367 (2008).
-
Berends MA, Snoek J, DE Jong EM, VAN DE Kerkhof PC, VAN Oijen MG, VAN Krieken JH, Drenth JP. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Aliment. Pharmacol. Ther. 24: 805-811 (2006).
*
-
Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
J. Am. Acad. Dermatol. 41: 431-434 (1999).
-
Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, Jenkins JB, Jones EA. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Hepatology 27: 679-684 (1998).
*
-
Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.
Gastroenterology 102: 544-549 (1992).
-
Bergasa NV, Vergalla J, Turner ML, Loh PY, Jones EA. Alpha-melanocyte-stimulating hormone in primary biliary cirrhosis.
Ann. N. Y. Acad. Sci. 680: 454-458 (1993).
*
-
Berger J, Moller DE. The mechanisms of action of PPARs.
Annu. Rev. Med. 53: 409-435 (2002).
*
-
Berger J, Wagner JA. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
Diabetes Technol. Ther. 4: 163-174 (2002).
-
Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease.
Trends Pharmacol. Sci. 26: 244-251 (2005).
*
-
Berger JR, Weaver A, Greenlee J, Wahlen GE. Neurologic consequences of autoimmune polyglandular syndrome type 1.
Neurology 70: 2248-2251 (2008).
-
Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies.
Hum. Genet. 121: 169-178 (2007).
*
-
Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in ZDF rats: a comparison to PPARgamma agonism.
Endocrinology 147: 4252-4262 (2006).
*
-
Bergholdt R. Understanding type 1 diabetes genetics - approaches for identification of susceptibility genes in multi-factorial diseases.
Dan. Med. Bull. 56: 1-39 (2009).
-
Bergholdt R, Heding P, Nielsen K, Nolsoe R, Sparre T, Storling J, Nerup J, Pociot F, Mandrup-Poulsen T. Type 1 database mellitus: an inflammatory disease of the islet.
Adv. Exp. Med. Biol. 552: 129-153 (2004).
-
Bergholdt R, Karlsen AE, Hagedorn PH, Aalund M, Nielsen JH, Kruhoffer M, Orntoft T, Wang H, Wollheim CB, Nerup J, Pociot F. Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets.
Genes Immun. 8: 232-238 (2007).
*
-
Bergholdt R, Larsen ZM, Andersen NA, Johannesen J, Kristiansen OP, Mandrup-Poulsen T, Nerup J, Pociot F; Danish Study Group of IDDM in Childhood; Danish IDDM Epidemiology and Genetics Group. Characterization of new polymorphisms in the 5' UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level.
Genes Immun. 1: 495-500 (2000).
*
-
Bergholdt R, Nerup J, Pociot F. Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes.
J. Med. Genet. 42: 17-25 (2005).
*
-
Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.
J. Leukoc. 77: 579-585 (2005).
*
-
Bergman ML, Cilio CM, Penha-Goncalves C, Lamhamedi-Cherradi SE, Lofgren A, Colucci F, Lejon K, Garchon HJ, Holmberg D. CTLA-4-/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice.
J. Autoimmun. 16: 105-113 (2001).
-
Bergmann A, Li J, Selisko T, Reimann M, Fischer S, Grassler J, Schulze J, Bornstein SR, Schwarz PE. The A98V single nucleotide polymorphism (SNP) in hepatic nuclear factor 1 alpha (HNF-1alpha) is associated with insulin sensitivity and beta-cell function.
Exp. Clin. Endocrinol. Diabetes 116 Suppl. 1: S50-S55 (2008).
-
Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire.
Eur. J. Epidemiol. 19: 411-416 (2004).
-
Bergstrom JP, Helander A. HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels.
Clin. Chim. Acta 389: 164-166 (2008).
*
-
Bering B, Devendra D. Latent autoimmune diabetes in the young.
Clin. Med. 9: 93 (2009).
-
Berka N, Bland GN, Erabhaoui el H, Dunston GM. Heat-shock protein gene is not associated with type-1 diabetes in African Americans.
J. Natl. Med. Assoc. 99: 715-717 (2007).
*
-
Berka N, Nunlee-Bland G, Erabhaoui E, Belmamoun M, Dunston GM. IDDM2 and the polymorphism of the human tyrosine hydroxylase (hTH) gene in African Americans with type-1 diabetes.
J. Natl. Med. Assoc. 96: 1042-1046 (2004).
-
Berkovic M, Cacev T, Zjacic-Rotkvic V, Kapitanovic S. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.
Neuroendocrinology 84: 346-352 (2006).
-
Bernal-Reyes R, Escudero RB. Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report.
Rev. Gastroenterol. Mex. 67: 70-75 (2002).
-
Bernardo A, Minghetti L. Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists.
PPAR Res. 2008: 864140 (2008).
*
-
Berney T, Ferrari-Lacraz S, Buhler L, Oberholzer J, Marangon N, Philippe J, Villard J, Morel P. Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark.
Am. J. Transplant. 9: 419-423 (2009).
-
Berr C, Akbaraly T, Arnaud J, Hininger I, Roussel AM, Barberger Gateau P. Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids.
J. Nutr. Health Aging 13: 14-18 (2009).
-
Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM. Hypertriglyceridemia: management of atherogenic dyslipidemia.
J. Fam. Pract. 55: S1-S8 (2006).
-
Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes.
Clin. Chim. Acta 399: 112-116 (2009).
*
-
Berthold HK, Laaksonen R, Lehtimaki T, Gylling H, Krone W, Gouni-Berthold I. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
Exp. Clin. Endocrinol. Diabetes 116: 262-267 (2008).
-
Bertrams J. The HLA association of insulin-dependent (type I) diabetes mellitus.
Behring Inst. Mitt. 75: 89-99 (1984).
-
Bertuzzi F, Ricordi C. Beta-cell replacement in immunosuppressed recipients: old and new clinical indications.
Acta Diabetol. 44: 171-176 (2007).
-
Besin G, Gaudreau S, Menard M, Guindi C, Dupuis G, Amrani A. Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes.
Diabetes 57: 2107-2117 (2008).
*
-
Besler C, Doerries C, Giannotti G, Luscher TF, Landmesse U. Pharmacological approaches to improve endothelial repair mechanisms.
Expert Rev. Cardiovasc. Ther. 6: 1071-1082 (2008).
-
Bessa SS, Hamdy SM, Ali EM. Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: an Egyptian study.
Eur. J. Intern. Med. 18: 489-495 (2007).
-
Betteridge DJ. Lipid lowering in diabetes mellitus.
Curr. Opin. Lipidol. 19: 579-584 (2008).
-
Betteridge DJ. Lipid-lowering trials in diabetes.
Curr. Opin. Lipidol. 12: 619-623 (2001).
-
Betterle C, Dalpra C, Greggio N, Volpato M, Zanchetta R. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4.
Ann. Endocrinol. (Paris) 62: 193-201 (2001).
-
Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg?
Clin. Exp. Immunol. 137: 225-233 (2004).
*
-
Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, Caretto A. Premature ovarian failure: autoimmunity and natural history.
Clin. Endocrinol. (Oxf.) 39: 35-43 (1993).
-
Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS).
Acta Biomed. Ateneo. Parmense. 74: 9-33 (2003).
-
Betts P, Mulligan J, Ward P, Smith B, Wilkin T. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2).
Diabet. Med. 22: 144-151 (2005).
*
-
Beulens JW, Rimm EB, Hendriks HF, Hu FB, Manson JE, Hunter DJ, Mukamal KJ. Alcohol consumption and type 2 diabetes: influence of genetic variation in alcohol dehydrogenase.
Diabetes 56: 2388-2394 (2007).
*
-
Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD. A role for innate immunity in type 1 diabetes?
Diabetes Metab. Res. Rev. 19: 89-100 (2003).
-
Beyan H, Ola T, David R, Leslie G. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
Ann. N. Y. Acad. Sci. 1079: 81-89 (2006).
*
-
Beylot M. Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon.
Diabetes Metab. 22: 299-304 (1996).
-
Beysen C, Murphy EJ, Nagaraja H, Decaris M, Riiff T, Fong A, Hellerstein MK, Boyle PJ. A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes.
J. Lipid Res. 49: 2657-2663 (2008).
*
-
Bhadada SK, Udawat HP, Bhansali A, Rana SS, Sinha SK, Bhasin DK. Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis.
J. Gastroenterol. Hepatol. 23: 959-964 (2008).
*
-
Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis.
BMC Gastroenterol. 6: 42 (2006).
*
-
Bhat A, Koul A, Rai E, Sharma S, Dhar MK, Bamezai RN. PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study.
Hum. Genet. 121: 609-614 (2007).
*
-
Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, Elkadri A, Cho J, et al. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.
Am. J. Gastroenterol. Jun 9 [Epub ahead of print] (2009).
*
-
Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, Witt H. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations.
Gastroenterology 123: 1020-1025 (2002).
*
-
Bhatia V, Viswanathan P. Insulin resistance and PPAR insulin sensitizers.
Curr. Opin. Investig. Drugs 7: 891-897 (2006).
-
Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC, Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, Almahameed A, Abdel-Latif A, Tang HW, Brennan D, McErlean E, Hazen SL, Topol EJ. Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization - results of the PPAR study.
Am. Heart J. 154: 137-143 (2007).
*
-
Bhibhatbhan A, Kline G, Vincent A, Toth C. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
Muscle Nerve 36: 264-266 (2007).
-
Bi EG, Shi W, Zou J, Hao ZH, Li ZH, Cai D, Zhang HQ, Sun B. IL-12p40 is not required for islet allograft rejection.
Acta Pharmacol. Sin. 27: 1065-1070 (2006).
*
-
Bi Y, Sun WP, Chen X, Li M, Liang H, Cai MY, Zhu YH, He XY, Xu F, Weng JP. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats.
Acta Diabetol. 45: 167-178 (2008).
-
Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR. Prevalence of coeliac disease in Italian patients affected by Addison's disease.
Scand. J. Gastroenterol. 41: 302-305 (2006).
*
-
Biason-Lauber A, Boehm B, Lang-Muritano M, Gauthier BR, Brun T, Wollheim CB, Schoenle EJ. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.
Diabetologia 48: 900-905 (2005).
*
-
Bichet DG. Vasopressin receptor mutations in nephrogenic diabetes insipidus.
Semin. Nephrol. 28: 245-251 (2008).
-
Bid HK, Konwar R, Agrawal CG, Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population.
Indian J. Med. Sci. 62: 259-266 (2008).
*
-
Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes.
Eur. J. Clin. Nutr. 62: 178-185 (2008).
*
-
Bieda K, Pani MA, van der Auwera B, Seidl C, Tonjes RR, Gorus F, Usadel KH, Badenhoop K. A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies type I diabetes susceptibility on high risk DQ haplotypes.
Diabetologia 45: 443-447 (2002).
*
-
Bielinski SJ, Pankow JS, Boerwinkle E, Bray MS, Kao WH, Folsom AR. Lack of association between uncoupling protein-2 Ala55Val polymorphism and incident diabetes in the atherosclerosis risk in communities study.
Acta Diabetol. 45: 179-182 (2008).
-
Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products.
J. Mol. Med. 83: 876-886 (2005).
*
-
Bierhaus A, Humpert PM, Stern DM, Arnold B, Nawroth PP. Advanced glycation end product receptor-mediated cellular dysfunction.
Ann. N. Y. Acad. Sci. 1043: 676-680 (2005).
*
-
Biering H, Bohner G, Strasburger CJ. Autoimmune hypophysitis.
Dtsch. Med. Wochenschr. 130: 2826-2828 (2005).
-
Biernacka JM, Cordell HJ. Exploring causality via identification of SNPs or haplotypes responsible for a linkage signal.
Genet. Epidemiol. 31: 727-740 (2007).
-
Biernacka JM, Sun L, Bull SB. Simultaneous localization of two linked disease susceptibility genes.
Genet. Epidemiol. 28: 33-47 (2004).
*
-
Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD.
Gastroenterology 130: 1652-1660 (2006).
*
-
Bijl N, van Roomen CP, Triantis V, Sokolovic M, Ottenhoff R, Scheij S, van Eijk M, Boot RG, Aerts JM, Groen AK. Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice.
Hepatology 49: 637-645 (2009).
*
-
Bikle DD. What is new in vitamin D: 2006-2007.
Curr. Opin. Rheumatol. 19: 383-388 (2007).
-
Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease.
Genes Immun. 7: 550-554 (2006).
*
-
Bilbao JR, Martin-Pagola A, Calvo B, Perez de Nanclares G, Gepv-N, Castano L. Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques.
Ann. N. Y. Acad. Sci. 958: 321-324 (2002).
*
-
Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L. HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders.
Ann. N. Y. Acad. Sci. 1005: 314-318 (2003).
*
-
Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L. HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease.
Tissue Antigens 60: 71-76 (2002).
*
-
Bilbao JR, Villoslada P, Martin-Pagola A, Castano L. No evidence of pancreatic autoimmunity among patients with multiple sclerosis.
Ann. N. Y. Acad. Sci. 1037: 133-137 (2004).
*
-
Bilgic S, Aktas E, Salman F, Ersahin G, Erten G, Yilmaz MT, Deniz G. Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes.
Diabetes Res. Clin. Pract. 79: 31-36 (2008).
-
Billin AN. PPAR-beta/delta agonists for type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home.
Expert Opin. Investig. Drugs 17: 1465-1471 (2008).
-
Billotey C, Aspord C, Beuf O, Piaggio E, Gazeau F, Janier MF, Thivolet C. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging.
Radiology 236: 579-587 (2005).
*
-
Bilz S, Samuel V, Morino K, Savage D, Choi CS, Shulman GI. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.
Am. J. Physiol. Endocrinol. Metab. 290: E716-E722 (2006).
*
-
Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack.
Nat. Immunol. 7: 284-292 (2006).
*
-
Bircan R, Miehle K, Mladenova G, Ivanova R, Ivanova R, Sarafova A, Borissova AM, Lublinghoff J, Paschke R. Multiple relapses of hyperthyroidism after thyroid surgeries in a patient with long term follow-up of sporadic non-autoimmune hyperthyroidism.
Exp. Clin. Endocrinol. Diabetes 116: 341-346 (2008).
-
Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das PK. Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community.
Acta Derm. Venereol. 86: 209-214 (2006).
*
-
Birlea SA, Costin GE, Norris DA. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
Curr. Drug Targets 9: 345-359 (2008).
-
Birlea SA, Fain PR, Spritz RA. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases.
Arch. Dermatol. 144: 310-316 (2008).
*
-
Biros E, Jordan MA, Baxter AG. Genes mediating environment interactions in type 1 diabetes.
Rev. Diabet. Stud. 2: 192-207 (2005).
*
-
Biscetti F, Gaetani E, Flex A, Tamar A, Hopkins T, Straface G, Pecorini G, Stigliano E, Smith RC, Angelini F, Castellot JJ Jr, Pola R. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
Diabetes 57: 1394-1404 (2008).
*
-
Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation.
Prostaglandins Other Lipid Mediat. 71: 1-22 (2003).
-
Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert JJ. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis.
J. Pediatr. 152: 540-545.e1 (2008).
*
-
Bismuth M, Aguilar-Martinez P, Michel H. Hereditary haemochromatosis.
Presse. Med. 32: 1716-1723 (2003).
-
Bister V, Kolho KL, Karikoski R, Westerholm-Ormio M, Savilahti E, Saarialho-Kere U. Metalloelastase (MMP-12) is upregulated in the gut of pediatric patients with potential celiac disease and in type 1 diabetes.
Scand. J. Gastroenterol. 40: 1413-1422 (2005).
*
-
Biswas A, Chittari K, Gey van Pittius D, Stephens M, Tan BB. Palisaded neutrophilic and granulomatous dermatitis in a child with type I diabetes mellitus and coeliac disease.
Br. J. Dermatol. 159: 488-489 (2008).
*
-
Bitan M, Weiss L, Zeira M, Reich S, Pappo O, Vlodavsky I, Slavin S. Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production.
Diabetes Metab. Res. Rev. 24: 413-421 (2008).
-
Bizzaro N. The predictive significance of autoantibodies in organ-specific autoimmune diseases.
Clin. Rev. Allergy Immunol. 34: 326-331 (2007).
-
Bjelakovic G, Beninati S, Pavlovic D, Kocic G, Jevtovic T, Kamenov B, Saranac LJ, Bjelakovic B, Stojanovic I, Banic J. Glucocorticoids and oxidative stress.
J. Basic Clin. Physiol. Pharmacol. 18: 115-127 (2007).
-
Bjorksten B. Disease outcomes as a consequence of environmental influences on the development of the immune system.
Curr. Opin. Allergy Clin. Immunol. 9: 185-189 (2009).
-
Bjorksten B. Environmental influences on the development of the immune system: consequences for disease outcome.
Nestle Nutr. Workshop Ser. Pediatr. Program. 61: 243-254 (2008).
-
Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE. FOXP3 polymorphisms in type 1 diabetes and coeliac disease.
J. Autoimmun. 27: 140-144 (2006).
-
Bjornvold M, Munthe-Kaas MC, Egeland T, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Carlsen KC, Carlsen KH, Undlien DE. A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma.
Genes Immun. 10: 181-187 (2009).
-
Bjornvold M, Undlien DE, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Ronningen KS, Stene LC. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes.
Diabetologia 51: 589-596 (2008).
*
-
Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Med. Hypotheses 67: 879-891 (2006).
-
Blackman SM, Hsu S, Vanscoy LL, Collaco JM, Ritter SE, Naughton K, Cutting GR. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.
J. Clin. Endocrinol. Metab. 94: 1302-1309 (2009).
-
Blackwell JM, Searle S. Genetic regulation of macrophage activation: understanding the function of Nramp1 (=Ity/Lsh/Bcg).
Immunol. Lett. 65: 73-80 (1999).
-
Blagosklonny MV. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
Cell Cycle 5: 2087-2102 (2006).
*
-
Blaha V, Mistrík E. Hypolipidemic drugs and diabetes mellitus.
Vnitr. Lek. 55: 357-362 (2009).
-
Blandino-Rosano M, Perez-Arana G, Mellado-Gil J, Segundo C, Aguilar-Diosdado M. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with Erk1/2 pathway inhibition: protective role of GLP-1.
J. Mol. Endocrinol. 41: 35-44 (2008).
*
-
Blankenhorn EP, Descipio C, Rodemich L, Cort L, Leif JH, Greiner DL, Mordes JP. Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene.
Ann. N. Y. Acad. Sci. 1103: 128-131 (2007).
*
-
Blankenhorn EP, Rodemich L, Martin-Fernandez C, Leif J, Greiner DL, Mordes JP. The rat diabetes susceptibility locus iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.
Diabetes 54: 1233-1237 (2005).
*
-
Blanquicett C, Roman J, Hart CM. Thiazolidinediones as anti-cancer agents.
Cancer Ther. 6(A): 25-34 (2008).
-
Blaschke F, Caglayan E, Hsueh WA. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.
Endocrinol. Metab. Clin. North Am. 35: 561-574 (2006).
-
Blaschke F, Spanheimer R, Khan M, Law RE. Vascular effects of TZDs: new implications.
Vascul. Pharmacol. 45: 3-18 (2006).
-
Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Circ. Res. 99: e88-e99 (2006).
*
-
Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Arterioscler. Thromb. Vasc. Biol. 26: 28-40 (2006).
*
-
Blasi C. The autoimmune origin of atherosclerosis.
Atherosclerosis May 23 [Epub ahead of print] (2008).
-
Blau H, Livne M, Mussaffi H. Cystic fibrosis in adults: a changing scene.
Isr. Med. Assoc. J. 5: 491-495 (2003).
*
-
Blazovics A. Gallstone disease: free radical reactions and the ambivalent role of bilirubin in the pathomechanism of gallstone formation.
Orv. Hetil. 148: 589-596 (2007).
-
Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice.
J. Clin. Invest. 103: 1431-1436 (1999).
*
-
Bletter N. A quantitative synthesis of the medicinal ethnobotany of the Malinke of Mali and the Ashaninka of Peru, with a new theoretical framework.
J. Ethnobiol. Ethnomed. 3: 36 (2007).
*
-
Bloch AS. Low carbohydrate diets, pro: time to rethink our current strategies.
Nutr. Clin. Pract. 20: 3-12 (2005).
-
Block G, Jensen CD, Norkus EP, Dalvi TB, Wong LG, McManus JF, Hudes ML. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study.
Nutr. J. 6: 30 (2007).
*
-
Bloks VW, Bakker-Van Waarde WM, Verkade HJ, Kema IP, Wolters H, Vink E, Groen AK, Kuipers F. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes.
Diabetologia 47: 104-112 (2004).
*
-
Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease.
J. Clin. Endocrinol. Metab. 89: 3474-3476 (2004).
*
-
Bluestone JA. Opinion: Regulatory T-cell therapy: is it ready for the clinic?
Nat. Rev. Immunol. 5: 343-349 (2005).
*
-
Bluestone JA. CTLA-4Ig is finally making it: a personal perspective.
Am. J. Transplant. 5: 423-424 (2005).
*
-
Bluestone JA. A balanced attack.
The Scientist May, 2007 (http://www.the-scientist.com/2007/05/01/s32/1/ ) (2007).
-
Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells.
Nat. Rev. Immunol. 3: 253-257 (2003).
*
-
Bluestone JA, Boehmer H. Regulatory T cells.
Semin. Immunol. 18: 77 (2006).
*
-
Bluestone JA, St Clair EW, Turka LA. CTLA4Ig: bridging the basic immunology with clinical application.
Immunity 24: 233-238 (2006).
*
-
Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity?
Curr. Opin. Immunol. 17: 638-642 (2005).
-
Bluestone JA, Tang Q. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.
Proc. Natl. Acad. Sci. U.S.A. 101: 14622-14626 (2004).
*
-
Bluestone JA, Tang Q, Sedwick CE. T regulatory cells in autoimmune diabetes: past challenges, future prospects.
J. Clin. Immunol. 28: 677-684 (2008).
*
-
Blum S, Milman U, Shapira C, Miller-Lotan R, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy AP. Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
Arterioscler. Thromb. Vasc. Biol. 28: e18-e20 (2008).
-
Blumberg RS, Li L, Nusrat A, Parkos CA, Rubin DC, Carrington JL. Recent insights into the integration of the intestinal epithelium within the mucosal environment in health and disease.
Mucosal Immunol. 1: 330-334 (2008).
-
Blumenfeld Z. GnRH-agonists in fertility preservation.
Curr. Opin. Endocrinol. Diabetes Obes. 15: 523-528 (2008).
-
Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.
Diabetes 55: 2626-2630 (2006).
*
-
Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, Kaestner KH. Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress.
Nat. Med. 14: 828-836 (2008).
*
-
Bockenhauer D, Hug MJ, Kleta R. Cystic fibrosis, aminoglycoside treatment and acute renal failure: the not so gentle micin.
Pediatr. Nephrol. 24: 925-928 (2009).
-
Boden E, Tang Q, Bour-Jordan H, Bluestone JA. The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells.
Novartis Found. Symp. 252: 55-63 (2003).
-
Boden G. High or low carbohydrate diets: which is better for weight loss, insulin resistance and fatty livers?
Gastroenterology 136: 1490-1492 (2009).
*
-
Boden G, Zhang M. Recent findings concerning thiazolidinediones in the treatment of diabetes.
Expert Opin. Investig. Drugs 15: 243-250 (2006).
-
Bodhini D, Radha V, Deepa R, Ghosh S, Majumder PP, Rao MR, Mohan V. The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians.
Int. J. Obes. (Lond.) 31: 97-102 (2007).
*
-
Bodhini D, Radha V, Dhar M, Narayani N, Mohan V. The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians.
Metabolism 56: 1174-1178 (2007).
*
-
Bodmer M, Meier C, Kraenzlin ME, Meier CR. Risk of fractures with glitazones: a critical review of the evidence to date.
Drug Saf. 32: 539-547 (2009).
-
Bodolay E, Derfalvi B, Gergely P, Poor G. When does an autoimmune disease begin? Importance of the early diagnosis.
Orv. Hetil. 148: S25-S30 (2007).
-
Boehm BO, Bluestone JA. Differential roles of costimulatory signaling pathways in type 1 diabetes mellitus.
Rev. Diabet. Stud. 1: 156-164 (2004).
*
-
Boehm BO, Manfras B, Rosak C, Schoffling K, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus.
Klin. Wochenschr. 69: 146-150 (1991).
-
Boehm BO, Manfras B, Seidl S, Holzberger G, Kuhnl P, Rosak C, Schoffling K, Trucco M. The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease.
Tissue Antigens 37: 130-132 (1991).
-
Boehm BO, Rosinger S, Sauer G, Manfras BJ, Palesch D, Schiekofer S, Kalbacher H, Burster T. Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus.
Mol. Immunol. Jun 6 [Epub ahead of print] (2009).
*
-
Boehncke WH, Boehncke S. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
G. Ital. Dermatol. Venereol. 143: 307-313 (2008).
-
Boehncke WH, Boehncke S. Research in practice: the systemic aspects of psoriasis.
J. Dtsch. Dermatol. Ges. 6: 622-625 (2008).
-
Boehncke WH, Boehncke S. Research in practice: the systemic aspects of psoriasis.
J. Dtsch. Dermatol. Ges. Jun 16 [Epub ahead of print] (2008).
-
Boehncke WH, Buerger C, Boehncke S. Co-morbidities in psoriasis vulgaris.
Hautarzt. 60: 116-121 (2009).
-
Boesgaard TW, Zilinskaite J, Vanttinen M, Laakso M, Jansson PA, Hammarstedt A, Smith U, Stefan N, Fritsche A, Häring H, Hribal M, Sesti G, Zobel DP, Pedersen O, Hansen T; for the EUGENE 2 Consortium. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients-the EUGENE2 study.
Diabetologia 51: 816-820 (2008).
*
-
Boger CA, Stubanus M, Haak T, Gotz AK, Christ J, Hoffmann U, Riegger GA, Kramer BK. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
Nephrol. Dial. Transplant. 22: 154-162 (2007).
-
Bogoyevitch MA. The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting.
Bioessays 28: 923-934 (2006).
*
-
Bohme J, Carlsson B, Wallin J, Moller E, Persson B, Peterson PA, Rask L. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes.
J. Immunol. 137: 941-947 (1986).
-
Bohmova K, Hladikova Z, Cerny M, Flajsmanova K, Vrabelova Z, Skramlikova T, Spalova I, Cerna M, Chudoba D, Pithova P, Stadlerova G, Bartaskova D, Faresjo M, Stechova K. Cord blood cytokine profile detection in neonates with T1D parents - monitoring of cellular auto-reactivity using protein microarray.
Scand. J. Immunol. 66: 563-571 (2007).
*
-
Bohren KM, Gabbay KH, Owerbach D. Affinity chromatography of native SUMO proteins using His-tagged recombinant UBC9 bound to Co(2+)-charged talon resin.
Protein Expr. Purif. 54: 289-294 (2007).
*
-
Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.
J. Biol. Chem. 279: 27233-27238 (2004).
*
-
Boillot O, Mayer DA, Boudjema K, Salizzoni M, Gridelli B, Filipponi F, Trunecka P, Krawczyk M, Clavien PA, Ducerf C, Margarit C, Margreiter R, Pallardo JM, Hoeckerstedt K, Pageaux GP. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
Liver Transpl. 11: 61-67 (2005).
*
-
Boitard C, Debray-Sachs M, Bach JF. Autoimmune disorders in diabetes.
Adv. Nephrol. Necker Hosp. 15: 281-305 (1986).
-
Bollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE, Gersuk VH, Aderem A, Hawn TR, Nepom GT. The Toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury.
PLoS ONE 4: e5063 (2009).
*
-
Bongardt F, Schopfer-Wendels A, Huth C, Heid I, Rathmann W, Martin S, Vollmert C, Holle R, Thorand B, Wichmann HE, Koenig W, Kolb H, Herder C. Genetics of type 2 diabetes: impact of interleukin-6 gene variants.
Gesundheitswesen 67 Suppl. 1: 122-126 (2005).
-
Bongartz T, Coras B, Vogt T, Scholmerich J, Muller-Ladner U. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
Rheumatology (Oxford) 44: 126-129 (2005).
*
-
Bongiorno MR, Pistone G, de Giorgi V, Arico M. Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis.
Dermatol. Ther. 21 Suppl. 3: S15-S20 (2008).
-
Bonifacio E, Achenbach P, Pan L, Ziegler AG. Mucosal insulin vaccination for type 1 diabetes prevention.
Exp. Clin. Endocrinol. Diabetes 116 Suppl. 1: S26-S29 (2008).
-
Bonifacio E, Ziegler A, Achenbach P, Barker J, Eisenbarth G. Translating mucosal antigen based prevention of autoimmune diabetes to human.
Novartis Found. Symp. 292: 187-199 (2008).
-
Bonkovsky HL. Hepatic manifestations of systemic disease.
Clin. Liver Dis. 6: xiii-xiv (2002). *
-
Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, Lalic N, Walker M; on behalf of the EGIR-RISC Study group. Influence of the ACE gene I/D polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects.
Diabetes Care 31: 789-794 (2008).
*
-
Bonora E. Protection of pancreatic beta-cells: is it feasible?
Nutr. Metab. Cardiovasc. Dis. 18: 74-83 (2007).
-
Bookstaver PB, Norris L, Rudisill C, Dewitt T, Aziz S, Fant J. Multiple toxic effects of low-dose methotrexate in a patient treated for psoriasis.
Am. J. Health Syst. Pharm. 65: 2117-2121 (2008).
-
Boom A, Lybaert P, Pollet JF, Jacobs P, Jijakli H, Golstein PE, Sener A, Malaisse WJ, Beauwens R. Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas.
Endocrine 32: 197-205 (2007).
-
Boomgaarden I, Bosy-Westphal A, Muller MJ, Doring F. Influence of a type 2 diabetes associated prostaglandin E synthase 2 polymorphism on blood prostaglandin E2 levels.
Prostaglandins Leukot. Essent. Fatty Acids 80: 185-188 (2009).
*
-
Boraska V, Skrabic V, Culic VC, Becic K, Kapitanovic S, Zemunik T. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population.
Biol. Res. 41: 157-163 (2008).
*
-
Boraska V, Skrabic V, Zeggini E, Groves CJ, Buljubalic M, Peruzovic M, Zemunik T. Family-based analysis of vitamin D receptor gene polymorphisms and type 1 diabetes in the population of South Croatia.
J. Hum. Genet. 53: 210-214 (2008).
*
-
Boraska V, Terzic J, Skrabic V, Cacev T, Bucevic-Popovic V, Peruzovic M, Markotic A, Zemunik T. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia.
Croat. Med. J. 47: 571-578 (2006).
*
-
Boraska V, Torlak V, Skrabic V, Kacic Z, Jaksic J, Stipancic G, Spehar A, Markotic A, Zemunik T. Glycosyltransferase B4GALNT1 and type 1 diabetes in Croatian population.
Clin. Biochem. 42: 819-822 (2009).
*
-
Boraska V, Zeggini E, Groves CJ, Rayner NW, Skrabic V, Diakite M, Rockett KA, Kwiatkowski D, McCarthy MI, Zemunik T. Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia.
Hum. Immunol. 70: 195-199 (2009).
-
Borel V, Gallot D, Marceau G, Sapin V, Blanchon L. Placental implications of peroxisome proliferator-activated receptors in gestation and parturition.
PPAR Res. 2008: 758562 (2008).
*
-
Borgaonkar MR, Morgan DG. Primary biliary cirrhosis and type II autoimmune polyglandular syndrome.
Can. J. Gastroenterol. 13: 767-770 (1999).
-
Boris M, Kaiser C, Golblatt A, Elice MW, Edelson SM, Adams JB, Feinstein DL. Effect of pioglitazone treatment on behavioral symptoms in autistic children.
J. Neuroinflammation 4: 3 (2007).
*
-
Bornstein SR, Schumann RR, Rettori V, McCann SM, Zacharowski K. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals.
Horm. Metab. Res. 36: 470-473 (2004).
-
Bortell R, Pino SC, Greiner DL, Zipris D, Rossini AA. Closing the circle between the bedside and the bench: Toll-like receptors in models of virally induced diabetes.
Ann. N. Y. Acad. Sci. 1150: 112-122 (2008).
*
-
Boscolo S, Sarich A, Lorenzon A, Passoni M, Rui V, Stebel M, Sblattero D, Marzari R, Hadjivassiliou M, Tongiorgi E. Gluten ataxia: passive transfer in a mouse model.
Ann. N. Y. Acad. Sci. 1107: 319-328 (2007).
*
-
Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, Piemonti L, Pastore MR, Paroni R. Increased intestinal permeability precedes clinical onset of type 1 diabetes.
Diabetologia 49: 2824-2827 (2006).
*
-
Bosnjak AP, Grguric J. Long-term health effects of breastfeeding.
Lijec. Vjesn. 129: 293-298 (2007).
-
Botella Romero F, Alfaro Martinez JJ. Nutritional repercussions and management of chronic pancreatitis.
Nutr. Hosp. 23 Suppl. 2: 59-63 (2008).
-
Botes L, van der Westhuizen FH, Loots du T. Phytochemical contents and antioxidant capacities of two Aloe greatheadii var. davyana extracts.
Molecules 13: 2169-2180 (2008).
-
Botta S, Roveto S, Rimoldi D. Seric 21-hydroxilase antibodies in patients with anti-microsomal fraction antibodies. Autoimmune polyendocrine syndrome.
Medicina (B. Aires) 67: 143-146 (2007).
-
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.
Nat. Genet. 36: 337-338 (2004).
*
-
Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases.
Semin. Immunol. 18: 207-213 (2006).
*
-
Bouaziz JD, Yanaba K, Venturi GM, Wang Y, Tisch RM, Poe JC, Tedder TF. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice.
Proc. Natl. Acad. Sci. U.S.A. 104: 20878-20883 (2007).
*
-
Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice.
Endocr. Rev. 29: 726-776 (2008).
*
-
Boulton JG, Bourne JT. Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis.
Rheumatology (Oxford) 46: 178-179 (2007).
*
-
Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J, Comas D. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population.
Genes Immun. 4: 132-137 (2003).
*
-
Bour-Jordan H, Bluestone JA. B cell depletion: a novel therapy for autoimmune diabetes?
J. Clin. Invest. 117: 3642-3645 (2007).
*
-
Bour-Jordan H, Bluestone JA. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.
Immunol. Rev. 229: 41-66 (2009).
*
-
Bour-Jordan H, Bluestone JA. Sensory neurons link the nervous system and autoimmune diabetes.
Cell 127: 1097-1099 (2006).
*
-
Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment.
Nat. Immunol. 4: 182-188 (2003).
*
-
Bour-Jordan H, Salomon BL, Thompson HL, Santos R, Abbas AK, Bluestone JA. Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse.
J. Immunol. 179: 1004-1012 (2007).
*
-
Bour-Jordan H, Thompson HL, Bluestone JA. Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice.
J. Immunol. 175: 5649-5655 (2005).
*
-
Bourre JM. Dietary omega-3 fatty acids for women.
Biomed. Pharmacother. 61: 105-112 (2007).
-
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients.
J. Nutr. Health Aging 10: 386-399 (2006).
-
Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ. Infection-induced inflammatory response of adipocytes in vitro.
Int. J. Obes. (Lond.) 32: 892-901 (2008).
*
-
Bouwman LH, Eerligh P, Terpstra OT, Daha MR, de Knijff P, Ballieux BE, Bruining GJ, van der Slik AR, Roos A, Roep BO. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles.
Diabetes 54: 3002-3006 (2005).
*
-
Bouwman LH, Ling Z, Duinkerken G, Pipeleers DG, Roep BO. HLA incompatibility and immunogenicity of human pancreatic islet preparations cocultured with blood cells of healthy donors.
Hum. Immunol. 66: 494-500 (2005).
-
Bouzat P, Broux C, Soriano E, Pavese P, Croize J, Stahl JP, Jacquot C. Streptococcus pneumoniae cellulitis in a diabetic patient.
Med. Mal. Infect. 37: 290-292 (2007).
-
Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, Rich SS, Freedman BI, Carr JJ, Langefeld CD. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study.
Diabetes 55: 1985-1994 (2006).
*
-
Boyle PJ. Diabetes mellitus and macrovascular disease: mechanisms and mediators.
Am. J. Med. 120: S12-S17 (2007).
*
-
Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. The pathogenic role of tissue-resident immune cells in psoriasis.
Trends Immunol. 28: 51-57 (2007).
*
-
Bozkurt O, de Boer A, Grobbee DE, Kroon AA, Schiffers P, de Leeuw P, Klungel OH. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
J. Renin Angiotensin Aldosterone Syst. 10: 101-108 (2009).
-
Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
J. Hum. Hypertens. 22: 774-780 (2008).
-
Bradbury RA, Shirkhedkar D, Glanville AR, Campbell LV. Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an "orphan" area?
Intern. Med. J. Aug 16 [Epub ahead of print] (2008).
*
-
Bradley R, Oberg EB, Calabrese C, Standish LJ. Algorithm for complementary and alternative medicine practice and research in type 2 diabetes.
J. Altern. Complement. Med. 13: 159-176 (2007).
-
Bradna P. Gout and diabetes.
Vnitr. Lek. 52: 488-492 (2006).
-
Braga-Neto UM, Marques ET. From functional genomics to functional immunomics: new challenges, old problems, big rewards.
PLoS Comput. Biol. 2: e81 (2006).
*
-
Bragt MC, Popeijus HE. Peroxisome proliferator-activated receptors and the metabolic syndrome.
Physiol. Behav. 94: 187-197 (2008).
*
-
Braier J, Chantada G, Rosso D, Bernaldez P, Amaral D, Latella A, Balancini B, Masautis A, Goldberg J. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
Pediatr. Hematol. Oncol. 16: 377-385 (1999).
-
Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs.
Clin. Endocrinol. (Oxf.) 66: 508-512 (2007).
*
-
Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical form of celiac disease. Which is now the main form of celiac disease in clinical practice?
Minerva Gastroenterol. Dietol. 48: 121-130 (2002).
-
Brant SR. Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease.
Gastroenterology 136: 396-399 (2009).
*
-
Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus: a population-based study.
Br. J. Dermatol. 159: 1331-1337 (2008).
*
-
Braun J, Arnemann J, Lohrey M, Donner H, Siegmund T, Usadel KH, Badenhoop K. No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus.
Exp. Clin. Endocrinol. Diabetes 107: 568-569 (1999).
-
Braun WE. HLA molecules in autoimmune diseases.
Clin. Biochem. 25: 187-191 (1992).
*
-
Brazionis L, Rowley K, Itsiopoulos C, O'Dea K. Plasma carotenoids and diabetic retinopathy.
Br. J. Nutr. 101: 270-277 (2009).
*
-
Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A. Polymorphisms of TGF-beta1 in cystic fibrosis patients.
Clin. Immunol. 121: 350-357 (2006).
*
-
Breant B, Gesina E, Blondeau B. Nutrition, glucocorticoids and pancreas development.
Horm. Res. 65 Suppl. 3: 98-104 (2006).
-
Bregenzer N, Hartmann A, Strauch U, Scholmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn's disease.
Inflamm. Bowel Dis. 12: 53-56 (2006).
*
-
Bregenzer N, Schaffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Scholmerich J, Andus T. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease.
Exp. Clin. Endocrinol. Diabetes 114: 1-5 (2006).
-
Breidert M, Zimmermann TF, Schneider R, Ehninger G, Brabant G. Ghrelin/leptin-imbalance in patients with primary biliary cirrhosis.
Exp. Clin. Endocrinol. Diabetes 112: 123-126 (2004).
-
Brenol CV, Monticielo OA, Xavier RM, Brenol JC. Rheumatoid arthritis and atherosclerosis.
Rev. Assoc. Med. Bras. 53: 465-470 (2007).
-
Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, Herold KC, von Herrath M. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
J. Clin. Invest. 116: 1371-1381 (2006).
*
-
Brewer GJ, Dick R, Zeng C, Hou G. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
J. Inorg. Biochem. 100: 927-930 (2006).
*
-
Briani C, Doria A, Ruggero S, Toffanin E, Luca M, Albergoni MP, D'Odorico A, Grassivaro F, Lucchetta M, De Lazzari F, Balzani I, Battistin L, Vernino S. Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease.
Autoimmunity 41: 100-104 (2008).
-
Bridoux F, Kyndt X, Abou-Ayache R, Mougenot B, Baillet S, Bauwens M, Lemaitre V, Goujon JM, Touchard G, Vanhille P. Proximal tubular dysfunction in primary Sjogren's syndrome: a clinicopathological study of 2 cases.
Clin. Nephrol. 61: 434-439 (2004).
-
Briede J, Stivrina M, Stoldere D, Vigante B, Duburs G. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Cell. Biochem. Funct. 25: 673-680 (2007).
*
-
Bright JJ. Curcumin and autoimmune disease.
Adv. Exp. Med. Biol. 595: 425-451 (2007).
-
Brilot F, Geenen V. Role of viral infections in the pathogenesis of type 1 diabetes.
Rev. Med. Liege 60: 297-302 (2005).
-
Brinar VV, Petelin Z, Brinar M, Djakovic V, Zadro I, Vranjes D. CNS demyelination in autoimmune diseases.
Clin. Neurol. Neurosurg. 108: 318-326 (2006).
-
Brinckerhoff CE, Sporn MB. Retinoids and rexinoids for the 21st century: a brave new world for arthritis.
J. Rheumatol. 30: 211-213 (2003).
-
Briscoe CP, Looper D, Tran P, Herrera J, McDonnell SR, Bhat BG. LPS-induced biomarkers in mice: a potential model for identifying insulin sensitizers.
Biochem. Biophys. Res. Commun. 361: 140-145 (2007).
*
-
Brittan M, Alison MR, Schier S, Wright NA. Bone marrow stem cell-mediated regeneration in IBD: where do we go from here?
Gastroenterology 132: 1171-1173 (2007).
*
-
Britten AC, Mijovic CH, Barnett AH, Kelly MA. Differential expression of HLA-DQ alleles in peripheral blood mononuclear cells: alleles associated with susceptibility to and protection from autoimmune type 1 diabetes.
Int. J. Immunogenet. 36: 47-57 (2009).
*
-
Broady R, Levings MK. Graft-versus-host disease: suppression by statins.
Nat. Med. 14: 1155-1156 (2008).
*
-
Brock JW, Jenkins AJ, Lyons TJ, Klein RL, Yim E, Lopes-Virella M, Carter RE, Thorpe SR, Baynes JW. Increased methionine sulfoxide content of ApoAI in type 1 diabetes.
J. Lipid Res. 49: 847-855 (2008).
*
-
Brod SA, Hood Z. Ingested (oral) SIRS peptide 1-21 suppresses type 1 diabetes in NOD mice.
J. Interferon Cytokine Res. 28: 25-30 (2008).
-
Brode S, Raine T, Zaccone P, Cooke A. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
J. Immunol. 177: 6603-6612 (2006).
*
-
Brody F, Hill S, Celenski S, Kar R, Kluk B, Pinzone J, Fu S. Expression of ectonucleotide pyrophosphate phosphodiesterase and peroxisome proliferator activated receptor gamma in morbidly obese patients.
Surg. Endosc. 21: 941-944 (2007).
*
-
Bromberg JS, LeRoith D. Diabetes cure - is the glass half full?
N. Engl. J. Med. 355: 1372-1374 (2006).
*
-
Bronson PG, Ramsay PP, Thomson G, Barcellos LF; Diabetes Genetics Consortium. Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes.
Diabetes Obes. Metab. 11 Suppl. 1: 74-83 (2009).
*
-
Brooks-Worrell B, Warsen A, Palmer JP. Improved T cell assay for identification of type 1 diabetes patients.
J. Immunol. Methods 344: 79-83 (2009).
-
Brophy S, Davies H, Bain S, Stephens JW, Cheung WY, Richards K, Wareham K, Beaverstock C, Lloyd J, Page D, Williams M, Russell I, Williams R. Randomized, controlled, parallel-group prospective study to investigate the clinical effectiveness of early insulin treatment in patients with latent autoimmune diabetes in adults.
BMC Endocr. Disord. 8: 8 (2008).
*
-
Brophy S, Yderstræde K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N, Buzzetti R, Davies H, Leslie R, Williams DR; on behalf of the Action LADA Group. Time to insulin initiation can not be used in defining latent autoimmune diabetes in adults.
Diabetes Care 31: 439-441 (2008).
*
-
Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, Pociot F; Diabetes Genetics Consortium. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.
Diabetes Obes. Metab. 11 Suppl. 1: 60-66 (2009).
*
-
Brousseau ME. Statins, super-statins and cholesterol absorption inhibitors.
IDrugs 6: 458-463 (2003).
-
Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.
N. Engl. J. Med. 350: 1505-1515 (2004).
*
-
Brown EM. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.
Endocrinol. Metab. Clin. North Am. 38: 437-445 (2009).
-
Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.
Arthritis Res. Ther. 10: 212 (2008).
*
-
Brown KK, Henke BR, Blanchard SG, Cobb JE, Mook R, Kaldor I, Kliewer SA, Lehmann JM, Lenhard JM, Harrington WW, Novak PJ, Faison W, Binz JG, Hashim MA, Oliver WO, Brown HR, Parks DJ, Plunket KD, Tong WQ, Menius JA, Adkison K, Noble SA, Willson TM. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
Diabetes 48: 1415-1424 (1999).
*
-
Brown LC, Majumdar SR, Newman SC, Johnson JA. Type 2 diabetes does not increase risk of depression.
CMAJ 175: 42-46 (2006).
*
-
Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, Cowen EW. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae.
Arch. Dermatol. 145: 63-66 (2009).
*
-
Brown WM. Anti-CD3 antibody MacroGenics Inc.
Curr. Opin. Investig. Drugs 7: 381-388 (2006).
-
Brown WM, Pierce J, Hilner JE, Perdue LH, Lohman K, Li L, Venkatesh RB, Hunt S, Mychaleckyj JC, Deloukas P; Diabetes Genetics Consortium. Overview of the MHC fine mapping data.
Diabetes Obes. Metab. 11 Suppl. 1: 2-7 (2009).
*
-
Brown WV. Expert commentary: the safety of fibrates in lipid-lowering therapy.
Am. J. Cardiol. 99: S19-S21 (2007).
*
-
Browning JD, Kumar KS, Saboorian MH, Thiele DL. Ethnic differences in the prevalence of cryptogenic cirrhosis.
Am. J. Gastroenterol. 99: 292-298 (2004).
*
-
Browning LM, Krebs JD, Moore CS, Mishra GD, O'connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype.
Diabetes Obes. Metab. 9: 70-80 (2007).
*
-
Browning SR, Briley JD, Briley LP, Chandra G, Charnecki JH, Ehm MG, Johansson KA, Jones BJ, Karter AJ, Yarnall DP, Wagner MJ. Case-control single-marker and haplotypic association analysis of pedigree data.
Genet. Epidemiol. 28: 110-122 (2005).
*
-
Bruck P, Bartsch W, Penna-Martinez M, Kahles H, Seidl C, Bohme A, Badenhoop K, Ramos-Lopez E. Polymorphisms of CXCR3-binding chemokines in type 1 diabetes.
Hum. Immunol. Apr 30 [Epub ahead of print] (2009).
-
Bruck P, Ramos-Lopez E, Bartsch W, Bohme A, Badenhoop K. TIM-3 polymorphisms in type 1 diabetes families.
J. Hum. Genet. 53: 559-564 (2008).
*
-
Bruder D, Westendorf AM, Hansen W, Prettin S, Gruber AD, Qian Y, von Boehmer H, Mahnke K, Buer J. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes.
Diabetes 54: 3395-3401 (2005).
*
-
Brugman S, Visser JT, Hillebrands JL, Bos NA, Rozing J. Prolonged exclusive breastfeeding reduces autoimmune diabetes incidence and increases regulatory T-cell frequency in bio-breeding diabetes-prone rats.
Diabetes Metab. Res. Rev. 25: 380-387 (2009).
-
Brumeanu TD, Bona CA, Casares S. T-cell tolerance and autoimmune diabetes.
Int. Rev. Immunol. 20: 301-331 (2001).
-
Brumeanu TD, Goldstein R, Casares S. Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors.
Clin. Immunol. 119: 1-12 (2006).
*
-
Brun T, Gauthier BR. A focus on the role of Pax4 in mature pancreatic islet beta-cell expansion and survival in health and disease.
J. Mol. Endocrinol. 40: 37-45 (2008).
*
-
Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, Marsh BJ, Rodrigues B, Johnson JD, Parks JS, Verchere CB, Hayden MR. beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.
Nat. Med. 13: 340-347 (2007).
*
-
Brunner W. Pruritus - also a challenge in internal medicine.
Schweiz. Med. Wochenschr. 125: 2244-2250 (1995).
-
Bruno S, Cattaneo D, Perico N, Remuzzi G. Emerging drugs for diabetic nephropathy.
Expert Opin. Emerg. Drugs 10: 747-771 (2005).
-
Brunt EM. Nonalcoholic steatohepatitis.
Semin. Liver Dis. 24: 3-20 (2004).
-
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
Am. J. Gastroenterol. 94: 2467-2474 (1999).
*
-
Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, Neuschwander-Tetri BA; NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix .. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.
Hepatology 49: 809-820 (2009).
-
Brunt EM, Ramrakhiani S, Cordes BG, Neuschwander-Tetri BA, Janney CG, Bacon BR, Di Bisceglie AM. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.
Mod. Pathol. 16: 49-56 (2003).
*
-
Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Diabetes 56: 604-612 (2007).
*
-
Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities.
Immunol. Rev. 223: 371-390 (2008).
*
-
Bryan J, Munoz A, Zhang X, Dufer M, Drews G, Krippeit-Drews P, Aguilar-Bryan L. ABCC8 and ABCC9: ABC transporters that regulate K(+) channels.
Pflugers Arch. 453: 703-718 (2007).
*
-
Buc M, Bucova M, Javor J, Krivosikova M, Stuchlikova M, Shawkatova I, Michalkova D, Barak L, Jancova E, Petrek M. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population.
Endocr. Regul. 40: 1-6 (2006).
*
-
Bucala R, Lolis E. Macrophage migration inhibitory factor: a critical component of autoimmune inflammatory diseases.
Drug News Perspect. 18: 417-426 (2005).
-
Buckingham RE. Thiazolidinediones: pleiotropic drugs with potent anti-inflammatory properties for tissue protection.
Hepatol. Res. 33: 167-170 (2005).
-
Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D"ecline?
Mol. Aspects Med. 29: 415-422 (2008).
-
Buettner C, Phillips RS, Davis RB, Gardiner P, Mittleman MA. Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks.
Am. J. Cardiol. 99: 661-666 (2007).
*
-
Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R, Pozzilli P, Erlich HA. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
Tissue Antigens 59: 452-469 (2002).
*
-
Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos.
Am. J. Hum. Genet. 72: 1505-1514 (2003).
*
-
Bugianesi E. Non-alcoholic steatohepatitis and cancer.
Clin. Liver Dis.11: 191-207 (2007).
-
Buhler MM, Craig M, Donaghue KC, Badhwar P, Willis J, Manolios N, Tait BD, Silink M, Bennetts BH, Stewart GJ. CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort.
Autoimmunity 35: 457-461 (2002).
-
Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, Garcia-Urkia N, Sarasqueta C, Cosme A, Irastorza B, Gonzalez A, Arenas J Jr. Resveratrol inhibits nonalcoholic fatty liver disease in rats.
BMC Gastroenterol. 8: 40 (2008).
*
-
Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjoquist PO, Pernow J. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-kinase/Akt and NO pathway.
Am. J. Physiol. Heart Circ. Physiol. 296: H719-H727 (2009).
*
-
Bull AW. The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease.
Arch. Pathol. Lab. Med. 127: 1121-1123 (2003).
*
-
Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.
Nephron. Physiol. 106: 69-75 (2007).
-
Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes.
Hum. Immunol. 70: 121-124 (2009).
-
Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.
Nephrol. Dial. Transplant. 22: 827-832 (2007).
-
Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A. Heat-shock protein gene polymorphisms and the risk of nephropathy in type 2 diabetes patients.
Clin. Sci. (Lond.) 116: 81-86 (2009).
-
Burch LR, Zhou K, Donnelly LA, Doney AS, Brady J, Goddard C, Morris AD, Hansen MK, Palmer CN. A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children.
J. Clin. Endocrinol. Metab. Apr 21 [Epub ahead of print] (2009).
*
-
Burgermeister E, Schnoebelen A, Flament A, Benz J, Stihle M, Gsell B, Rufer A, Ruf A, Kuhn B, Marki HP, Mizrahi J, Sebokova E, Niesor E, Meyer M. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1 alpha (PGC1alpha), prevents triglyceride accumulation and potentiates insulin signaling in vitro.
Mol. Endocrinol. 20: 809-830 (2006).
*
-
Buriak VN, Shaban NI. Clinical and pathogenetic mechanisms of the formation of complicated course of I type diabetes mellitus in children.
Lik. Sprava. 3: 24-29 (2007).
-
Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.
Am. J. Transplant. 4: 686-693 (2004).
*
-
Burke MA, Mutharasan RK, Ardehali H. The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel.
Circ. Res. 102: 164-176 (2008).
*
-
Burns KA, Vanden Heuvel JP. Modulation of PPAR activity via phosphorylation.
Biochim. Biophys. Acta 1771: 952-960 (2007).
*
-
Burster T, Marin-Esteban V, Boehm BO, Dunn S, Rotzschke O, Falk K, Weber E, Verhelst SH, Kalbacher H, Driessen C. Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions.
Biochem. Pharmacol. 74: 1514-1523 (2007).
*
-
Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA. Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.
Clin. Ther. 27: 1181-1195 (2005).
*
-
Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies.
Autoimmun. Rev. 8: 332-336 (2009).
-
Butler MG, Hodes ME, Conneally PM, Biegel AA, Wright JC. Linkage analysis in a large kindred with autosomal dominant transmission of polyglandular autoimmune disease type II (Schmidt syndrome).
Am. J. Med. Genet. 18: 61-65 (1984).
-
Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study.
Arthritis Res. Ther. 8: R27-R30 (2006).
*
-
Butt MS, Tahir-Nadeem M, Khan MK, Shabir R, Butt MS. Oat: unique among the cereals.
Eur. J. Nutr. 47: 68-79 (2008).
*
-
Butty V, Campbell C, Mathis D, Benoist C; the Diabetes Prevention Trial-Type 1 Study Group. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).
Diabetes 57: 2348-2359 (2008).
*
-
Butty V, Roy M, Sabeti P, Besse W, Benoist C, Mathis D. Signatures of strong population differentiation shape extended haplotypes across the human CD28, CTLA4, and ICOS costimulatory genes.
Proc. Natl. Acad. Sci. U.S.A. 104: 570-575 (2007).
*
-
Buyse I, Sandkuyl LA, Zamani Ghabanbasani M, Gu XX, Bouillon R, Bex M, Dooms L, Emonds MP, Duhamel M, Marynen P, et al. Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population.
Diabetologia 37: 808-817 (1994).
-
Buysschaert M, Tomasi JP, Hermans MP. Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with type 1 diabetes.
Diabet. Med. 22: 889-892 (2005).
*
-
Buzi F, Badolato R, Mazza C, Giliani S, Notarangelo LD, Radetti G, Plebani A, Notarangelo LD. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria?
J. Clin. Endocrinol. Metab. 88: 3146-3148 (2003).
*
-
Buzzetti R, Petrone A, Capizzi M, Bosi E; for the Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes: response to Kobayashi et al.
Diabetes Care 30: e127 (2007).
-
Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA, Maiani F, Tiberti C, Baroni MG, Vecci E, Arca M, Leonetti F, Mario UD. The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.
Eur. J. Hum. Genet. 12: 1050-1054 (2004).
*
-
Cabral VL, Patrício FR, Gabbay MA, Dib SA, Miszputen SJ. Intraepithelial lymphocytes in duodenum from Brazilian adolescents with type 1 diabetes. Influence of Helicobacter pylori.
Pediatr. Diabetes Nov 10 [Epub ahead of print] (2008).
-
Cabrera-Rode E, Sarmiento L, Molina G, Perez C, Arranz C, Galvan JA, Prieto M, Barrios J, Palomera R, Fonseca M, Mas P, Diaz-Diaz O, Diaz-Horta O. Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report.
J. Med. Virol. 76: 373-377 (2005).
*
-
Cabrero A, Alegret M, Sanchez RM, Adzet T, Laguna JC, Vazquez M. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes.
Diabetes 50: 1883-1890 (2001).
*
-
Cadahia V, Rodrigo L, Fuentes D, Riestra S, De Francisco R, Fernandez M. Celiac disease (CD), ulcerative colitis (UC), and primary sclerosing cholangitis (PSC) in one patient: a family study.
Rev. Esp. Enferm. Dig. 97: 907-913 (2005).
*
-
Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function.
Aliment. Pharmacol. Ther. 26: 1-8 (2007).
*
-
Caffrey C, Hitman GA, Niven MJ, Cassell PG, Kumar P, Fry L, Mackintosh P, Gallagher R, Feighery C, Weir D, et al. HLA-DP and coeliac disease: family and population studies.
Gut 31: 663-667 (1990).
*
-
Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK, Hsueh WA. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
Diabetes 57: 2470-2479 (2008).
*
-
Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
Nat. Med. 11: 183-190 (2005).
*
-
Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.
Free Radic. Biol. Med. 41: 851-861 (2006).
-
Caicedo RA, Li N, DES Robert C, Scumpia PO, Hubsher CP, Wasserfall CH, Schatz DA, Atkinson MA, Neu J. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes.
Pediatr. Res. 63: 303-307 (2008).
*
-
Caillat-Zucman S. Molecular mechanisms of HLA association with autoimmune diseases.
Tissue Antigens 73: 1-8 (2009).
*
-
Caillat-Zucman S, Daniel S, Djilali-Saiah I, Timsit J, Garchon HJ, Boitard C, Bach JF. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus.
Hum. Immunol. 44: 80-87 (1995).
-
Cakir M, Akcay S, Karakas T, Gedik Y, Okten A, Orhan F. Prevalence of atopy in children with type 1 diabetes mellitus, hepatitis B virus carriers, and healthy children: role of T helper 1 (Th1)-type immune response.
Allergy Asthma Proc. 29: 166-170 (2008).
-
Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, Corneli RB, Ferretti E, Gulino A, Grasso F, De Simone C, Di Mario U, Falorni A, Boirivant M, Dotta F. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.
Diabetologia 48: 1565-1575 (2005).
*
-
Calderon B, Suri A, Miller MJ, Unanue ER. Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules.
Proc. Natl. Acad. Sci. U.S.A. 105: 6121-6126 (2008).
*
-
Calderon B, Suri A, Pan XO, Mills JC, Unanue ER. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.
J. Immunol. 181: 6964-6974 (2008).
-
Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma.
Gastroenterology 127 (5 Suppl. 2): S97-S103 (2004).
*
-
Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Am. J. Gastroenterol. 96: 519-525 (2001).
*
-
Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Hepatology 29: 664-669 (1999).
*
-
Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR-alpha and gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.
Nephrol. Dial. Transplant. 21: 2399-2405 (2006).
-
Calkin AC, Jandeleit-Dahm KA, Sebekova E, Allen TJ, Mizrahi J, Cooper ME, Tikellis C. PPARs and diabetes-associated atherosclerosis.
Curr. Pharm. Des. 13: 2736-2741 (2007).
-
Calkin AC, Thomas MC. PPAR agonists and cardiovascular disease in diabetes.
PPAR Res. 2008: 245410 (2008).
*
-
Calsolari MR, Rosario PW, Reis JS, Silva SC, Purisch S. Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?
Arq. Bras. Endocrinol. Metabol. 52: 315-321 (2008).
-
Calverley DC, Baldermann LV, Moran K, Chen NN, McFann K. Platelet FcgammaRIIA expression is associated with the alpha(2) integrin C807T gene polymorphism in type 2 diabetes.
Platelets 17: 78-83 (2006).
-
Calvisi DF, Evert M, Dombrowski F. Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats.
Arch. Physiol. Biochem. 115: 97-104 (2009).
*
-
Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status.
J. Nutr. 135: 310-316 (2005).
*
-
Calzascia T, Pellegrini M, Lin A, Garza KM, Elford AR, Shahinian A, Ohashi PS, Mak TW. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.
Proc. Natl. Acad. Sci. U.S.A. 105: 2999-3004 (2008).
*
-
Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells?
Nat. Rev. Immunol. 7: 633-643 (2007).
*
-
Cambon-Thomsen A, Roth MP. Genetics of autoimmune diseases.
Rev. Prat. 44: 43-52 (1994).
-
Cameron EA, Martinez-Marignac VL, Chan A, Valladares A, Simmonds LV, Wacher N, Kumate J, McKeigue P, Shriver MD, Kittles R, Cruz M, Parra EJ. MGEA5-14 polymorphism and type 2 diabetes in Mexico City.
Am. J. Hum. Biol. 19: 593-596 (2007).
-
Cameron NE, Cotter MA. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
Exp. Neurol. 207: 23-29 (2007).
-
Campbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance.
Sci. Prog. 88: 157-202 (2005).
-
Campbell JN, Meyer RA. Mechanisms of neuropathic pain.
Neuron 52: 77-92 (2006).
*
-
Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, Markmann JF, Olthoff KM, Shaked A, Reddy KR. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation.
Liver Transpl. 11: 1048-1055 (2005).
*
-
Campbell PD, Estella E, Dudek NL, Jhala G, Thomas HE, Kay TW, Mannering SI. Cytotoxic T-lymphocyte-mediated killing of human pancreatic islet cells in vitro.
Hum. Immunol. 69: 543-551 (2008).
-
Campbell-Thompson M, Dixon LR, Wasserfall C, Monroe M, McGuigan JM, Schatz D, Crawford JM, Atkinson MA. Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area.
Diabetologia 52: 262-270 (2009).
*
-
Campese AF, Grazioli P, Colantoni S, Anastasi E, Mecarozzi M, Checquolo S, De Luca G, Bellavia D, Frati L, Gulino A, Screpanti I. Notch3 and pTalpha/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells.
Int. Immunol. 21: 727-743 (2009).
-
Campise M. Post-transplant diabetes mellitus: diagnosis and treatment.
G. Ital. Nefrol. 24: 547-557 (2007).
-
Campos GM, Bambha K, Vittinghoff E, Rabl C, Posselt AM, Ciovica R, Tiwari U, Ferrel L, Pabst M, Bass NM, Merriman RB. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
Hepatology 47: 1916-1923 (2008).
*
-
Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes.
Diabetes 54: 3326-3330 (2005).
*
-
Candeloro P, Voltattorni CB, Perniola R, Bertoldi M, Betterle C, Mannelli M, Giordano R, De Bellis A, Tiberti C, Laureti S, Santeusanio F, Falorni A. Mapping of human autoantibody epitopes on aromatic L-amino acid decarboxylase.
J. Clin. Endocrinol. Metab. 92: 1096-1105 (2007).
*
-
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck AM, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.
Gut Feb 24 [Epub ahead of print] (2009).
*
-
Cannon CP. Combination therapy in the management of mixed dyslipidaemia.
J. Intern. Med. 263: 353-365 (2008).
*
-
Cannon JL, Collins A, Mody PD, Balachandran D, Henriksen KJ, Smith CE, Tong J, Clay BS, Miller SD, Sperling AI. CD43 regulates Th2 differentiation and inflammation.
J. Immunol. 180: 7385-7393 (2008).
*
-
Cannons JL, Chamberlain G, Howson J, Smink LJ, Todd JA, Peterson LB, Wicker LS, Watts TH. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
J. Autoimmun. 25: 13-20 (2005).
-
Cano DA, Hebrok M, Zenker M. Pancreatic development and disease.
Gastroenterology 132: 745-762 (2007).
*
-
Cano DA, Sekine S, Hebrok M. Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis.
Gastroenterology 131: 1856-1869 (2006).
*
-
Cantor J, Haskins K. Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1.
J. Immunol. 179: 5760-5767 (2007).
*
-
Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?
Proc. Soc. Exp. Biol. Med. 223: 230-233 (2000).
*
-
Cantorna MT, Mahon BD. D-hormone and the immune system.
J. Rheumatol. Suppl. 76: 11-20 (2005).
*
-
Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.
Exp. Biol. Med. (Maywood) 229: 1136-1142 (2004).
*
-
Cao L, Xu X, Cao LL, Wang RH, Coumoul X, Kim SS, Deng CX. Absence of full-length Brca1 sensitizes mice to oxidative stress, and carcinogen-induced tumorigenesis in the esophagus and forestomach.
Carcinogenesis 28: 1401-1407 (2007).
*
-
Cap J. Hypothyroidism substitution and adrenal insufficiency in diabetic patients.
Vnitr. Lek. 55: 371-374 (2009).
-
Capeau J. The story of adiponectin and its receptors AdipoR1 and R2: to follow.
J. Hepatol. 47: 736-738 (2007).
-
Capell WH, Eckel RH. Severe hypertriglyceridemia with a history of treatment failure.
Nat. Clin. Pract. Endocrinol. Metab. 1: 53-58 (2005).
*
-
Capitani G, De Biase D, Gut H, Ahmed S, Grutter MG. Structural model of human GAD65: prediction and interpretation of biochemical and immunogenic features.
Proteins 59: 7-14 (2005).
*
-
Capitano ML, Ertel BR, Repasky EA, Ostberg JR. Winner of the 2007 Society for Thermal Medicine Young Investigator Award. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice.
Int. J. Hyperthermia 24: 141-149 (2008).
-
Capittini C, Pasi A, Bergamaschi P, Tinelli C, De Silvestri A, Mercati MP, Badulli C, Garlaschelli F, Sbarsi I, Guarene M, Martinetti M, Salvaneschi L, Cuccia M. HLA haplotypes and birth weight variation: is your future going to be light or heavy?
Tissue Antigens Jun 4 [Epub ahead of print] (2009).
-
Capobianco E, Martínez N, Higa R, White V, Jawerbaum A. The effects of maternal dietary treatments with natural PPAR ligands on lipid metabolism in fetuses from control and diabetic rats.
Prostaglandins Leukot. Essent. Fatty Acids 79: 191-199 (2008).
*
-
Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
Eur. Cytokine Netw. 17: 167-174 (2006).
-
Caputo M, Cerrone GE, Lopez AP, Villalba A, Krochik GA, Cedola FN, Targovnik HM, Frechtel GD. Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA).
Autoimmunity 38: 277-281 (2005).
-
Caputo M, Cerrone GE, Mazza C, Cédola N, Targovnik HM, Gustavo DF. No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes.
Immunol. Invest. 36: 259-270 (2007).
-
Carbone J, Sarmiento E, Rodriguez-Molina J, Fernandez-Cruz E. Atypical presentation of common variable immunodeficiency without infections.
Allergol. Immunopathol. (Madr.) 32: 218-222 (2004).
-
Cardell SL. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Clin. Exp. Immunol. 143: 194-202 (2006).
*
-
Cardenas A, Kelly CP. Celiac sprue.
Semin. Gastrointest. Dis. 13: 232-244 (2002).
-
Carella AM, Conte M. Therapeutic options for metabolic syndrome in obese patients.
Clin. Ter. 158: 457-464 (2007).
-
Carey AL, Petersen EW, Bruce CR, Southgate RJ, Pilegaard H, Hawley JA, Pedersen BK, Febbraio MA. Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion.
Diabetologia 49: 1000-1007 (2006).
*
-
Cariou B. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
Diabetes Metab. 34: 685-691 (2008).
-
Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
J. Biol. Chem. 281: 11039-11049 (2006).
*
-
Carlberg C, Dunlop TW. An integrated biological approach to nuclear receptor signaling in physiological control and disease.
Crit. Rev. Eukaryot. Gene Expr. 16: 1-22 (2006).
-
Carless M. Investigation of genomic methylation status using methylation-specific and bisulfite sequencing polymerase chain reaction.
Methods Mol. Biol. 523: 1-18 (2009).
-
Carlile GW, Robert R, Zhang D, Teske KA, Luo Y, Hanrahan JW, Thomas DY. Correctors of protein trafficking defects identified by a novel high-throughput screening assay.
Chembiochem. 8: 1012-1020 (2007).
-
Carlsen M, Cilio CM. Normal T cell development in the absence of thymic insulin expression.
Ann. N. Y. Acad. Sci. 1079: 205-212 (2006).
*
-
Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies.
Nature 429: 446-452 (2004).
*
-
Carmena R. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.
Am. Heart J. 150: 859-870 (2005).
*
-
Carmena R, Betteridge DJ. Statins and diabetes.
Semin. Vasc. Med. 4: 321-332 (2004).
-
Carmona MC, Louche K, Lefebvre B, Pilon A, Hennuyer N, Audinot-Bouchez V, Fievet C, Torpier G, Formstecher P, Renard P, Lefebvre P, Dacquet C, Staels B, Casteilla L, Penicaud L. S 26948, a new specific PPARgamma modulator (SPPARM) with potent antidiabetic and antiatherogenic effects.
Diabetes 56: 2797-2808 (2007).
*
-
Carneiro M, Dumont C. Pernicious anemia in an adolescent with type 1 diabetes mellitus.
Arch. Pediatr. 16: 357-359 (2009).
-
Carpenter DO. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health.
Rev. Environ. Health 21: 1-23 (2006).
-
Carpentier YA, Portois L, Malaisse WJ. n-3 Fatty acids and the metabolic syndrome.
Am. J. Clin. Nutr. 83: 1499S-1504S (2006).
*
-
Carpo M, Scarlato M, Bardella M, Terrani C, Peracchi M, Allaria S, Nobile-Orazio E, Bresolin N. Painful sensory neuropathy and dysimmunity: is there a relation?
J. Peripher. Nerv. Syst. 9: 121 (2004).
-
Carr EJ, Clatworthy MR, Lowe CE, Todd JA, Wong A, Vyse TJ, Kamesh L, Watts RA, Lyons PA, Smith KG. Contrasting genetic association of IL2RA with SLE and ANCA - associated vasculitis.
BMC Med. Genet. 10: 22 (2009).
*
-
Carrier CM, Mollen N, Rothman WC, Rodriguez de Cordoba S, Rey-Campos J, Ginsberg-Fellner F, Carpenter C, Rubinstein P. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships.
Hum. Immunol. 24: 51-63 (1989).
-
Carroccio A, Di Prima L, Scalici C, Soresi M, Cefalu AB, Noto D, Averna MR, Montalto G, Iacono G. Unexplained elevated serum pancreatic enzymes: a reason to suspect celiac disease.
Clin. Gastroenterol. Hepatol. 4: 455-459 (2006).
-
Carson KL, Hunt CM. Medical problems occurring after orthotopic liver transplantation.
Dig. Dis. Sci. 42: 1666-1674 (1997).
*
-
Carter JD, Chen M, Ellett JD, Smith KM, Nadler JL, Yang Z. Impact of donor immune cells in pancreatic islet transplantation.
Transplant. Proc. 36: 2866-2868 (2004).
*
-
Carvajal K, Hernandez-Esquivel Mde L, Moreno-Sanchez R. PPARs, metabolic syndrome and cardiac diseases.
Arch. Cardiol. Mex. 77 Suppl. 4: S4-S66-S76 (2007).
-
Carvalho JF, Blank M, Shoenfeld Y. Vascular endothelial growth factor (VEGF) in autoimmune diseases.
J. Clin. Immunol. 27: 246-256 (2007).
*
-
Casals-Casas C, Feige JN, Desvergne B. Interference of pollutants with PPARs: endocrine disruption meets metabolism.
Int. J. Obes. (Lond.) 32 Suppl. 6: S53-S61 (2008).
*
-
Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries S, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review.
Am. J. Epidemiol. 164: 921-935 (2006).
*
-
Casas L, Berry DR, Logan K, Copeland KC, Royall JA. Cystic fibrosis related diabetes in an extremely young patient.
J. Cyst. Fibros. 6: 247-249 (2007).
-
Cases Amenos A, Goicoechea Diezhandino M, de Alvaro Moreno F. Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment.
Nefrologia 28 Suppl. 3: 39-48 (2008).
-
Casey WM, Brodie T, Yoon L, Ni H, Jordan HL, Cariello NF. Correlation analysis of gene expression and clinical chemistry to identify biomarkers of skeletal myopathy in mice treated with PPAR agonist GW610742X.
Biomarkers 13: 364-376 (2008).
-
Cashman KD. Vitamin D in childhood and adolescence.
Postgrad. Med. J. 83: 230-235 (2007).
*
-
Casper RC. Nutrients, neurodevelopment, and mood.
Curr. Psychiatry Rep. 6: 425-429 (2004).
-
Cassuto H, Kochan K, Chakravarty K, Cohen H, Blum B, Olswang Y, Hakimi P, Xu C, Massillon D, Hanson RW, Reshef L. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver via an extended glucocorticoid regulatory unit.
J. Biol. Chem. 280: 33873-33884 (2005).
*
-
Castano G, Fernandez L, Mas R, Illnait J, Mesa M, Fernandez JC. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
Clin. Drug Investig. 23: 639-650 (2003).
-
Castellani C, Quinzii C, Altieri S, Mastella G, Assael BM. A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes.
Genet. Test. 5: 249-254 (2001).
-
Castellanos-Rubio A, Martin-Pagola A, Santin I, Hualde I, Aransay AM, Castano L, Vitoria JC, Bilbao JR. Combined functional and positional gene information for the identification of susceptibility variants in celiac disease.
Gastroenterology 134: 738-746 (2008).
*
-
Castellanos-Rubio A, Santin I, Irastorza I, Castano L, Carlos Vitoria J, Ramon Bilbao J. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin.
Autoimmunity 42: 69-73 (2009).
-
Castiblanco J, Varela DC, Castano-Rodriguez N, Rojas-Villarraga A, Hincapie ME, Anaya JM. TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus.
Infect. Genet. Evol. 8: 541-544 (2008).
-
Castriota G, Thompson GM, Lin Y, Scherer PE, Moller DE, Berger JP. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein.
Cell Biol. Int. 31: 586-591 (2007).
*
-
Casu A, Trucco M, Pietropaolo M. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
Pediatr. Clin. North Am. 52: 1779-1804 (2005).
-
Catalan V, Gomez-Ambrosi J, Ramirez B, Rotellar F, Pastor C, Silva C, Rodriguez A, Gil MJ, Cienfuegos JA, Fruhbeck G. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass.
Obes. Surg. 17: 1464-1474 (2007).
-
Catnach SM, Ballinger AB, Stevens M, Fairclough PD, Trembath RC, Drury PL, Watkins PJ. Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy.
Gut 34: 1123-1127 (1993).
*
-
Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis.
J. Mol. Med. 85: 777-782 (2007).
*
-
Cavalier E, Delanaye P, Chapelle JP, Souberbielle JC. Vitamin D: current status and perspectives.
Clin. Chem. Lab. Med. 47: 120-127 (2009).
*
-
Cavallini M. Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients.
Wound Repair Regen. 15: 35-38 (2007).
-
Cavan DA, Jacobs KH, Penny MA, Kelly MA, Mijovic C, Jenkins D, Fletcher JA, Barnett AH. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population.
Diabetologia 36: 252-257 (1993).
-
Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology.
FEBS Lett. 582: 117-131 (2008).
*
-
Cebeci AN, Nuhoglu Y, Arslanoglu I, Erguven M, Agachan N. The role of IL-18 in Th1/Th2 balance in children.
Allergy Asthma Proc. 27: 365-370 (2006).
-
Cejkova P, Fojtikova M, Cerna M. Immunomodulatory role of prolactin in diabetes development.
Autoimmun. Rev. Feb 24 [Epub ahead of print] (2009).
-
Cejkova P, Novota P, Cerna M, Kololtova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. KCNJ11 E23K polymorphism and diabetes mellitus with adult onset in Czech patients.
Folia Biol. (Praha) 53: 173-175 (2007).
-
Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
Int. J. Immunogenet. 35: 133-140 (2008).
*
-
Celik S, Doesch A, Erbel C, Blessing E, Ammon K, Koch A, Katus HA, Dengler TJ. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
Transplantation 86: 245-250 (2008).
-
Ceperuelo-Mallafre V, Miranda M, Chacon MR, Vilarrasa N, Megia A, Gutierrez C, Fernandez-Real JM, Gomez JM, Caubet E, Fruhbeck G, Vendrell J. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes.
J. Clin. Endocrinol. Metab. 92: 3640-3645 (2007).
*
-
Cerna M. Genetics of autoimmune diabetes mellitus.
Wien. Med. Wochenschr. 158: 2-12 (2008).
*
-
Cerna M, Kolostova K, Novota P, Romzova M, Cejkova P, Pinterova D, Pruhova S, Treslova L, Andel M. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions.
Ann. N. Y. Acad. Sci. 1110: 140-150 (2007).
*
-
Cernea S, Pozzilli P. New potential treatments for protection of pancreatic B-cell function in type 1 diabetes.
Diabet. Med. 25: 1259-1267 (2008).
*
-
Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults.
Mol. Diagn. 8: 43-49 (2004).
-
Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T, Cilio CM, Groop L. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes.
Diabetes 57: 1433-1437 (2008).
*
-
Cetin I, Alvino G, Cardellicchio M. Long chain fatty acids and dietary fats in fetal nutrition.
J. Physiol. Jun 15 [Epub ahead of print] (2009).
-
Ch'ng CL, Jones MK, Kingham JG. Celiac disease and autoimmune thyroid disease.
Clin. Med. Res. 5: 184-192 (2007).
*
-
Cha DR, Zhang X, Zhang Y, Wu J, Su DM, Han JY, Fang X, Yu B, Breyer MD, Guan Y. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Diabetes 56: 2036-2045 (2007).
*
-
Chabchoub G, Mnif M, Maalej A, Charfi N, Ayadi H, Abid M. Epidemiologic study of autoimmune thyroid disease in south Tunisia.
Ann. Endocrinol. (Paris) 67: 591-595 (2006).
-
Chakravarthy MV, Semenkovich CF. The ABCs of beta-cell dysfunction in type 2 diabetes.
Nat. Med. 13: 241-242 (2007).
*
-
Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis.
Arthritis Rheum. 54: 899-907 (2006).
*
-
Chalasani N, Teal E, Hall SD. Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.
Am. J. Gastroenterol. 100: 1317-1321 (2005).
*
-
Chamberlain G, Wallberg M, Rainbow D, Hunter K, Wicker LS, Green EA. A 20-Mb region of chromosome 4 controls TNF-alpha-mediated CD8+ T cell aggression toward beta cells in type 1 diabetes.
J. Immunol. 177: 5105-5114 (2006).
*
-
Chamberland D, Weight C, Rasmussen M, Abraham D. Thyroxine malabsorption in a patient with type 1 diabetes and celiac disease.
Endocr. Pract. 11: 203-204 (2005).
-
Chan AW, Butzner JD, McKenna R, Fritzler MJ. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients.
Pediatrics 107: e8 (2001).
*
-
Chan EY, Larson AM, Gernsheimer TB, Kowdley KV, Carithers RL Jr, Reyes JD, Perkins JD. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients.
Liver Transpl. 13: 516-522 (2007).
*
-
Chan J, Clements W, Field J, Nasa Z, Lock P, Yap F, Toh BH, Alderuccio F. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
J. Gene Med. 8: 1281-1290 (2006).
-
Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, De Rosa V, Perna F, Fontana S, Mantzoros CS. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans.
Proc. Natl. Acad. Sci. U.S.A. 103: 8481-8486 (2006).
*
-
Chan KM, Raikwar SP, Zavazava N. Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence.
Immunol. Res. 39: 261-270 (2007).
-
Chan PS, Kanwar M, Kowluru RA. Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory.
J. Diabetes Complications Dec 2 [Epub ahead of print] (2008).
-
Chandak GR, Idris MM, Reddy DN, Mani KR, Bhaskar S, Rao GV, Singh L. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
Gut 53: 723-728 (2004).
*
-
Chang F, Jaber LA, Berlie HD, O'Connell MB. Evolution of peroxisome proliferator-activated receptor agonists.
Ann. Pharmacother. 41: 973-983 (2007).
-
Chang KY, Unanue ER. Prediction of HLA-DQ8 beta cell peptidome using a computational program and its relationship to autoreactive T cells.
Int. Immunol. 21: 705-713 (2009).
-
Chang LT, Sun CK, Wang CY, Youssef AA, Wu CJ, Chua S, Yip HK. Downregulation of peroxisme proliferator activated receptor gamma co-activator 1alpha in diabetic rats.
Int. Heart J. 47: 901-910 (2006).
-
Chang Y, Yap S, Ge X, Piganelli J, Bertera S, Giannokakis N, Mathews C, Prud'homme G, Trucco M. DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice.
Gene Ther. 12: 1679-1685 (2005).
*
-
Chang YH, Huang CN, Wu CY, Shiau MY. Association of Interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus.
Hum. Immunol. 66: 1258-1263 (2005).
-
Chang YT, Chen TJ, Liu PC, Chen YC, Chen YJ, Huang YL, Jih JS, Chen CC, Lee DD, Wang WJ, Lin MW, Liu HN. Epidemiological study of psoriasis in the national health insurance database in Taiwan.
Acta Derm. Venereol. 89: 262-266 (2009).
-
Channual J, Wu JJ, Dann FJ. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
Dermatol. Ther. 22: 61-73 (2009).
-
Chaparro RJ, Burton AR, Serreze DV, Vignali DA, Dilorenzo TP. Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.
J. Immunol. Methods 335: 106-115 (2008).
*
-
Chaparro RJ, Konigshofer Y, Beilhack GF, Shizuru JA, McDevitt HO, Chien Yh. Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.
Proc. Natl. Acad. Sci. U.S.A. 103: 12475-12480 (2006).
*
-
Charalabopoulos K, Mittari E, Peschos D, Golias C, Charalabopoulos A, Tsanou E, Batistatou A. Rare association of chronic lymphocytic thyroiditis with dermatomyositis.
Arch. Med. Res. 37: 563-565 (2006).
-
Charbonnel B. PPAR-alpha and PPAR-gamma agonists for type 2 diabetes.
Lancet Jun 8 [Epub ahead of print] (2009).
-
Charbonnel B. What a psychiatrist needs to know about diabetes.
Eur. Psychiatry 20 Suppl. 4: S330-S334 (2005).
-
Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, Le Coquil E, Sassolas A, Moulin P, Marcais C. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.
Clin. Chim. Acta 394: 99-103 (2008).
*
-
Chatenoud L. The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.
Handb. Exp. Pharmacol. 181: 221-236 (2008).
-
Chatenoud L. CD3-specific antibody-induced active tolerance: from bench to bedside.
Nat. Rev. Immunol. 3: 123-132 (2003).
-
Chatenoud L. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications.
Curr. Opin. Immunol. 17: 632-637 (2005).
-
Chatenoud L. One step towards restoration of self-tolerance in human autoimmune diseases.
Med. Sci. (Paris) 23: 167-172 (2007).
-
Chatenoud L, Bach JF. Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance.
Expert Opin. Biol. Ther. 5 Suppl. 1: S73-S81 (2005).
-
Chatfield SM, Brand C, Ebeling PR, Russell DM. Vitamin D deficiency in general medical inpatients in summer and winter.
Intern. Med. J. 37: 377-382 (2007).
*
-
Chattopadhyay N. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
Am. J. Physiol. Endocrinol. Metab. 290: E761-E770 (2006).
*
-
Chaudhary N, Pfluger PT. Metabolic benefits from Sirt1 and Sirt1 activators.
Curr. Opin. Clin. Nutr. Metab. Care May 26 [Epub ahead of print] (2009).
-
Chauffert M, Cisse A, Chevenne D, Parfait B, Michel S, Trivin F. HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal.
Diabetes Care 18: 677-680 (1995).
-
Chavez ML. Herbal-drug interactions.
InetCE 9: 2-30 (www.InetCE.com; 221-999-05-056-H01) (2005). *
-
Chawla PS, Kochar MS. What's new in clinical pharmacology and therapeutics.
WMJ 105: 24-29 (2006).
-
Cheepsattayakorn A, Cheepsattayakorn R. Human genetic influence on susceptibility of tuberculosis: from infection to disease.
J. Med. Assoc. Thai. 92: 136-141 (2009).
-
Chelala C, Duchatelet S, Joffret ML, Bergholdt R, Dubois-Laforgue D, Ghandil P, Pociot F, Caillat-Zucman S, Timsit J, Julier C. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits.
Diabetes 56: 522-526 (2007).
*
-
Chello M, Spadaccio C, Lusini M, Covino E, Blarzino C, De Marco F, Di Domenico F, Coccia R. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Diabetes Metab. Res. Rev. Apr 29 [Epub ahead of print] (2009).
-
Chemli J, Abid I, Yacoub M, Guedira I, Korbi S, Sahloul Essoussi A, Harbi A. Paediatric celiac disease in the region of Sousse: epidemiological and evolutive study of 80 cases.
Tunis. Med. 86: 636-642 (2008).
-
Chen B, Zhang Y, Liu G, Guan GJ, Hou XH, Li XG, Liu JL. Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats.
Zhonghua Yi Xue Za Zhi 88: 540-545 (2008).
-
Chen C, Lee WH, Zhong L, Liu CP. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide.
J. Immunol. 176: 3449-3460 (2006).
*
-
Chen FJ, Yu H, Fan F, Lu JX. Mitochondrial D-loop gene polymorphisms in the patients with type 2 diabetes mellitus.
Yi Chuan 31: 265-272 (2009).
-
Chen G, Brunt EM. Diabetic hepatosclerosis: a 10-year autopsy series.
Liver Int. Jan 8 [Epub ahead of print] (2009).
*
-
Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway.
Science 296: 1634-1635 (2002).
*
-
Chen G, Han G, Wang J, Wang R, Xu R, Shen B, Qian J, Li Y. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
J. Leukoc. Biol. 83: 280-287 (2008).
*
-
Chen G, Han G, Wang J, Wang R, Xu R, Shen B, Qian J, Li Y. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.
Am. J. Pathol. 172: 972-979 (2008).
*
-
Chen G, Zhang Y, Lu D, Li NQ, Ross AC. Retinoids synergize with insulin to induce hepatic Gck Expression.
Biochem. J. 419: 645-653 (2009).
*
-
Chen H, Hewison M, Adams JS. Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element binding protein.
J. Biol. Chem. 281: 39114-39120 (2006).
*
-
Chen J, Gusdon AM, Thayer TC, Mathews CE. Role of increased ROS dissipation in prevention of T1D.
Ann. N. Y. Acad. Sci. 1150: 157-166 (2008).
*
-
Chen J, Liu X. The role of interferon gamma in regulation of CD4(+) T-cells and its clinical implications.
Cell. Immunol. 254: 85-90 (2009).
*
-
Chen J, Lu Y, Lee CH, Li R, Leiter EH, Mathews CE. Commonalities of genetic resistance to spontaneous autoimmune and free radical-mediated diabetes.
Free Radic. Biol. Med. 45: 1263-1270 (2008).
-
Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.
Rev. Diabet. Stud. 3: 21-30 (2006).
*
-
Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination.
J. Autoimmun. 16: 309-318 (2001).
-
Chen S, Glenn DJ, Ni W, Grigsby CL, Olsen K, Nishimoto M, Law CS, Gardner DG. Expression of the vitamin D receptor is increased in the hypertrophic heart.
Hypertension 52: 1106-1112 (2008).
-
Chen S, Olsen K, Grigsby C, Gardner DG. Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells.
Kidney Int. 72: 300-306 (2007).
*
-
Chen SF, Lu XF, Yan WL, Huang JF, Gu DF. Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population.
Chin. Med. J. (Engl.) 120: 2218-2223 (2007).
-
Chen W, Herold KC, Bluestone JA. Achieving antigen-specific tolerance in diabetes: regulating specifically.
Int. Rev. Immunol. 24: 287-305 (2005).
-
Chen W, Li YM, Yu MH. Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice.
Exp. Clin. Endocrinol. Diabetes 116: 468-474 (2008).
-
Chen X, Makala LH, Jin Y, Hopkins D, Muir A, Garge N, Podolsky RH, She JX. Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood.
Clin. Immunol. 129: 413-418 (2008).
*
-
Chen Y, Akirav EM, Chen W, Henegariu O, Moser B, Desai D, Shen JM, Webster JC, Andrews RC, Mjalli AM, Rothlein R, Schmidt AM, Clynes R, Herold KC. RAGE ligation affects T cell activation and controls T cell differentiation.
J. Immunol. 181: 4272-4278 (2008).
-
Chen YG, Scheuplein F, Osborne MA, Tsaih SW, Chapman HD, Serreze DV. The Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in non-obese diabetic (NOD) mice.
Diabetes 57: 3273-3280 (2008).
-
Chen YG, Silveira PA, Osborne MA, Chapman HD, Serreze DV. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
Diabetes 56: 424-430 (2007).
*
-
Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.
J. Am. Acad. Dermatol. 60: 225-230 (2009).
-
Chen YJ, Wu CY, Shen JL, Chu SY, Chen CK, Chang YT, Chen CM. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
Arch. Dermatol. 144: 1571-1575 (2008).
*
-
Chen Z, Stockton J, Mathis D, Benoist C. Modeling CTLA4-linked autoimmunity with RNA interference in mice.
Proc. Natl. Acad. Sci. U.S.A. 103: 16400-16405 (2006).
*
-
Chen ZY, Istfan NW. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells.
Prostaglandins Leukot. Essent. Fatty Acids 63: 301-308 (2000).
*
-
Cheng AY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Curr. Opin. Cardiol. 21: 400-404 (2006).
-
Cheng AY, Leiter LA. PPAR-alpha: therapeutic role in diabetes-related cardiovascular disease.
Diabetes Obes. Metab. 10: 691-698 (2008).
-
Cheng MH, Shum AK, Anderson MS. What's new in the Aire?
Trends Immunol. 28: 321-327 (2007).
*
-
Cheng PT, Mukherjee R. PPARs as targets for metabolic and cardiovascular diseases.
Mini. Rev. Med. Chem. 5: 741-753 (2005).
-
Chentoufi AA, Binder NR, Berka N, Abunadi T, Polychronakos C. Advances in type I diabetes associated tolerance mechanisms.
Scand. J. Immunol. 68: 1-11 (2008).
*
-
Cheong KY, Allcock RJ, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes.
Hum. Immunol. 62: 1363-2370 (2001).
-
Chernajovsky Y, Gould DJ, Podhajcer OL. Gene therapy for autoimmune diseases: quo vadis?
Nat. Rev. Immunol. 4: 800-811 (2004).
*
-
Cheung C, Akiyama TE, Kudo G, Gonzalez FJ. Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice.
Biochem. Pharmacol. 66: 2011-2020 (2003).
*
-
Cheung D, Bryer-Ash M. Persistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis.
J. Am. Acad. Dermatol. 60: 1032-1036 (2009).
-
Cheunsuk S, Hsu T, Gershwin ME, Bowlus CL. Analysis of the IDDM candidate gene Prss16 in NOD and NON mice.
Dev. Immunol. 9: 183-186 (2002).
*
-
Cheunsuk S, Lian ZX, Yang GX, Gershwin ME, Gruen JR, Bowlus CL. Prss16 is not required for T-cell development.
Mol. Cell. Biol. 25: 789-796 (2005).
*
-
Chew P, Yuen DY, Koh P, Stefanovic N, Febbraio MA, Kola I, Cooper ME, de Haan JB. Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.
Arterioscler. Thromb. Vasc. Biol. 29: 823-830 (2009).
-
Chia SY, Chua R, Lo YL, Wong MC, Chan LL, Tan EK. Acute ataxia, Graves' disease, and stiff person syndrome.
Mov. Disord. 22: 1969-1971 (2007).
-
Chianelli M, Parisella MG, Visalli N, Mather SJ, D'Alessandria C, Pozzilli P, Signore A; IMDIAB study group. Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy.
Diabetes Metab. Res. 24: 115-122 (2008).
-
Chiang JY. Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.
Expert Opin. Drug Metab. Toxicol. 5: 137-147 (2009).
-
Chiang JY. Bile acids: regulation of synthesis.
J. Lipid Res. Apr 3 [Epub ahead of print] (2009).
*
-
Chiang JY. Nuclear receptor regulation of lipid metabolism: potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver diseases.
Curr. Opin. Investig. Drugs 6: 994-1001 (2005).
-
Chikuma S, Abbas AK, Bluestone JA. B7-independent inhibition of T cells by CTLA-4.
J. Immunol. 175: 177-181 (2005).
*
-
Chikuma S, Bluestone JA. CTLA-4 and tolerance: the biochemical point of view.
Immunol. Res. 28: 241-253 (2003).
*
-
Chikuma S, Bluestone JA. CTLA-4: acting at the synapse.
Mol. Interv. 2: 205-208 (2002).
*
-
Chikuma S, Bluestone JA. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease.
Eur. J. Immunol. 37: 1285-1289 (2007).
*
-
Chilton PM, Rezzoug F, Ratajczak MZ, Fugier-Vivier I, Ratajczak J, Kucia M, Huang Y, Tanner MK, Ildstad ST. Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients.
Blood 105: 2189-2197 (2005).
*
-
Chinetti-Gbaguidi G, Fruchart JC, Staels B. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
Curr. Opin. Pharmacol. 5: 177-183 (2005).
-
Chirino YI, Orozco-Lbarra M, Pedraza-Chaverri J. Role of peroxynitrite anion in different diseases.
Rev. Invest. Clin. 58: 350-358 (2006).
-
Chistiakov D, Zotova E, Savost'anov K, Bursa T, Galeev I, Strokov Ia, Nosikov V. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients.
Diabetes Metab. 32: 63-68 (2006).
-
Chistiakov DA, Chernisheva A, Savost'anov KV, Turakulov RI, Kuraeva TL, Dedov II, Nosikov VV. The TAF5L gene on chromosome 1q42 is associated with type 1 diabetes in Russian affected patients.
Autoimmunity 38: 283-293 (2005).
-
Chistiakov DA, Potapov VA, Khodirev DC, Shamkhalova MS, Shestakova MV, Nosikov VV. Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes.
Acta Diabetol. 46: 43-49 (2009).
-
Chistiakov DA, Savost'anov KV, Nosikov VV. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population.
BMC Genet. 2: 6 (2001).
*
-
Chistiakov DA, Savost'anov KV, Shestakova MV, Chugunova LA, Samkhalova MSh, Dedov II, Nosikov VV. Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients.
Diabetes Res. Clin. Pract. 66: 79-86 (2004).
-
Chistiakov DA, Savost'anov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population.
Diabetes Metab. Res. Rev. 20: 219-224 (2004).
-
Chistiakov DA, Seryogin Y, Savost'anov KV, Zilberman LI, Titovich EV, Kuraeva TL, Dedov II, Nosikov VV. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on chromosome 10p11-q11 in a Russian population.
Scand. J. Immunol. 60: 316-323 (2004).
*
-
Chistiakov DA, Seryogin YA, Turakulov RI, Savost'anov KV, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set.
J. Autoimmun. 24: 243-250 (2005).
-
Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis.
Semin. Liver Dis. 21: 27-41 (2001).
-
Chiu MW, Haley JC. Acquired perforating dermatosis associated with primary biliary cirrhosis and Hashimoto thyroiditis.
Cutis 79: 451-455 (2007).
-
Cho J. Update on inflammatory bowel disease genetics.
Curr. Gastroenterol. Rep. 2: 434-439 (2000).
-
Cho JH. Update on the genetics of inflammatory bowel disease.
Curr. Gastroenterol. Rep. 3: 458-463 (2001).
-
Cho N, Momose Y. Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress.
Curr. Top. Med. Chem. 8: 1483-1507 (2008).
-
Cho SM, Kim J, Ryu HJ, Kim JJ, Kim HH, Park JH, Kim HT, Kim KH, Cho HY, Oh B, Park C, Kimm K, Jo I, Lee JE, Shin HD, Lee JK. Identification of single nucleotide polymorphisms in the tumor necrosis factor (TNF) and TNF receptor superfamily in the Korean population.
Hum. Immunol. 65: 710-718 (2004).
-
Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, Park J, Lee KM, Park KG, Lee IK, Kim JB. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis.
Diabetes 56: 1534-1543 (2007).
*
-
Choi EK, Kim MH, Kim JC, Han J, Oh SI, Jeong WJ, Jeong JY, Lee SS, Seo DW, Lee SK. The long-term follow-up results after steroid treatment in patients with autoimmune chronic pancreatitis.
Korean J. Gastroenterol. 47: 440-448 (2006).
-
Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Biochem. Biophys. Res. Commun. 336: 747-753 (2005).
*
-
Choi YS, Hong JM, Lim S, Ko KS, Pak YK. Impaired coactivator activity of the Gly(482) variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.
Biochem. Biophys. Res. Commun. 344: 708-712 (2006).
*
-
Chong AS, Shen J, Tao J, Yin D, Kuznetsov A, Hara M, Philipson LH. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
Science 311: 1774-1775 (2006).
*
-
Choquet H, Cavalcanti-Proenca C, Lecoeur C, Dina C, Cauchi S, Vaxillaire M, Hadjadj S, Horber F, Potoczna N, Charpentier G, Ruiz J, Hercberg S, Maimaitiming S, Roussel R, Boenhnke M, Jackson AU, Patsch W, Krempler F, Voight BF, Altshuler D, Groop L, et al. The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49,279 subjects.
Hum. Mol. Genet. Apr 18 [Epub ahead of print] (2009).
-
Chou SM, Chong YY, Kinkel R. A proposed pathogenetic process in the formation of Aspergillus mycotic aneurysm in the central nervous system.
Ann. Acad. Med. Singapore 22: S518-S525 (1993).
-
Chou YC, Prakash E, Huang CF, Lien TW, Chen X, Su IJ, Chao YS, Hsieh HP, Hsu JT. Bioassay-guided purification and identification of PPARalpha/gamma agonists from Chlorella sorokiniana.
Phytother. Res. 22: 605-613 (2008).
-
Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease.
BMC Gastroenterol. 5: 27 (2005).
*
-
Choudhury RP, Reddy AV, Garg AN. Availability of essential elements in nutrient supplements used as antidiabetic herbal formulations.
Biol. Trace Elem. Res. 120: 148-162 (2007).
-
Choukem SP, Boudou P, Sobngwi E, Villette JM, Ibrahim F, Moulin P, Hadjadj S, Eberle D, Foufelle F, Vexiau P, Gautier JF. The polymorphism Arg585Gln in the gene of the sterol regulatory element binding protein-1 (SREBP-1) is not a determinant of ketosis prone type 2 diabetes (KPD) in Africans.
Diabetes Metab. 35: 20-24 (2009).
-
Chounta A, Zouridakis S, Ellinas C, Tsiodras S, Zoumpouli C, Kopanakis S, Giamarellou H. Cholestatic liver injury after glimepiride therapy.
J. Hepatol. 42: 944-946 (2005).
*
-
Chowdhury TA, Lasker SS. Subclinical type 1 diabetes.
J. R. Soc. Med. 95: 203-204 (2002).
*
-
Chowdhury ZM, McDermott MF, Davey S, Hassan Z, Sinnott PJ, Hemmatpour SK, Sherwin S, Ali L, Aganna E, Allotey RA, North BV, Cassell PG, Azad Khan AK, Hitman GA. Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study.
Genes Immun. 3: 5-8 (2002).
*
-
Christakos S, Barletta F, Huening M, Dhawan P, Liu Y, Porta A, Peng X. Vitamin D target proteins: function and regulation.
J. Cell. Biochem. 88: 238-244 (2003).
*
-
Christakos S, Dhawan P, Shen Q, Peng X, Benn B, Zhong Y. New insights into the mechanisms involved in the pleiotropic actions of 1,25dihydroxyvitamin D3.
Ann. N. Y. Acad. Sci. 1068: 194-203 (2006).
*
-
Christen U. Chemokines as drug targets in type 1 diabetes.
Endocr. Metab. Immune Disord. Drug Targets 7: 7-12 (2007).
-
Christen U, von Herrath MG. Factors that determine enhancement versus abrogation of autoimmunity by viral infections.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 20 (2004). *
-
Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK, Miller SD, Oldstone MB, von Herrath MG. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes.
J. Clin. Invest. 114: 1290-1298 (2004).
*
-
Christensen KB, Minet A, Svenstrup H, Grevsen K, Zhang H, Schrader E, Rimbach G, Wein S, Wolffram S, Kristiansen K, Christensen LP. Identification of plant extracts with potential antidiabetic properties: effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake.
Phytother. Res. Jan 27 [Epub ahead of print] (2009).
-
Christensen T, Moller-Larsen A. Human endogenous retroviruses and disease?
Ugeskr. Laeger. 165: 556-561 (2003).
-
Christodoulides C, Dyson P, Sprecher D, Tsintzas K, Karpe F. Circulating FGF21 is induced by PPAR agonists but not ketosis in man.
J. Clin. Endocrinol. Metab. Jun 16 [Epub ahead of print] (2009).
-
Christophers E. Comorbidities in psoriasis.
J. Eur. Acad. Dermatol. Venereol. 20 Suppl. 2: 52-55 (2006). *
-
Chu X, Bleasby K, Yabut J, Cai X, Chan GH, Hafey MJ, Xu S, Bergman AJ, Braun MP, Dean DC, Evers R. Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human renal transporters hOAT3, OATP4C1, and MDR1 P-glycoprotein.
J. Pharmacol. Exp. Ther. 321: 673-683 (2007).
*
-
Chuah MK. Cutting through the obstacles and resurrecting the promise of gene therapy.
IDrugs 8: 818-821 (2005).
-
Chuang YM, Ho YC, Chang HT, Yu CJ, Yang PC, Hsueh PR. Disseminated cryptococcosis in HIV-uninfected patients.
Eur. J. Clin. Microbiol. Infect. Dis. 27: 307-310 (2008).
*
-
Chuang YP, Chu CH, Sytwu HK. Genetic manipulation of islet cells in autoimmune diabetes: from bench to bedside.
Front. Biosci. 13: 6155-6169 (2008).
-
Chui MH, Papanikolaou Y, Fontaine-Bisson B, Turcotte J, Wolever TM, El-Sohemy A, Chiasson JL, Rabasa-Lhoret R, Maheux P, Ryan E, Greenwood CE. The TNF-alpha-238A single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes.
Behav. Neurosci. 121: 619-624 (2007).
-
Chung SA, Criswell LA. PTPN22: its role in SLE and autoimmunity.
Autoimmunity 40: 582-590 (2007).
-
Chung SS, Choi HH, Cho YM, Lee HK, Park KS. Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes.
Biochem. Biophys. Res. Commun. 348: 253-258 (2006).
*
-
Chung SS, Kim M, Youn BS, Lee NS, Park JW, Lee IK, Lee YS, Kim JB, Cho YM, Lee HK, Park KS. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells.
Mol. Cell. Biol. 29: 20-30 (2009).
*
-
Chuu CP, Kokontis JM, Hiipakka RA, Liao S. Modulation of liver X receptor signaling as novel therapy for prostate cancer.
J. Biomed. Sci. 14: 543-553 (2007).
*
-
Ciana P, Biserni A, Tatangelo L, Tiveron C, Sciarroni AF, Ottobrini L, Maggi A. A novel PPRE-luciferase reporter mouse reveals gender specificity of peroxisome proliferators activated receptor activity in liver.
Mol. Endocrinol. 21: 388-400 (2007).
*
-
Ciantar M, Adlam DM. Treatment with infliximab: implications in oral surgery? A case report.
Br. J. Oral Maxillofac. Surg. 45: 507-510 (2007).
-
Cignarella A, Bellosta S, Corsini A, Bolego C. Hypolipidemic therapy for the metabolic syndrome.
Pharmacol. Res. 53: 492-500 (2006).
*
-
Cigrovski-Berkovic M, Solter D, Solter M. Why does the patient with Graves' disease remain euthyroid/mildly hyperthyroid following total thyroidectomy - the role of thyrotropin receptor antibodies (TRAb) and vestigial remnants of the thyroglossal tract.
Acta Clin. Croat. 47: 171-174 (2008).
-
Cinek O, Drevinek P, Sumnik Z, Bendlova B, Vavrinec J. Association of insulin gene variants with type 1 diabetes mellitus in Czech population.
Cas. Lek. Cesk. 143: 318-322 (2004).
-
Cinek O, Hradsky O, Ahmedov G, Slavcev A, Kolouskova S, Kulich M, Sumnik Z. No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations.
Diabetes Res. Clin. Pract. 76: 297-303 (2007).
-
Ciric B, El-Behi M, Cabrera R, Zhang GX, Rostami A. IL-23 drives pathogenic IL-17-producing CD8+ T cells.
J. Immunol. 182: 5296-5305 (2009).
-
Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, Torbett BE, Meda P, Crisa L. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G.
Diabetes 55: 1214-1222 (2006).
*
-
Claesson MH, Nicoletti F, Stosic-Grujicic S, Doria A, Zampieri S. Interactions between infections and immune-inflammatory cells in type 1 diabetes mellitus and inflammatory bowel diseases: evidences from animal models.
Clin. Exp. Rheumatol. 26: S8-S11 (2008).
-
Claiborn KC, Stoffers DA. Toward a cell-based cure for diabetes: advances in production and transplant of beta cells.
Mt. Sinai J. Med. 75: 362-371 (2008).
*
-
Clapham JC, Arch JR. Thermogenic and metabolic antiobesity drugs: rationale and opportunities.
Diabetes Obes. Metab. 9: 259-275 (2007).
*
-
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States.
Am. J. Gastroenterol. 98: 960-967 (2003).
*
-
Clarke HJ, Gregoire F, Ma F, Martin R, Zhao S, Lavan BE. Cross-species differential plasma protein binding of MBX-102/JNJ39659100: a novel PPAR-gamma agonist.
PPAR Res. 2008: 465715 (2008).
*
-
Classen JB, Classen DC. Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals.
J. Pediatr. Endocrinol. Metab. 16: 495-508 (2003).
-
Clee SM, Yandell BS, Schueler KM, Rabaglia ME, Richards OC, Raines SM, Kabara EA, Klass DM, Mui ET, Stapleton DS, Gray-Keller MP, Young MB, Stoehr JP, Lan H, Boronenkov I, Raess PW, Flowers MT, Attie AD. Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus.
Nat. Genet. 38: 688-693 (2006).
*
-
Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.
Eur. J. Heart Fail. 8: 105-110 (2006).
-
Clemenz M, Frost N, Schupp M, Caron S, Foryst-Ludwig A, Bohm C, Hartge M, Gust R, Staels B, Unger T, Kintscher U. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
Diabetes 57: 1405-1413 (2008).
*
-
Cock TA, Houten SM, Auwerx J. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm.
EMBO Rep. 5: 142-147 (2004).
*
-
Cohen AD, Dreiher J, Shapiro Y, Vidavsky L, Vardy DA, Davidovici B, Meyerovitch J. Psoriasis and diabetes: a population-based cross-sectional study.
J. Eur. Acad. Dermatol. Venereol. 22: 585-589 (2008).
-
Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, Vardy DA. Psoriasis and the metabolic syndrome.
Acta Derm. Venereol. 87: 506-509 (2007).
-
Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. A cross-sectional study.
Dermatology 216: 152-155 (2008).
-
Cohen D, Cohen O, Marcadet A, Massart C, Lathrop M, Deschamps I, Hors J, Schuller E, Dausset J. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.
Proc. Natl. Acad. Sci. U.S.A. 81: 1774-1778 (1984).
*
-
Cohen IR. Functional immunomics and immune homeostasis.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 21 (2004). *
-
Cohen N, Brautbar C, Font MP, Dausset J, Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.
Immunogenetics 23: 84-89 (1986).
-
Cohen ND, Shaw JE. Diabetes: advances in treatment.
Intern. Med. J. 37: 383-388 (2007).
*
-
Cohen R, Robinson D Jr, Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002.
Inflamm. Bowel Dis. 14: 738-743 (2008).
*
-
Cole GM, Frautschy SA. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease.
Exp. Gerontol. 42: 10-21 (2007).
*
-
Cole GM, Ma QL, Frautschy SA. Omega-3 fatty acids and dementia.
Prostaglandins Leukot. Essent. Fatty Acids Jun 10 [Epub ahead of print] (2009).
-
Cole TJ. Glucocorticoid action and the development of selective glucocorticoid receptor ligands.
Biotechnol. Annu. Rev. 12: 269-300 (2006).
-
Coletta DK, Balas B, Chavez AO, Baig M, Abdul-Ghani M, Kashyap S, Folli F, Tripathy D, Mandarino LJ, Cornell JE, Defronzo RA, Jenkinson CP. Effect of acute physiologic hyperinsulinemia on gene expression in human skeletal muscle in vivo.
Am. J. Physiol. Endocrinol. Metab. 294: E910-E917 (2008).
*
-
Coletta DK, Schneider J, Hu SL, Dyer TD, Puppala S, Farook VS, Arya R, Lehman DM, Blangero J, Defronzo RA, Duggirala R, Jenkinson CP. Genomewide linkage scan for genes influencing plasma triglyceride levels in the Veterans Administration Genetic Epidemiology Study (VAGES).
Diabetes 58: 279-284 (2009).
*
-
Collet-Gaudillat C, Billon-Bancel A, Beressi JP. Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report.
Diabetes Metab. 35: 151-154 (2009).
-
Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease - associated disorders and survival.
Gut 35: 1215-1218 (1994).
*
-
Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, Gough SC. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians.
Clin. Endocrinol. (Oxf.) 60: 618-624 (2004).
*
-
Collins JL. Therapeutic opportunities for liver X receptor modulators.
Curr. Opin. Drug Discov. Devel. 7: 692-702 (2004).
-
Collins S, Reynolds F. How do adults with cystic fibrosis cope following a diagnosis of diabetes?
J. Adv. Nurs. 64: 478-487 (2008).
-
Colome Pavon JA, Arranz Garcia F, Vinuela Alejandre MA, Espinos Perez D. Chronic autoimmune type II hepatitis with various extrahepatic clinical manifestations.
An. Med. Interna 10: 390-392 (1993).
-
Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing.
Proc. Natl. Acad. Sci. U.S.A. 89: 3932-3936 (1992).
*
-
Colucci F, Bergman ML, Penha-Goncalves C, Cilio CM, Holmberg D. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region.
Proc. Natl. Acad. Sci. U.S.A. 94: 8670-8674 (1997).
*
-
Colwell JA. Does aspirin use reduce cardiovascular risk in diabetes?
Nat. Rev. Endocrinol. 5: 188-190 (2009).
-
Comabella M, Altet L, Peris F, Villoslada P, Sanchez A, Montalban X. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.
Mult. Scler. 10: 618-620 (2004).
*
-
Concannon P, Chen WM, Julier C, Morahan G, Akolkar B, Erlich HA, Hilner JE, Nerup J, Nierras C, Pociot F, Todd JA, Rich SS; and the Type 1 Diabetes Genetics Consortium. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium.
Diabetes 58: 1018-1022 (2009).
-
Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families.
Diabetes 54: 2995-3001 (2005).
*
-
Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes.
N. Engl. J. Med. 360: 1646-1654 (2009).
*
-
Cong GN, Qin MW, You H, Liu W, Xu K. Imaging features of autoimmune pancreatitis.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao 30: 479-484 (2008).
-
Connor WE. Importance of n-3 fatty acids in health and disease.
Am. J. Clin. Nutr. 71: 171S-175S (2000).
*
-
Connor WE, Connor SL. The importance of fish and docosahexaenoic acid in Alzheimer disease.
Am. J. Clin. Nutr. 85: 929-930 (2007).
*
-
Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes.
Cell 90: 303-313 (1997).
*
-
Consoli A, Devangelio E. Thiazolidinediones and inflammation.
Lupus 14: 794-797 (2005).
-
Contreas G, Valletta E, Ulmi D, Cantoni S, Pinelli L. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing.
Acta Paediatr. 93: 628-632 (2004).
-
Contu D, Morelli L, Santoni F, Foster JW, Francalacci P, Cucca F. Y-chromosome based evidence for pre-neolithic origin of the genetically homogeneous but diverse Sardinian population: inference for association scans.
PLoS ONE 3: e1430 (2008).
*
-
Conway BR, Savage DA, Brady HR, Maxwell AP. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility.
Nephron. Exp. Nephrol. 105: e75-e79 (2007).
-
Cooke A. Infection and autoimmunity.
Blood Cells Mol. Dis. 42: 105-107 (2009).
-
Cooke A. Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?
Immunology 126: 12-17 (2009).
*
-
Cooke A. Th17 cells in inflammatory conditions.
Rev. Diabet. Stud. 3: 72-75 (2006).
*
-
Cooke A, Zaccone P, Raine T, Phillips JM, Dunne DW. Infection and autoimmunity: are we winning the war, only to lose the peace?
Trends Parasitol. 20: 316-321 (2004).
*
-
Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta cell apoptosis and decreased insulin secretory capacity in mouse models of hemochromatosis.
Endocrinology 145: 5305-5312 (2004).
*
-
Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: implications for environmental research.
Environ. Health Perspect. 107 Suppl. 5: 693-700 (1999).
-
Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, Masters J, Zeitels LR, Vella A, Walker NM, Todd JA. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes.
BMC Med. Genet. 8: 71 (2007).
*
-
Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, Downes K, Barrett JC, Healy BC, Mychaleckyj JC, Warram JH, Todd JA. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
Nat. Genet. 40: 1399-1401 (2008).
*
-
Coppola G, Marmolino D, Lu D, Wang Q, Cnop M, Rai M, Acquaviva F, Cocozza S, Pandolfo M, Geschwind DH. Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia.
Hum. Mol. Genet. Apr 17 [Epub ahead of print] (2009).
*
-
Coppotelli G, Summers A, Chidakel A, Ross JM, Celi FS. Functional characterization of the 258 A/G (D2-ORFa-Gly3Asp) human type-2 deiodinase polymorphism: a naturally occurring variant increases the enzymatic activity by removing a putative repressor site in the 5' UTR of the gene.
Thyroid 16: 625-632 (2006).
-
Coquerelle C, Oldenhove G, Acolty V, Denoeud J, Vansanten G, Verdebout JM, Mellor A, Bluestone JA, Moser M. Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis.
Gut Jun 7 [Epub ahead of print] (2009).
-
Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404.
Tissue Antigens 65: 448-458 (2005).
*
-
Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study.
Diabetes 57: 518-522 (2008).
*
-
Corella D, Qi L, Tai ES, Deurenberg-Yap M, Tan CE, Chew SK, Ordovas JM. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet.
Diabetes Care 29: 1313-1319 (2006).
*
-
Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, Alves H, Barrera P, de Vries N, Balsa A, Pascual-Salcedo D, Maenaut K, Westhovens R, Migliorini P, Tran TH, Delaye A, Prince N, Lefevre C, Thomas G, Poirier M, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study.
Proc. Natl. Acad. Sci. U.S.A. 95: 10746-10750 (1998).
*
-
Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women.
Am. J. Clin. Nutr. 89: 1256-1262 (2009).
-
Cornick CL, Strongitharm BH, Sassano G, Rawlins C, Mayes AE, Joseph AN, O'Dowd J, Stocker C, Wargent E, Cawthorne MA, Brown AL, Arch JR. Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) mice.
J. Nutr. Biochem. Oct 14 [Epub ahead of print] (2008).
*
-
Coroi M, Bontas E, Defranceschi M, Bartos D, Dorobantu M. Ocular manifestations of antiphospholipid (Hughes') syndrome - minor features?
Oftalmologia 51: 16-22 (2007).
-
Corpeleijn E, van der Kallen CJ, Kruijshoop M, Magagnin MG, de Bruin TW, Feskens EJ, Saris WH, Blaak EE. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with type 2 diabetes mellitus and insulin resistance.
Diabet. Med. 23: 907-911 (2006).
*
-
Corper AL, Stratmann T, Apostolopoulos V, Scott CA, Garcia KC, Kang AS, Wilson IA, Teyton L. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.
Science 288: 505-511 (2000).
*
-
Cortez-Pinto H, Ermelinda Camilo M. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
Best Pract. Res. Clin. Gastroenterol. 18: 1089-1104 (2004).
-
Corton JC, Brown-Borg HM. Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity.
J. Gerontol. A. Biol. Sci. Med. Sci. 60: 1494-1509 (2005).
-
Cosar M, Songur A, Sahin O, Uz E, Yilmaz R, Yagmurca M, Ozen OA. The neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats.
Nutr. Neurosci. 11: 161-166 (2008).
-
Cosentino A, Gambelunghe G, Tortoioli C, Falorni A. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults.
Ann. N. Y. Acad. Sci. 958: 337-340 (2002).
*
-
Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence?
Angiogenesis 10: 149-166 (2007).
*
-
Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, Levesque R, Chiasson J, Rabasa-Lhoret R. Diabetes: a major co-morbidity of cystic fibrosis.
Diabetes Metab. 31: 221-232 (2005).
*
-
Costa M, Potvin S, Hammana I, Malet A, Berthiaume Y, Jeanneret A, Lavoie A, Levesque R, Perrier J, Poisson D, Karelis AD, Chiasson JL, Rabasa-Lhoret R. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.
J. Cyst. Fibros. 6: 376-383 (2007).
-
Costa V, Casamassimi A, Esposito K, Villani A, Capone M, Iannella R, Schisano B, Ciotola M, Di Palo C, Corrado FC, Santangelo F, Giugliano D, Ciccodicola A. Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy.
J. Biomed. Biotechnol. 2009: 126917 (2009).
*
-
Costacou T, Ferrell RE, Orchard TJ. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Diabetes 57: 1702-1706 (2008).
*
-
Cotellessa M, Minicucci L, Diana MC, Prigione F, Di Febbraro L, Gagliardini R, Manca A, Battistini F, Taccetti G, Magazzu G, Padoan R, Pizzamiglio G, Raia V, Iapichino L, Cardella F, Grinzich G, Lucidi V, Tuccio G, Bignamini E, Salvatore D, Lorini R. Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study).
J. Pediatr. Endocrinol. Metab. 13: 1087-1093 (2000).
-
Coulombe M, Gill RG. The immunobiology of pancreatic islet transplantation.
Adv. Exp. Med. Biol. 552: 154-169 (2004).
-
Couper JJ, Peña AS. Folate, homocysteine, and candidate genes for vascular disease in children with type 1 diabetes.
Pediatr. Diabetes 9: 345-347 (2008).
-
Couri CE, Voltarelli JC. Potencial role of stem cell therapy in type 1 diabetes mellitus.
Arq. Bras. Endocrinol. Metabol. 52: 407-415 (2008).
-
Cousins L, Graham M, Tooze R, Carter C, Miller JR, Powrie FM, Macpherson GG, Butcher GW. Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene.
Gastroenterology 131: 1475-1485 (2006).
*
-
Couzin J. Clinical research. Deaths in diabetes trial challenge a long-held theory.
Science 319: 884-885 (2008).
*
-
Couzin J. Immunology. Diabetes studies conflict on power of spleen cells.
Science 311: 1694 (2006).
*
-
Cox D. Understanding your blood glucose - a new internet-based program.
Diabetes Forecast 58: 66 (2005).
-
Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.
Am. J. Hum. Genet. 69: 820-830 (2001).
*
-
Cox SL. Tesaglitazar: a promising approach in type 2 diabetes.
Drugs Today (Barc.) 42: 139-146 (2006).
-
Coyle AT, O'keeffe MB, Kinsella BT. 15-Deoxy delta-prostaglandin J suppresses transcription by promoter 3 of the human thromboxane A receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
FEBS J. 272: 4754-4773 (2005).
*
-
Cozzone D, Debard C, Dif N, Ricard N, Disse E, Vouillarmet J, Rabasa-Lhoret R, Laville M, Pruneau D, Rieusset J, Lefai E, Vidal H. Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells.
Diabetologia 49: 990-999 (2006).
*
-
Craig D, Robins G, Howdle PD. Advances in celiac disease.
Curr. Opin. Gastroenterol. 23: 142-148 (2007).
-
Crane IJ, Forrester JV. Th1 and Th2 lymphocytes in autoimmune disease.
Crit. Rev. Immunol. 25: 75-102 (2005).
-
Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Khanolkar M, Evans M, Harte AL, Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.
Am. J. Physiol. Endocrinol. Metab. 292: E740-E747 (2007).
*
-
Cresci S. Pharmacogenetics of the PPAR genes and cardiovascular disease.
Pharmacogenomics 8: 1581-1595 (2007).
-
Cresti S, Ouaissi M, Sielezneff I, Chaix JB, Pirro N, Berthet B, Consentino B, Sastre B. Advantage of vacuum assisted closure on healing of wound associated with omentoplasty after abdominoperineal excision: a case report.
World J. Surg. Oncol. 6: 136 (2008).
*
-
Creusot RJ, Fathman CG. Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity.
J. Clin. Invest. 114: 892-894 (2004).
*
-
Creusot RJ, Yaghoubi SS, Chang P, Chia J, Contag CH, Gambhir SS, Fathman CG. Lymphoid tissue specific homing of bone marrow-derived dendritic cells.
Blood Apr 10 [Epub ahead of print] (2009).
*
-
Creusot RJ, Yaghoubi SS, Kodama K, Dang DN, Dang VH, Breckpot K, Thielemans K, Gambhir SS, Fathman CG. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice.
Clin. Immunol. 127: 176-187 (2008).
*
-
Crimmins NA, Martin LJ. Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance.
Obes. Rev. 8: 419-423 (2007).
-
Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.
Am. J. Hum. Genet. 76: 561-571 (2005).
*
-
Cruz AA, Akaishi PM, Vargas MA, de Paula SA. Association between thyroid autoimmune dysfunction and non-thyroid autoimmune diseases.
Ophthal. Plast. Reconstr. Surg. 23: 104-108 (2007).
-
Cruz JC, Rode EC, Gomez LS, Cabrera JA, Ortega AH, Mato GM, Amador PA, Puig ME, Alonso ED, Diaz-Horta O. Celiac disease associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes.
Autoimmunity 40: 103-107 (2007).
-
Cruz M, Maldonado-Bernal C, Mondragon-Gonzalez R, Sanchez-Barrera R, Wacher NH, Carvajal-Sandoval G, Kumate J. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes.
J. Endocrinol. Invest. 31: 694-699 (2008).
-
Csaszar A, Abel T. Receptor polymorphisms and diseases.
Eur. J. Pharmacol. 414: 9-22 (2001).
*
-
Csiszar A, Ungvari ZI. Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNFalpha signaling.
Am. J. Physiol. Heart Circ. Physiol. 295: H475-H476 (2008).
*
-
Cuadrado A, Aresti S, Cortes MA, Gomez-Ortega JM, Salcines JR. Autoimmune hepatitis and agranulocytosis.
Dig. Liver Dis. Feb 26 [Epub ahead of print] (2008).
-
Cubero FJ, Nieto N. Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms.
Hepatology 48: 2027-2039 (2008).
-
Cucca F, Congia M, Trowsdale J, Powis SH. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence.
Tissue Antigens 44: 234-240 (1994).
-
Cucca F, Contu D, Zavattari P, Murru D. Correlation between major histocompatibility complex (MHC)-class II and type 1 diabetes.
Minerva Endocrinol. 28: 111-122 (2003).
-
Cucca F, Dudbridge F, Loddo M, Mulargia AP, Lampis R, Angius E, De Virgiliis S, Koeleman BP, Bain SC, Barnett AH, Gilchrist F, Cordell H, Welsh K, Todd JA. The HLA-DPB1-associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1.
Diabetes 50: 1200-1205 (2001).
*
-
Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins.
Hum. Mol. Genet. 10: 2025-2037 (2001).
*
-
Cui G, Zhang Y, Gong Z, Zhang JZ, Zang YQ. Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes.
Cell. Res. 19: 574-583 (2009).
-
Cvetkovic I, Al-Abed Y, Miljkovic D, Maksimovic-Ivanic D, Roth J, Bacher M, Lan HY, Nicoletti F, Stosic-Grujicic S. Critical role of macrophage migration inhibitory factor (MIF) activity in experimental autoimmune diabetes.
Endocrinology 146: 2942-2951 (2005).
*
-
Cvjeticanin T, Stojanovic I, Timotijevic G, Stosic-Grujicic S, Miljkovic D. T cells cooperate with palmitic acid in induction of beta cell apoptosis.
BMC Immunol. 10: 29 (2009).
*
-
Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, Wolkow P, Skupien J, Bobrek J, Czogala M, Klupa T, Sieradzki J. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients.
Acta Diabetol. 43: 114-119 (2006).
*
-
Czaja AJ. Autoimmune liver disease.
Curr. Opin. Gastroenterol. 23: 255-262 (2007).
-
Czaja AJ. Autoimmune hepatitis - approach to diagnosis.
MedGenMed. 8: 55 (2006).
*
-
Czako L, Hegyi P, Rakonczay Z Jr, Wittmann T, Otsuki M. Interactions between the endocrine and exocrine pancreas and their clinical relevance.
Pancreatology 9: 351-359 (2009).
-
Czupryniak L, Mlynarski W, Pawlowski M, Saryusz-Wolska M, Borkowska A, Klich I, Bodalski J, Loba J. Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism.
Diabetes Res. Clin. Pract. 80: 386-391 (2008).
-
D'Alise AM, Auyeung V, Feuerer M, Nishio J, Fontenot J, Benoist C, Mathis D. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
Proc. Natl. Acad. Sci. U.S.A. 105: 19857-19862 (2008).
*
-
d'Annunzio G, Giannattasio A, Poggi E, Castellano E, Calvi A, Pistorio A, Barabino A, Lorini R. beta-Cell autoimmunity in pediatric celiac: the case for routine screening?
Diabetes Care 32: 254-256 (2009).
-
d'Annunzio G, Minuto N, D'Amato E, de Toni T, Lombardo F, Pasquali L, Lorini R. Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy and deafness): similar phenotypes by different genetic mechanisms.
Diabetes Care 31: 1743-1745 (2008).
*
-
da Silva Krause M, de Bittencourt PI Jr. Type 1 diabetes: can exercise impair the autoimmune event? The L-arginine/glutamine coupling hypothesis.
Cell Biochem. Funct. 26: 406-433 (2008).
*
-
Daberkow U, Dorffel Y, Schmidt H, Scholze J. Multifocal nodular fatty infiltration of the liver associated with porphyria and haemochromatosis.
Dtsch. Med. Wochenschr. 129: 617-620 (2004).
-
Dag A, Firat ET, Arikan S, Kadiroglu AK, Kaplan A. The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients.
Aust. Dent. J. 54: 17-22 (2009).
-
Dagdelen S, Hascelik G, Bayraktar M. Simultaneous triple organ specific autoantibody profiling in adult patients with type 1 diabetes mellitus and their first-degree relatives.
Int. J. Clin. Pract. 63: 449-456 (2009).
-
Dai J, Su YX, Bartell S, Le NA, Ling WH, Liang YQ, Gao L, Wu HY, Veledar E, Vaccarino V. Beneficial effects of designed dietary fatty acid compositions on lipids in triacylglycerol-rich lipoproteins among Chinese patients with type 2 diabetes mellitus.
Metabolism 58: 510-518 (2009).
*
-
Dai YD, Carayanniotis G, Sercarz E. Antigen processing by autoreactive B cells promotes determinant spreading.
Cell. Mol. Immunol. 2: 169-175 (2005).
*
-
Dai YD, Marrero IG, Gros P, Zaghouani H, Wicker LS, Sercarz EE. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.
Diabetes 58: 156-164 (2009).
-
Daikh BE, Ryan CK, Schwartz RH. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture.
Ann. Allergy Asthma Immunol. 90: 23-27 (2003).
-
Daimon M, Oizumi T, Toriyama S, Karasawa S, Jimbu Y, Wada K, Kameda W, Susa S, Muramatsu M, Kubota I, Kawata S, Kato T. Association of the Ser326Cys polymorphism in the OGG1 gene with type 2 DM.
Biochem. Biophys. Res. Commun. May 29 [Epub ahead of print] (2009).
*
-
Daimon M, Sato H, Sasaki S, Toriyama S, Emi M, Muramatsu M, Hunt SC, Hopkins PN, Karasawa S, Wada K, Jimbu Y, Kameda W, Susa S, Oizumi T, Fukao A, Kubota I, Kawata S, Kato T. Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM.
Biochem. Biophys. Res. Commun. 374: 576-580 (2008).
*
-
Dal Pra C, Chen S, Betterle C, Zanchetta R, McGrath V, Furmaniak J, Rees Smith B. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase.
Eur. J. Endocrinol. 150: 313-321 (2004).
*
-
Dallaire P, Bellmann K, Laplante M, Gelinas S, Centeno-Baez C, Penfornis P, Peyot ML, Latour MG, Lamontagne J, Trujillo ME, Scherer PE, Prentki M, Deshaies Y, Marette A. Obese mice lacking iNOS are sensitized to the metabolic actions of PPARgamma agonism.
Diabetes 57: 1999-2011 (2008).
*
-
Dallos T, Avbelj M, Barak L, Zapletalova J, Pribilincova Z, Krajcirova M, Kostalova L, Battelino T, Kovacs L. CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease.
Neuro. Endocrinol. Lett. 29: 334-340 (2008).
-
Damiani G, Campo I, Zorzetto M, Bozzi V, Disabella E, Caroli A, Ferrarotti I, D'Annunzio G, Pasi A, Martinetti M, Cuccia M. Pro-inflammatory variants of DRB1 and RAGE genes are associated with susceptibility to pediatric type 1 diabetes: a new hypothesis on the adaptive role of autoimmunity.
Riv. Biol. 100: 285-304 (2007).
-
Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors.
PLoS Med. 6: e1000058 (2009).
*
-
Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE. Kidney involvement in a nongenetic rat model of type 2 diabetes.
Kidney Int. 68: 2562-2571 (2005).
*
-
Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus.
Endocrine 35: 11-17 (2009).
-
Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease.
Crit. Rev. Immunol. 25: 103-122 (2005).
-
Danese S, Rutella S. The Janus face of CD4(+)CD25(+) regulatory T cells in cancer and autoimmunity.
Curr. Med. Chem. 14: 649-666 (2007).
-
Dangour AD, Allen E, Elbourne D, Fletcher A, Richards M, Uauy R. Fish consumption and cognitive function among older people in the UK: baseline data from the Opal study.
J. Nutr. Health Aging 13: 198-202 (2009).
-
Das K, Kar P. Non-alcoholic steatohepatitis.
J. Assoc. Physicians India 53: 195-199 (2005).
-
Das KM. Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen.
J. Gastroenterol. Hepatol. 19: S290-S294 (2004). *
-
Das P, Abraham R, David C. HLA transgenic mice as models of human autoimmune diseases.
Rev. Immunogenet. 2: 105-114 (2000).
-
Das S, Bhoi SK, Baliarsinha AK, Baig MA. Autoimmunity, insulin resistance and Beta cell function in subjects with low body weight type 2 diabetes mellitus.
Metab. Syndr. Relat. Disord. 5: 136-141 (2007).
-
Das SK, Chakrabarti R. Role of PPAR in cardiovascular diseases.
Recent Patents Cardiovasc. Drug Discov. 1: 193-209 (2006).
-
Das SK, Chu W, Zhang Z, Hasstedt SJ, Elbein SC. Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians.
Diabetes 53: 3300-3306 (2004).
*
-
Das UN. Can essential fatty acids reduce the burden of disease(s)?
Lipids Health Dis. 7: 9 (2008).
*
-
Das UN. A defect in the activity of Delta(6) and Delta(5) desaturases may be a factor predisposing to the development of insulin resistance syndrome.
Prostaglandins Leukot. Essent. Fatty Acids 72: 343-350 (2005).
*
-
Das UN. Essential fatty acids - a review.
Curr. Pharm. Biotechnol. 7: 467-482 (2006).
-
Das UN. A defect in the activity of Delta(6) and Delta(5) desaturases may be a factor in the initiation and progression of atherosclerosis.
Prostaglandins Leukot. Essent. Fatty Acids 76: 251-268 (2007).
*
-
Das UN. Essential fatty acids: biochemistry, physiology and pathology.
Biotechnol. J. 1: 420-439 (2006).
*
-
Das UN. Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases.
Med. Sci. Monit. 10: HY19-HY25 (2004).
*
-
Das UN, Rao AA. Gene expression profile in obesity and type 2 diabetes mellitus.
Lipids Health Dis. 6: 35 (2007).
*
-
Dassopoulos T, Nguyen GC, Bitton A, Bromfield GP, Schumm LP, Wu Y, Elkadri A, Regueiro M, Siemanowski B, Torres EA, Gregory FJ, Kane SV, Harrell LE, Franchimont D, Achkar JP, Griffiths A, Brant SR, Rioux JD, Taylor KD, Duerr RH, Silverberg MS, et al. Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC).
Inflamm. Bowel Dis. 13: 975-983 (2007).
*
-
Dasu MR, Devaraj S, Ling Z, Hwang DH, Jialal I. High glucose induces Toll-like receptor expression in human monocytes: mechanism of activation.
Diabetes 57: 3090-3098 (2008).
-
Dasu MR, Park S, Devaraj S, Jialal I. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice.
Endocrinology Apr 23 [Epub ahead of print] (2009).
*
-
Daum S, Zeitz M. Native sprue.
Schweiz. Rundsch. Med. Prax. 95: 1983-1986 (2006).
-
Davey JC, Nomikos AP, Wungjiranirun M, Sherman JR, Ingram L, Batki C, Lariviere JP, Hamilton JW. Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis.
Environ. Health Perspect. 116: 165-172 (2008).
*
-
Davi G, Falco A. Oxidant stress, inflammation and atherogenesis.
Lupus 14: 760-764 (2005).
-
David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB; NASH CRN Research Group. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.
Hepatology 49: 1904-1912 (2009).
-
Davidson MH. Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
Expert Opin. Drug Saf. 5: 145-156 (2006).
-
Davidson MH, Yannicelli HD. New concepts in dyslipidemia in the metabolic syndrome and diabetes.
Metab. Syndr. Relat. Disord. 4: 299-314 (2006).
-
Davies E, Tsang CW, Ghazali AR, Harris RM, Waring RH. Effects of culture with TNF-alpha, TGF-beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines.
Toxicol. In Vitro 18: 749-754 (2004).
-
Davies H, Brophy S, Fielding A, Bingley P, Chandler M, Hilldrup I, Brooks C, Williams R. Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization.
Diabet. Med. 25: 1354-1357 (2008).
*
-
Davies JM. Molecular mimicry: can epitope mimicry induce autoimmune disease?
Immunol. Cell Biol. 75: 113-126 (1997).
-
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.
Gut 54: 533-539 (2005).
*
-
Davis PB, di Sant'Agnese PA. Diagnosis and treatment of cystic fibrosis. An update.
Chest 85: 802-809 (1984).
*
-
Davison LJ, Weenink SM, Christie MR, Herrtage ME, Catchpole B. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Vet. Immunol. Immunopathol. 126: 83-90 (2008).
-
Davoodi-Semiromi A, McDuffie M, Litherland S, Clare-Salzler M. Truncated pStat5B is associated with the Idd4 locus in NOD mice.
Biochem. Biophys. Res. Commun. 356: 655-661 (2007).
*
-
Dawkins RL, Kay PH, Christiansen FT. Immunogenetics of rheumatoid arthritis.
Ann. Acad. Med. Singapore 12: 155-163 (1983).
-
Dayspring T, Pokrywka G. Fibrate therapy in patients with metabolic syndrome and diabetes mellitus.
Curr. Atheroscler. Rep. 8: 356-364 (2006).
-
de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears.
J. Hepatol. 48 Suppl. 1: S104-S112 (2008).
*
-
De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity.
Pituitary 8: 25-30 (2005).
*
-
De Bellis A, Kelestimur F, Sinisi AA, Ruocco G, Tirelli G, Battaglia M, Bellastella G, Conzo G, Tanriverdi F, Unluhizarci K, Bizzarro A, Bellastella A. Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome.
Eur. J. Endocrinol. 158: 147-152 (2008).
*
-
De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review.
J. Clin. Endocrinol. Metab. 93: 363-371 (2008).
*
-
de Campo A, Toplak H, Wascher TC, Schallmoser K, Friehs A, Schmidt H, Kostner GM. Evaluation of a newly discovered LDL receptor mutation (exon 10, GAC>AAC, D271N, "FH Graz-1") in familial hypercholesterolemia - a family study.
Acta Med. Austriaca 26: 20-25 (1999).
-
de Carmo Silva R, Kater CE, Dib SA, Laureti S, Forini F, Cosentino A, Falorni A. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
Eur. J. Endocrinol. 142: 187-194 (2000).
*
-
De Carvalho Bittencourt M, Herren S, Graber P, Vilbois F, Pasquali C, Berney C, Plitz T, Nicoletti F, Kosco-Vilbois MH. Extracellular lysosome-associated membrane protein-1 (LAMP-1) mediates autoimmune disease progression in the NOD model of type 1 diabetes.
Eur. J. Immunol. 35: 1501-1509 (2005).
*
-
De Cosmo S, Minenna A, Zhang YY, Thompson R, Miscio G, Vedovato M, Rauseo A, Saller A, Mastroianno S, Pellegrini F, Trevisan R, Fioretto P, Doria A, Trischitta V. Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.
Am. J. Kidney Dis. 53: 273-280 (2009).
-
De Fabiani E, Mitro N, Godio C, Gilardi F, Caruso D, Crestani M. Bile acid signaling to the nucleus: finding new connections in the transcriptional regulation of metabolic pathways.
Biochimie 86: 771-778 (2004).
-
De Franco S, Chiocchetti A, Ferretti M, Castelli L, Cadario F, Cerutti F, Rabbone I, Indelicato M, Mazzarino C, Chessa M, Bona G, Dianzani U. Defective function of the Fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset.
Int. J. Immunopathol. Pharmacol. 20: 567-576 (2007).
-
de Gottardi A, de Saussure P. Celiac disease in disguise.
Rev. Med. Suisse. 1: 2008-2011 (2005).
-
de Graaff LC, Smit JW, Radder JK. Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus.
Neth. J. Med. 65: 235-247 (2007).
*
-
De Jager PL, Sawcer S, Waliszewska A, Farwell L, Wild G, Cohen A, Langelier D, Bitton A, Compston A, Hafler DA, Rioux JD. Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis.
Eur. J. Hum. Genet. 14: 317-321 (2006).
*
-
de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis; a cross-sectional study.
Ann. Rheum. Dis. 66: 589-598 (2007).
*
-
de Jersey J, Snelgrove SL, Palmer SE, Teteris SA, Mullbacher A, Miller JF, Slattery RM. beta Cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
Proc. Natl. Acad. Sci. U.S.A. 104: 1295-1300 (2007).
*
-
de Jongh BM, Bruining GJ, Schreuder GM, Schuurman RK, Radder JK, van Loghem E, Meera Khan P, Hauptmann G, van Rood JJ. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study.
Hum. Immunol. 10: 5-21 (1984).
-
De Juan D, Martín-Villa JM, Gomez-Reino JJ, Vicario JL, Corell A, Martinez-Laso J, Benmammar D, Arnaiz-Villena A. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility.
Hum. Genet. 91: 579-584 (1993).
-
de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.
J. Alzheimers Dis. 10: 89-109 (2006).
-
de Ledinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le Provost N, Cadranel JF; Association Francaise pour l'Etude du Foie Groupe Epidemiologie et Evaluation. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.
J. Hepatol. 45: 592-599 (2006).
*
-
de Luis D, Ballesteros M, Cano I, Fernandez M, Izaola O, de la Lama G, Lopez Guzman A, Maldonado A, Martin MA, Munoz C, Ruiz E. Current status of clinical nutrition at the network of public hospitals from Castilla y Leon.
Nutr. Hosp. 21: 357-361 (2006).
-
De Luis DA, Conde R, Aller R, Izaola O, Gonzalez Sagrado M, Perez Castrillon JL, Duenas A, Romero E. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study.
Eur. Rev. Med. Pharmacol. Sci. 13: 51-55 (2009).
-
de Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R. Influence of Lys656Asn polymorphism of leptin receptor gene on insulin resistance in patients with diabetes mellitus type 2.
Diabetes Res. Clin. Pract. 81: e9-e11 (2008).
-
de Luis DA, Pacheco D, Aller R, Gonzalez Sagrado M, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T. Influence of G308A polymorphism of tumor necrosis factor alpha gene on surgical results of biliopancreatic diversion.
Obes. Surg. Jun 20 [Epub ahead of print] (2008).
-
de Luis DA, Pacheco D, Aller R, Gonzalez Sagrado M, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T, Perez Castrillon JL. Influence of -55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion.
Obes. Surg. May 17 [Epub ahead of print] (2008).
-
de Luis DA, Sagrado MG, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion.
Nutrition 24: 300-304 (2008).
-
de Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Defesche JC, Bossuyt PM, Michels RP, Bleker OP, Roseboom TJ. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famine.
Diabetes Care 29: 1052-1057 (2006).
*
-
De Silva NM, Steele A, Shields B, Knight B, Parnell K, Weedon MN, Hattersley AT, Frayling TM. The transcription factor 7-like 2 (TCF7L2) gene is associated with type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies.
Diabet. Med. 24: 1067-1072 (2007).
*
-
de Villiers EM, Kimmel R, Leppik L, Gunst K. Intragenomic rearrangement in TT viruses: a possible role in the pathogenesis of disease.
Curr. Top. Microbiol. Immunol. 331: 91-107 (2009).
-
de Wet H, Rees MG, Shimomura K, Aittoniemi J, Patch AM, Flanagan SE, Ellard S, Hattersley AT, Sansom MS, Ashcroft FM. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
Proc. Natl. Acad. Sci. U.S.A. 104: 18988-18992 (2007).
*
-
de Witte MA, Jorritsma A, Swart E, Straathof KC, de Punder K, Haanen JB, Rooney CM, Schumacher TN. An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease.
J. Immunol. 180: 6365-6373 (2008).
*
-
Deakin S, Guernier S, James RW. Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin.
Pharmacogenet. Genomics 17: 451-457 (2007).
-
Debril MB, Renaud JP, Fajas L, Auwerx J. The pleiotropic functions of peroxisome proliferator-activated receptor gamma.
J. Mol. Med. 79: 30-47 (2001).
*
-
Deckelbaum RJ, Worgall TS, Seo T. n-3 Fatty acids and gene expression.
Am. J. Clin. Nutr. 83: 1520S-1525S (2006).
*
-
Decochez K, Rippley RK, Miller JL, De Smet M, Yan KX, Matthijs Z, Riffel KA, Song H, Zhu H, Maynor HO, Tanaka W, Johnson-Levonas AO, Davies MJ, Gottesdiener KM, Keymeulen B, Wagner JA. A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjects.
Drugs R. D. 7: 99-110 (2006).
-
Decsi T, Szabo E, Burus I, Marosvolgyi T, Kozari A, Erhardt E, Soltesz G. Low contribution of n-3 polyunsaturated fatty acids to plasma and erythrocyte membrane lipids in diabetic young adults.
Prostaglandins Leukot. Essent. Fatty Acids 76: 159-164 (2007).
*
-
Dedoussis GV, Kaliora AC, Panagiotakos DB. Genes, diet and type 2 diabetes mellitus: a review.
Rev. Diabet. Stud. 4: 13-24 (2007).
*
-
Deeb SS, Brunzell JD. The role of the PGC1alpha Gly482Ser polymorphism in weight gain due to intensive diabetes therapy.
PPAR Res. 2009: 649286 (2009).
*
-
Deedwania PC, Gupta R. Management issues in the metabolic syndrome.
J. Assoc. Physicians India 54: 797-810 (2006).
-
DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes.
Int. J. Clin. Pract. Suppl. 143: 9-21 (2004).
-
Deitel M. From bariatric to metabolic surgery in non-obese subjects: time for some caution.
Arq. Bras. Endocrinol. Metabol. 53: 246-251 (2009).
*
-
Deja G, Myrda A, Jarosz-Chobot P, Siekiera U. The assessment of autoimmunological status and prevalence of different forms of celiac disease among children with type 1 diabetes mellitus and celiac disease.
Mediators Inflamm. 2008: 285989 (2008).
*
-
Del Bas JM, Ricketts ML, Vaque M, Sala E, Quesada H, Ardevol A, Salvado MJ, Blay M, Arola L, Moore DD, Pujadas G, Fernandez-Larrea J, Blade C. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.
Mol. Nutr. Food Res. Jun 3 [Epub ahead of print] (2009),.
-
Del Poggio P, Mazzoleni M. Screening in liver disease.
World J. Gastroenterol. 12: 5272-5280 (2006).
*
-
Del Rio R, Noubade R, Subramanian M, Saligrama N, Diehl S, Rincon M, Teuscher C. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.
Genes Immun. 9: 115-121 (2008).
*
-
Delarue J, LeFoll C, Corporeau C, Lucas D. n-3 Long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?
Reprod. Nutr. Dev. 44: 289-299 (2004).
-
Delarue J, Magnan C. Free fatty acids and insulin resistance.
Curr. Opin. Clin. Nutr. Metab. Care 10: 142-148 (2007).
-
Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP, Leceta J. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.
J. Mol. Med. 80: 16-24 (2002).
*
-
Delgado M, Abad C, Martinez C, Juarranz MG, Leceta J, Ganea D, Gomariz RP. PACAP in immunity and inflammation.
Ann. N. Y. Acad. Sci. 992: 141-157 (2003).
*
-
Della Manna T. Not every diabetic child has type 1 diabetes mellitus.
J. Pediatr. (Rio J.) 83: S178-S183 (2007).
-
Della Manna T, Setian N, Rodrigues JC. Cystic fibrosis-related diabetes: a frequent co-morbidity.
Arq. Bras. Endocrinol. Metabol. 52: 188-197 (2008).
-
Dellon ES, Shaheen NJ. Diabetes and hepatocellular carcinoma: associations, biologic plausibility, and clinical implications.
Gastroenterology 129: 1132-1134 (2005).
*
-
Delogu LG, Magrini A, Bergamaschi A, Rosato N, Dawson MI, Bottini N, Bottini M. Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes.
Bioconjug. Chem. 20: 427-431 (2009).
*
-
Delorme D, Miller SC. Dietary consumption of Echinacea by mice afflicted with autoimmune (type I) diabetes: effect of consuming the herb on hemopoietic and immune cell dynamics.
Autoimmunity 38: 453-461 (2005).
-
Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology.
FASEB J. 15: 2579-2585 (2001).
*
-
Delvecchio CJ, Capone JP. Protein kinase C alpha modulates liver X receptor alpha transactivation.
J. Endocrinol. 197: 121-130 (2008).
*
-
Delvecchio M, Zecchino C, Faienza MF, Acquafredda A, Barbetti F, Cavallo L. Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: impact of low compliance to the gluten free diet.
Diabetes Res. Clin. Pract. 84: 332-334 (2009).
-
Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C, Almgren P, Sjögren M, Hattersley A, Dina C, Tuomi T, McCarthy MI, Froguel P, Groop LC. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes.
Hum. Mol. Genet. 12: 1865-1873 (2003).
*
-
Demerjian M, Man MQ, Choi EH, Brown BE, Crumrine D, Chang S, Mauro T, Elias PM, Feingold KR. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model.
Exp. Dermatol. 15: 154-160 (2006).
*
-
Demers A, Rodrigue-Way A, Tremblay A. Hexarelin signaling to PPARgamma in metabolic diseases.
PPAR Res. 2008: 364784 (2008).
*
-
Demirci H, Yurtcu E, Ergun MA, Yazici AC, Karasu C, Yetkin I. Calpain 10 SNP-44 gene polymorphism affects susceptibility to type 2 diabetes mellitus and diabetic-related conditions.
Genet.Test. 12: 305-309 (2008).
-
Deng QG, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H. Steatohepatitis induced by intragastric overfeeding in mice.
Hepatology 42: 905-914 (2005).
*
-
Deng T, Shan S, Li ZB, Wu ZW, Liao CZ, Ko B, Lu XP, Cheng J, Ning ZQ. A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice.
Biol. Pharm. Bull. 28: 1192-1196 (2005).
*
-
Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes.
Proc. Natl. Acad. Sci. U.S.A. 101: 12634-12639 (2004).
*
-
Denning GM, Stoll LL. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
Pediatr. Pulmonol. 41: 23-34 (2006).
-
Dentelli P, Trombetta A, Togliatto G, Zeoli A, Rosso A, Uberti B, Orso F, Taverna D, Pegoraro L, Brizzi MF. Formation of STAT5/PPARgamma transcriptional complex modulates angiogenic cell bioavailability in diabetes.
Arterioscler. Thromb. Vasc. Biol. 29: 114-120 (2009).
-
Depczynski B. Coeliac disease and its relation to glycaemic control in adults with type 1 diabetes mellitus.
Diabetes Res. Clin. Pract. 79: e10 (2008).
-
Derbel S, Doumaguet C, Hubert D, Mosnier-Pudar H, Grabar S, Chelly J, Bienvenu T. Calpain 10 and development of diabetes mellitus in cystic fibrosis.
J. Cyst. Fibros. 5: 47-51 (2006).
-
Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Clin. Ther. 26: 1599-1607 (2004).
*
-
Desai M, Clark A. Autoimmune diabetes in adults: lessons from the UKPDS.
Diabet. Med. 25 Suppl. 2: 30-34 (2008).
-
Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Walker M, Gillespie KM, Bingley PJ, Hitman GA, Holman RR, McCarthy MI, Clark A. An association analysis of the HLA gene region in latent autoimmune diabetes in adults.
Diabetologia 50: 68-73 (2007).
*
-
Deschamps I, Khalil I. The role of the HLA system in the genetics of type I diabetes mellitus.
Diabete. Metab. 18: 253-263 (1992).
-
Deschamps I, Marcelli-Barge A, Lallemand N, Poirier JC, Bochu V, Prevost P, Busson A, Masset M, Lestradet H, Hors J. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes.
Tissue Antigens 31: 259-269 (1988).
-
Deshpande AV, Lahei ER, Shun A, Martin HC, O'loughlin EV. Idiopathic fibrosing pancreatitis in children-a single-center experience.
J. Pediatr. Surg. 41: 1987-1991 (2006).
-
Dessein PH, Norton GR, Woodiwiss AJ, Joffe BI, Wolfe F. Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis.
J. Rheumatol. 34: 943-951 (2007).
-
Dessein R, Peyrin-Biroulet L, Chamaillard M. Intestinal microbiota gives a Nod to the hygiene hypothesis in type 1 diabetes.
Gastroenterology May 28 [Epub ahead of print] (2009).
*
-
DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.
Pediatrics 108: e112 (2001).
*
-
Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased TLR2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a pro-inflammatory state.
J. Clin. Endocrinol. Metab. 93: 578-583 (2008).
*
-
Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.
Free Radic. Biol. Med. 44: 1203-1208 (2008).
-
Devendra D, Galloway TS, Horton SJ, Wilkin TJ. Exploring the idiotypes of insulin antibodies as markers for remission in type 1 diabetes.
Diabet. Med. 21: 1316-1324 (2004).
*
-
Devendra D, Miao D, Nakayama M, Eisenbarth GS, Liu E. Pancreatic autoimmunity induction with insulin B:9-23 peptide and viral mimics in the NZB mouse.
Ann. N. Y. Acad. Sci. 1079: 135-137 (2006).
*
-
Devoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, Chang H, Caspi R, Fong L, Anderson MS. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen.
J. Exp. Med. 203: 2727-2735 (2006).
*
-
Devoss JJ, Anderson MS. Lessons on immune tolerance from the monogenic disease APS1.
Curr. Opin. Genet. Dev. 17: 193-200 (2007).
-
Devoss JJ, Shum AK, Johannes KP, Lu W, Krawisz AK, Wang P, Yang T, Leclair NP, Austin C, Strauss EC, Anderson MS. Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1.
J. Immunol. 181: 4072-4079 (2008).
-
Dezsofi A, Szebeni B, Hermann CS, Kapitany A, Veres G, Sipka S, Korner A, Madacsy L, Korponay-Szabo I, Rajczy K, Arato A. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both.
J. Pediatr. Gastroenterol. Nutr. 47: 283-287 (2008).
-
Dharancy S, Louvet A, Hollebecque A, Desreumaux P, Mathurin P, Dubuquoy L. Nuclear receptor PPAR and hepatology: pathophysiological and therapeutical aspects.
Gastroenterol. Clin. Biol. 32: 339-350 (2008).
-
Di Cesare E, Previti M, Lombardo F, Di Benedetto A, Mazzu N, Romano G, De Luca F, Lasco A, Cucinotta D. Serum anti-p53 autoantibodies in patients with type 1 diabetes.
Ann. Clin. Lab. Sci. 31: 253-258 (2001).
-
Di Dio G, Zanetta F, Zanetta S, Petri A, Bellone S, Bona G. Polyuria and polydipsia in a 5 year-old child: diagnostic problems.
Minerva Pediatr. 59: 813-816 (2007).
-
Di Lorenzo TP, Peakman M, Roep BO. Translational mini-meview series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes.
Clin. Exp. Immunol. 148: 1-16 (2007).
*
-
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J. Long-term effect of diabetes and its treatment on cognitive function.
N. Engl. J. Med. 356: 1842-1852 (2007).
*
-
Diallo EM, Wilhelm KG Jr, Thompson DL, Koenig RJ. Variable RXR requirements for thyroid hormone responsiveness of endogenous genes.
Mol. Cell. Endocrinol. 264: 149-156 (2007).
-
Diamant AL, Babey SH, Hastert TA, Brown ER. Diabetes: the growing epidemic.
Policy Brief UCLA Cent. Health Policy Res. PB2007-9: 1-12 (2007).
-
Díaz Gomez JM. Cardiovascular mortality in kidney transplatation.
Nefrologia 28: 27-30 (2008).
-
Dib SA. Heterogeneity of type 1 diabetes mellitus.
Arq. Bras. Endocrinol. Metabol. 52: 205-218 (2008).
-
Dib SA. Insulin resistance and metabolic syndrome in type 1 diabetes mellitus.
Arq. Bras. Endocrinol. Metabol. 50: 250-263 (2006).
-
Diehl AM. Role of the immune system in the pathogenesis of nonalcoholic steatohepatitis.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 78 (2005). *
-
Diehl AM, Li ZP, Lin HZ, Yang SQ. Cytokines and the pathogenesis of non-alcoholic steatohepatitis.
Gut 54: 303-306 (2005).
*
-
Dieterle C. (Auto)immunological aspects of type 1 diabetes mellitus.
MMW Fortschr. Med. 148: 36-39 (2006).
-
Dieude P, Teixeira VH, Pierlot C, Cornelis F, Petit-Teixeira E; ECRAF. Testing for linkage and association with rheumatoid arthritis a PTPN22 promoter polymorphism reported to be associated and linked with type 1 diabetes in the Caucasian population.
Ann. Rheum. Dis. 67: 900-901 (2008).
-
Dilmec F, Uzer E, Akkafa F, Kose E, van Kuilenburg AB. Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population.
J. Diabetes Complications Jan 29 [Epub ahead of print] (2009).
-
Dilorenzo TP, Serreze DV. The good turned ugly: immunopathogenic basis for diabetogenic CD8 T cells in NOD mice.
Immunol. Rev. 204: 250-263 (2005).
*
-
Dinarello CA. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases.
Semin. Immunol. 4: 133-145 (1992).
-
Ding H, Cheng H, Fu Z, Yan L, Yang G. Relationship of large multifunctional proteasome 7 gene polymorphism with susceptibility to type 1 diabetes mellitus and DR3 gene.
Chin. Med. J. (Engl.) 114: 1263-1266 (2001).
-
Ding L, Liu G, Guo W, Zhao H, Zong Z. Ghrelin attenuates plasminogen activator inhibitor-1 production induced by tumor necrosis factor-alpha in HepG2 cells via NF-kappaB pathway.
Cell Biol. Int. 32: 1310-1317 (2008).
-
Ding SY, Tigno XT, Braileanu GT, Ito K, Hansen BC. A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys.
Metabolism 56: 1334-1339 (2007).
*
-
Diniz-Santos DR, Brandao F, Adan L, Moreira A, Vicente EJ, Silva LR. Bone mineralization in young patients with type 1 diabetes mellitus and screening-identified evidence of celiac disease.
Dig. Dis. Sci. 53: 1240-1245 (2008).
*
-
Dite P, Novotny I, Trna J, Sevcikova A. Autoimmune pancreatitis.
Best Pract. Res. Clin. Gastroenterol. 22: 131-143 (2008).
-
Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up.
J. Clin. Endocrinol. Metab. 88: 2983-2992 (2003).
*
-
Dittmar M, Poppe R, Bischofs C, Fredenhagen G, Kanitz M, Kahaly GJ. Impaired deoxyribonuclease activity in monoglandular and polyglandular autoimmunity.
Exp. Clin. Endocrinol. Diabetes 115: 387-391 (2007).
-
Dizier MH, Deschamps I, Hors J, Blanc M, Rivat-Peran L, Feingold N, Clerget-Darpoux F. Interaction between HLA and Gm for susceptibility to insulin-dependent diabetes.
Rev. Epidemiol. Sante Publique 33: 337-340 (1985).
-
Djilali-Saiah I, Benini V, Schmitz J, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease.
Hum. Immunol. 49: 22-27 (1996).
-
Djilali-Saiah I, Bertin E, Larger E, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity.
Hum. Immunol. 59: 176-182 (1998).
-
Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E, Assan R, Boitard C, Bach JF, Caillat-Zucman S. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM.
Diabetes 47: 125-127 (1998).
-
Djurica S, Trbojevic B, Milosevic DP, Markovic N. Autoimmune thyroid disease and associated autoimmunity.
Srp. Arh. Celok. Lek. 133 Suppl. 1: 16-24 (2005).
-
Dobretsov M, Romanovsky D, Stimers JR. Early diabetic neuropathy: triggers and mechanisms.
World J. Gastroenterol. 13: 175-191 (2007).
*
-
Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management.
Best Pract. Res. Clin. Gastroenterol. 20: 531-546 (2006).
-
Dodge R, Loomans C, Sharma A, Bonner-Weir S. Developmental pathways during in vitro progression of human islet neogenesis.
Differentiation 77: 135-147 (2009).
-
Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
Mediators Inflamm. 2006: 59206 (2006).
*
-
Doggrell SA. Bradykinin B2 receptors as a target in diabetic nephropathy.
Curr. Opin. Investig. Drugs 7: 251-255 (2006).
-
Doggrell SA. Muraglitazar: beneficial or detrimental in the treatment of type 2 diabetes?
Expert Opin. Pharmacother. 7: 1229-1233 (2006).
-
Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: the Hisayama study.
Diabetes Aug 17 [Epub ahead of print] (2007).
*
-
Dolezalova R, Haluzik M, Bosanska L, Lacinova Z, Stulc T, Haluzik M. Effect of PPAR-gama agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus.
Physiol. Res. 56: 741-748 (2007).
*
-
Domberg J, Chao L, Papewalis C, Pfleger C, Xu K, Willenberg HS, Hermsen D, Scherbaum WA, Schloot NC, Schott M. Circulating chemokines in patients with autoimmune thyroid diseases.
Horm. Metab. Res. 40: 416-421 (2008).
-
Dominguez-Garcia A, Quinteiro-Gonzalez S, Pena-Quintana L, Ramos-Macias L, Quintana-Martel M, Saavedra-Santana P. Carbohydrate metabolism changes in cystic fibrosis.
J. Pediatr. Endocrinol. Metab. 20: 621-632 (2007).
-
Donadieu J, Rolon MA, Pion I, Thomas C, Doz F, Barkaoui M, Robert A, Deville A, Mazingue F, David M, Brauner R, Cabrol S, Garel C, Polak M; French LCH Study Group. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment.
J. Clin. Endocrinol. Metab. 89: 604-609 (2004).
*
-
Donaghue KC, Margan SH, Chan AK, Holloway B, Silink M, Rangel T, Bennetts B. The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents.
Diabet. Med. 22: 1315-1320 (2005).
*
-
Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet.
Nutr. J. 3: 19 (2004).
*
-
Donaldson PT, Czaja AJ. Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis.
Clin. Liver Dis. 6: 419-437 (2002).
-
Donath MY, Ehses JA. Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it was.
Proc. Natl. Acad. Sci. U.S.A. 103: 12217-12218 (2006).
*
-
Dong B, Qatanani M, Moore DD. Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes.
Hepatology Apr 17 [Epub ahead of print] (2009).
-
Dong C, He L, Li J, Ye F, He M, Wang Y. Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25: 447-451 (2008).
-
Dong GP, Yu ZS, Liang L, Zou CC, Fu JF, Wang CL. IL-18 gene promoter -137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus.
Int. J. Immunogenet. 34: 75-79 (2007).
*
-
Dong JJ, Zhao JJ, Lee KO, Lir MC, Chan SW, Liao L. Distribution of polymorphism in endothelial nitric oxide synthase gene in Singapore Chinese and its association with diabetic nephropathy.
Zhonghua Yi Xue Za Zhi 87: 3415-3417 (2007).
-
Donnelly A. Skin signs of systemic disease.
Aust. Fam. Physician 28: 1217-1222 (1999).
-
Donnelly R, Wang B, Qu X. Type 2 diabetes in China: partnerships in education and research to evaluate new antidiabetic treatments.
Br. J. Clin. Pharmacol. 61: 702-705 (2006).
*
-
Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.
J. Clin. Endocrinol. Metab. 82: 4130-4132 (1997).
*
-
Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
J. Clin. Endocrinol. Metab. 82: 143-146 (1997).
*
-
Donner H, Tonjes RR, Van der Auwera B, Siegmund T, Braun J, Weets I, Herwig J, Kurth R, Usadel KH, Badenhoop K. The presence or absence of a retroviral long terminal repeat influences the genetic risk for type 1 diabetes conferred by human leukocyte antigen DQ haplotypes. Belgian Diabetes Registry.
J. Clin. Endocrinol. Metab. 84: 1404-1408 (1999).
*
-
Doo EC, Hoofnagle JH. The hepatitis B research network.
Hepatology 49: S196-S197 (2009).
-
Doolan A, Donaghue K, Fairchild J, Wong M, Williams AJ. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes.
Diabetes Care 28: 806-809 (2005).
*
-
Doran M. Rheumatoid arthritis and diabetes mellitus: evidence for an association?
J. Rheumatol. 34: 460-462 (2007).
-
Doria A, Wojcik J, Xu R, Gervino EV, Hauser TH, Johnstone MT, Nolan D, Hu FB, Warram JH. Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes.
JAMA 300: 2389-2397 (2008).
*
-
Dorman J, Steenkiste A, O'Leary L, McCarthy B, Lorenzen T, Foley T. Type 1 diabetes in offspring of parents with type 1 diabetes: the tip of an autoimmune iceberg?
Pediatr. Diabetes 1: 17-22 (2000).
-
Dos Santos Jr RR, Sartori A, Deperon Bonato VL, Coelho Castelo AA, Vilella CA, Zollner RL, Lopes Silva C. Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.
Clin. Exp. Immunol. 149: 570-578 (2007).
*
-
Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes.
Mol. Genet. Metab. 88: 280-284 (2006).
*
-
Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes.
Dis. Markers 22: 355-359 (2006).
-
Dotta F, Fondelli C, Falorni A. Can NK cells be a therapeutic target in human type 1 diabetes?
Eur. J. Immunol. 38: 2961-2963 (2008).
*
-
Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuomilehto J. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
Diabetes 50: 886-890 (2001).
*
-
Douroudis K, Laine AP, Heinonen M, Hermann R, Lipponen K, Veijola R, Simell O, Knip M, Uibo R, Ilonen J, Kisand K. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates.
Hum. Immunol. Apr 16 [Epub ahead of print] (2009).
-
Douroudis K, Prans E, Haller K, Nemvalts V, Rajasalu T, Tillmann V, Kisand K, Uibo R. Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population.
Tissue Antigens 72: 425-430 (2008).
*
-
Douroudis K, Prans E, Kisand K, Nemvalts V, Uibo R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults.
Clin. Chim. Acta 403: 226-228 (2009).
*
-
Dow CT. Paratuberculosis and type I diabetes. Is this the trigger?
Med. Hypotheses 67: 782-785 (2006).
-
Downes M, Liddle C. Look who's talking: nuclear receptors in the liver and gastrointestinal tract.
Cell Metab. 7: 195-199 (2008).
*
-
Draghia-Akli R, Khan AS. Muscle and fat mass modulation in different clinical models.
Methods Mol. Biol. 423: 449-460 (2008).
-
Dragomir E, Manduteanu I, Calin M, Gan AM, Stan D, Koenen RR, Weber C, Simionescu M. High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells.
Thromb. Haemost. 100: 1155-1165 (2008).
-
Dray C, Daviaud D, Guigne C, Valet P, Castan-Laurell I. Caffeine reduces TNFalpha up-regulation in human adipose tissue primary culture.
J. Physiol. Biochem. 63: 329-336 (2007).
-
DREAM Trial Investigators; Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR. Effect of ramipril on the incidence of diabetes.
N. Engl. J. Med. 355: 1551-1562 (2006).
*
-
Dreiher J, Shapiro J, Cohen AD. Lichen planus and dyslipidaemia: a case-control study.
Br. J. Dermatol. May 12 [Epub ahead of print] (2009).
*
-
Dreiher J, Weitzman D, Davidovici B, Shapiro J, Cohen AD. Psoriasis and dyslipidaemia: a population-based study.
Acta Derm. Venereol. 88: 561-565 (2008).
-
Dresch C, Edelmann SL, Marconi P, Brocker T. Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo.
J. Immunol. 181: 4495-4506 (2008).
-
Drescher KM, Sosnowska D. Being a mouse in a man's world: what TMEV has taught us about human disease.
Front. Biosci. 13: 3775-3785 (2008).
-
Drew BG, Calkin AC. Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonist.
Curr. Opin. Investig. Drugs 8: 324-330 (2007).
-
Drew PD, Storer PD, Xu J, Chavis JA. Hormone regulation of microglial cell activation: relevance to multiple sclerosis.
Brain Res. Brain Res. Rev. 48: 322-327 (2005).
-
Driver JP, Foreman O, Mathieu C, van Etten E, Serreze DV. Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet.
Clin. Exp. Immunol. 151: 76-85 (2008).
*
-
Drzewoski J, Sliwinska A, Przybylowska K, Sliwinski T, Kasznicki J, Zurawska-Klis M, Kosmalski M, Majsterek I. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
Kardiol. Pol. 66: 1042-1048 (2008).
-
Du T, Zhou ZG, You S, Huang G, Lin J, Yang L, Li X, Zhou WD, Chao C. Modulation of monocyte hyperresponsiveness to TLR ligands by 1,25-dihydroxy-vitamin D3 from LADA and T2DM.
Diabetes Res. Clin. Pract. 83: 208-214 (2009).
-
Du T, Zhou ZG, You S, Lin J, Yang L, Zhou WD, Huang G, Chao C. Regulation by 1,25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes.
Clin. Chim. Acta 402: 133-138 (2009).
*
-
Du W, Sun H, Wang H, Qiang B, Shen Y, Yao Z, Gu J, Xiong M, Huang W, Chen Z, Zuo J, Hua X, Gao W, Sun Q, Fang F. Confirmation of susceptibility gene loci on chromosome 1 in Northern China Han families with type 2 diabetes.
Chin. Med. J. (Engl.) 114: 876-878 (2001).
-
Du W, Wong FS, Li MO, Peng J, Qi H, Flavell RA, Sherwin R, Wen L. TGF-beta signaling is required for the function of insulin-reactive T regulatory cells.
J. Clin. Invest. 116: 1360-1370 (2006).
*
-
Du WN, Sun HX, Wang H, Qiang BQ, Yao ZJ, Gu J, Xiong MM, Huang W, Chen Z, Zuo J, Hua XF, Gao W, Sun Q, Fang FD. Fine mapping of susceptibility genes loci within chromosome 1 in Chinese Han families with type 2 diabetes.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24: 234-237 (2002).
-
Du ZQ, Fan B, Zhao X, Amoako R, Rothschild MF. Association analyses between type 2 diabetes genes and obesity traits in pigs.
Obesity (Silver Spring) 17: 323-329 (2009).
*
-
Duan SZ, Usher MG, Mortensen RM. PPARs: the vasculature, inflammation and hypertension.
Curr. Opin. Nephrol. Hypertens. 18: 128-133 (2009).
-
Duarte PM, Neto JB, Casati MZ, Sallum EA, Nociti FH Jr. Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis.
Oral Dis. 13: 594-599 (2007).
-
Dubaniewicz A, Jamieson SE, Dubaniewicz-Wybieralska M, Fakiola M, Nancy Miller E, Blackwell JM. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland.
Eur. J. Hum. Genet. 13: 829-834 (2005).
*
-
Dubinsky MC, Fleshner PP. Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes.
Curr. Treat. Options Gastroenterol. 6: 183-200 (2003).
-
Dubois M, Vantyghem MC, Schoonjans K, Pattou F. Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma).
Ann. Endocrinol. (Paris) 63: 511-523 (2002).
-
Dubois PC, van Heel DA. Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.
Clin. Exp. Immunol. 153: 162-173 (2008).
*
-
Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes.
Obesity (Silver Spring) 14: 1543-1552 (2006).
*
-
Dubois-Laforgue D, Timsit J, Djilali-Saiah I, Boitard C, Caillat-Zucman S. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
Hum. Immunol. 57: 104-109 (1997).
-
Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, Timsit J, Julier C. FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits.
Biomed. Pharmacother. 62: 153-157 (2008).
-
Duclos P. Safety of immunisation and adverse events following vaccination against hepatitis B.
Expert Opin. Drug Saf. 2: 225-231 (2003).
-
Duclos-Vallee JC, Yilmaz F, Johanet C, Roque-Afonso AM, Gigou M, Trichet C, Feray C, Ballot E, Dussaix E, Castaing D, Bismuth H, Samuel D, Guettier C. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
Clin. Transplant. 19: 591-599 (2005).
*
-
Duerr RH. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research.
Gastroenterology 132: 2045-2049 (2007).
*
-
Dufaitre-Patouraux L, Riveline J, Renard E, Melki V, Belicar-Schaepelynck P, Selam J, Guerci B, Millot L, Brun J, Fermon C, Catargi B, Gin H, Jeandidier N, Lejeune P, Lassmann-Vague V. Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.
Diabetes Metab. 32: 427-432 (2006).
*
-
Duffy DL. Genetic determinants of diabetes are similarly associated with other immune-mediated diseases.
Curr. Opin. Allergy Clin. Immunol. 7: 468-474 (2007).
-
Dufour FD, Baxter AG, Silveira PA. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
J. Immunotoxicol. 5: 249-257 (2008).
-
Dugoujon JM, Cambon-Thomsen A. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review.
Autoimmunity 22: 245-260 (1995).
-
Dultz G, Matheis N, Dittmar M, Bender K, Kahaly GJ. CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity.
Horm. Metab. Res. 41: 426-429 (2009).
-
Dultz G, Matheis N, Dittmar M, Rohrig B, Bender K, Kahaly GJ. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.
Thyroid 19: 143-148 (2009).
-
Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L, Mukherjee D. Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective.
Curr. Drug Targets Cardiovasc. Haemato. Disord. 5: 377-386 (2005).
-
Duncan JG, Fong JL, Medeiros DM, Finck BN, Kelly DP. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.
Circulation 115: 909-917 (2007).
*
-
Duncan SA, Navas MA, Dufort D, Rossant J, Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism.
Science 281: 692-695 (1998).
*
-
Dunkelberg JC, Trotter JF, Wachs M, Bak T, Kugelmas M, Steinberg T, Everson GT, Kam I. Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications.
Liver Transpl. 9: 463-468 (2003).
*
-
Dunn AC, Walmsley RS, Dedrick RL, Wakefield AJ, Lockwood CM. Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain.
J. Infect. 39: 81-87 (1999).
-
Dunstan JA, Prescott SL. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants?
Curr. Opin. Allergy Clin. Immunol. 5: 215-221 (2005).
-
Dupouy-Camet J. Presidential address of ICT12 Conference: "Trichinella and trichinellosis - a never ending story"
Vet. Parasitol. 159: 194-196 (2009).
-
Durakovic C, Ray S, Holick MF. Topical paricalcitol (19-nor-1alpha,25-dihydroxyvitamin D) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
Br. J. Dermatol. 151: 190-195 (2004).
-
Duran C, Ediger D, Ersoy C, Coskun NF, Selimoglu H, Ercan I, Kiyici S, Guclu M, Saglam DA, Erturk E, Tuncel E, Imamoglu S. Frequency of atopy and allergic disorders among adults with Type 1 diabetes mellitus in the southern Marmara region of Turkey.
J. Endocrinol. Invest. 31: 211-215 (2008).
-
Duran-Sandoval D, Cariou B, Fruchart JC, Staels B. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
Biochimie 87: 93-98 (2005).
-
Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F, Staels B. Glucose regulates the expression of the farnesoid X receptor in liver.
Diabetes 53: 890-898 (2004).
*
-
Durand E, Boutin P, Meyre D, Charles MA, Clement K, Dina C, Froguel P. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians.
Diabetes 53: 2483-2486 (2004).
*
-
Durant S, Coulaud J, Homo-Delarche F. Bromocriptine-induced hyperglycemia in nonobese diabetic mice: kinetics and mechanisms of action.
Rev. Diabet. Stud. 4: 185-194 (2007).
*
-
Durieu I. Cystic fibrosis in adulthood.
Rev. Med. Interne. 22 Suppl. 3: 367s-373s (2001).
-
Durieu I, Nove Josserand R. Cystic fibrosis in 2008.
Rev. Med. Interne. 29: 901-907 (2008).
-
Durinovic-Bello I. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Autoimmunity 27: 159-177 (1998).
-
Durinovic-Bello I, Jelinek E, Schlosser M, Eiermann T, Boehm BO, Karges W, Marchand L, Polychronakos C. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals.
Diabetes 54: S18-S24 (2005).
*
-
Durinovic-Bello I, Rosinger S, Olson JA, Congia M, Ahmad RC, Rickert M, Hampl J, Kalbacher H, Drijfhout JW, Mellins ED, Al Dahouk S, Kamradt T, Maeurer MJ, Nhan C, Roep BO, Boehm BO, Polychronakos C, Nepom GT, Karges W, McDevitt HO, Sonderstrup G. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype.
Proc. Natl. Acad. Sci. U.S.A. 103: 11683-11688 (2006).
*
-
Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, Kalra N. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West.
Dig. Dis. Sci. 52: 2368-2374 (2007).
*
-
Duseja A, Nanda M, Das A, Das R, Bhansali A, Chawla Y. Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis.
Trop. Gastroenterol. 25: 15-17 (2004).
-
Dussault I, Beard R, Lin M, Hollister K, Chen J, Xiao JH, Chandraratna R, Forman BM. Identification of gene-selective modulators of the bile acid receptor FXR.
J. Biol. Chem. 278: 7027-7033 (2003).
*
-
Dussault I, Lin M, Hollister K, Wang EH, Synold TW, Forman BM. Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR.
J. Biol. Chem. 276: 33309-33312 (2001).
*
-
Dussault I, Yoo HD, Lin M, Wang E, Fan M, Batta AK, Salen G, Erickson SK, Forman BM. Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance.
Proc. Natl. Acad. Sci. U.S.A. 100: 833-838 (2003).
*
-
Dutra LA, Costa PG, Velasco LF, Amato AA, Barra GB. Allele-specific PCR assay to genotype SNP rs7903146 in TCF7L2 gene for rapid screening of diabetes susceptibility.
Arq. Bras. Endocrinol. Metabol. 52: 1362-1366 (2008).
*
-
Dvorak M. Gluten enteropathy - occurrence, diagnosis, therapy.
Cas. Lek. Cesk. 144 Suppl. 1: 48-51 (2005).
-
Dwarakanathan A. Diabetes update.
J. Insur. Med. 38: 20-30 (2006).
-
Dworacka M, Winiarska H, Jagodzinski PP. Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients.
Diabetes Res. Clin. Pract. 77: 258-262 (2007).
-
Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
Hum. Mol. Genet. 14: 2019-2026 (2005).
*
-
Dymot JA, McKay GA. Type 1 (distal) renal tubular acidosis in a patient with type 1 diabetes mellitus - not all cases of metabolic acidosis in type 1 diabetes mellitus are due to diabetic ketoacidosis.
Diabet. Med. 25: 114-115 (2008).
*
-
Earle KE, Tang Q, Zhou X, Liu W, Zhu S, Bonyhadi ML, Bluestone JA. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.
Clin. Immunol. 115: 3-9 (2005).
*
-
Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers.
Am. J. Psychiatry 163: 521-528 (2006).
*
-
Eaves IA, Wicker LS, Ghandour G, Lyons PA, Peterson LB, Todd JA, Glynne RJ. Combining mouse congenic strains and microarray gene expression analyses to study a complex trait: the NOD model of type 1 diabetes.
Genome Res. 12: 232-243 (2002).
*
-
Ebbesson SO, Ebbesson LO, Swenson M, Kennish JM, Robbins DC. A successful diabetes prevention study in Eskimos: the Alaska Siberia project.
Int. J. Circumpolar Health 64: 409-424 (2005).
-
Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project.
Int. J. Circumpolar Health 64: 396-408 (2005).
-
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome.
Lancet 365: 1415-1428 (2005).
*
-
Edgerton DS, Johnson KM, Cherrington AD. Current strategies for the inhibition of hepatic glucose production in type 2 diabetes.
Front. Biosci. 14: 1169-1181 (2009).
-
Edvardsson U, Alexandersson M, Brockenhuus von Lowenhielm H, Nystrom AC, Ljung B, Nilsson F, Dahllof B. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
Electrophoresis 20: 935-942 (1999).
*
-
Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic.
Mult. Scler. 10: 575-581 (2004).
-
Eeckhoute J, Briche I, Kurowska M, Formstecher P, Laine B. Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1.
J. Mol. Biol. 364: 567-581 (2006).
*
-
Eerligh P, Koeleman BP, Dudbridge F, Jan Bruining G, Roep BO, Giphart MJ. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes.
Genes Immun. 5: 36-40 (2004).
*
-
Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells.
Diabetes 53 Suppl. 3: S75-S78 (2004).
*
-
Efferth T. Adenosine triphosphate-binding cassette transporter genes in ageing and age-related diseases.
Ageing Res. Rev. 2: 11-24 (2003).
-
Efrati O, Harash O, Rivlin J, Bibi H, Meir MZ, Blau H, Mussaffi H, Barak A, Levy I, Vilozni D, Kerem E, Modan-Moses D. Hemoptysis in Israeli CF patients - prevalence, treatment, and clinical characteristics.
J. Cyst. Fibros. 7: 301-306 (2008).
-
Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, Kettler B, von Forstner C, Kneitz C, Tepel J, Adam D, Wajant H, Kalthoff H, Trauzold A. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
Cancer Res. 68: 1443-1450 (2008).
*
-
Egefjord L, Jensen JL, Bang-Berthelsen CH, Petersen AB, Smidt K, Schmitz O, Karlsen AE, Pociot F, Chimienti F, Rungby J, Magnusson NE. Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?
BMC Endocr. Disord. 9: 7 (2009).
*
-
Egido J, Ortiz A. ACE gene polymorphism and the prognosis and treatment of overt diabetic nephropathy.
Nat. Clin. Pract. Nephrol. 4: 472-473 (2008).
-
Egido J, Ruiz-Ortega M. Anti-inflammatory actions of quinapril.
Cardiovasc. Drugs Ther. 21: 211-220 (2007).
-
Eglen RM, Reisine T. The current status of drug discovery against the human kinome.
Assay Drug Dev. Technol. 7: 22-43 (2009).
-
Ehrmann J Jr, Vavrusova N, Collan Y, Kolar Z. Peroxisome proliferator-activated receptors (PPARs) in health and disease.
Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 146: 11-14 (2002).
*
-
Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MK, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F, Donath MY. Increased number of islet associated macrophages in type 2 diabetes.
Diabetes 56: 2356-2370 (2007).
*
-
Eike MC, Becker T, Humphreys K, Olsson M, Lie BA. Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B.
Genes Immun. 10: 56-67 (2009).
*
-
Eike MC, Humphreys K, Becker T, Olsson M, Lie BA; Diabetes Genetics Consortium. Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes.
Diabetes Obes. Metab. 11 Suppl. 1: 17-24 (2009).
*
-
Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MH; IBSEN study group, Dahl-Jorgensen K, Ronningen KS, Joner G, Flato B, Bergquist A, Thorsby E, Forre O, Kvien TK, Undlien DE, Lie BA. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases.
Ann. Rheum. Dis. 67: 1287-1291 (2008).
-
Eike MC, Olsson M, Undlien DE, Dahl-Jorgensen K, Joner G, Ronningen KS, Thorsby E, Lie BA. Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families.
Genes Immun. 10: 141-150 (2009).
*
-
Eilat-Adar S, Xu J, Zephier E, O'Leary V, Howard BV, Resnick HE. Adherence to dietary recommendations for saturated fat, fiber, and sodium is low in American Indians and other U.S. adults with diabetes.
J. Nutr. 138: 1699-1704 (2008).
*
-
Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
Eur. J. Hum. Genet. 11: 81-84 (2003).
*
-
Eisenbarth GS. Do NALP5 antibodies correlate with hypoparathyroidism in patients with APS-1?
Nat. Clin. Pract. Endocrinol. Metab. 4: 544-545 (2008).
-
Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes.
N. Engl. J. Med. 350: 2068-2079 (2004).
*
-
Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.
Nat. Rev. Endocrinol. 5: 219-226 (2009).
-
Ejrnaes M, Videbaek N, Christen U, Cooke A, Michelsen BK, von Herrath M. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
J. Immunol. 174: 2746-2755 (2005).
*
-
Ejrnaes M, von Herrath MG, Christen U. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
Clin. Dev. Immunol. 13: 67-77 (2006).
*
-
Ejrnaes M, von Herrath MG, Christen U. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
Clin. Dev. Immunol. 13: 337-347 (2006).
*
-
Ejskjaer N, Vestergaard ET, Hellstrom PM, Gormsen LC, Madsbad S, Madsen JL, Jensen TA, Pezzullo JC, Christiansen JS, Shaughnessy L, Kosutic G. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.
Aliment. Pharmacol. Ther. 29: 1179-1187 (2009).
*
-
Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus.
Diabetologia 44: 2220-2226 (2001).
*
-
Ek J, Hansen SP, Lajer M, Nicot C, Boesgaard TW, Pruhova S, Johansen A, Albrechtsen A, Yderstraede K, Lauenborg J, Parrizas M, Boj SF, Jorgensen T, Borch-Johnsen K, Damm P, Ferrer J, Lebl J, Pedersen O, Hansen T. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4alpha gene (HNF4A) associates with late-onset diabetes.
Diabetes 55: 1869-1873 (2006).
*
-
Ekstedt M, Franzen LE, Mathiesen UL, Holmqvist M, Bodemar G, Kechagias S. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.
J. Hepatol. 47: 135-141 (2007).
*
-
Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
Hepatology 44: 865-873 (2006).
*
-
Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjose S, Chiu BC, Dal Maso L, Cocco P, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
Blood 111: 4029-4038 (2008).
*
-
El Achhab Y, Meyre D, Bouatia-Naji N, Berraho M, Deweirder M, Vatin V, Delplanque J, Serhier Z, Lyoussi B, Nejjari C, Froguel P, Chikri M. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population.
Diabetes Metab. 35: 37-42 (2009).
-
El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
J. Pediatr. 150: 376-382 (2007).
*
-
El-Remessy AB, Tang Y, Zhu G, Matragoon S, Khalifa Y, Liu EK, Liu JY, Hanson E, Mian S, Fatteh N, Liou GI. Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation.
Mol. Vis. 14: 2190-2203 (2008).
*
-
El-Serag HB. Hepatocellular carcinoma: recent trends in the United States.
Gastroenterology 127 (5 Suppl. 2): S27-S34 (2004).
*
-
El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans.
Hepatology 49: 116-123 (2009).
-
El-Seraq HB, Johnson ML, Hachem C, Morgan RO. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
Gastroenterology 136: 1601-1608 (2009).
*
-
El-Sohemy A. Nutrigenetics.
Forum Nutr. 60: 25-30 (2007).
-
El-Zayadi AR. Hepatic steatosis: a benign disease or a silent killer.
World J. Gastroenterol. 14: 4120-4126 (2008).
*
-
Elagin RB, Balijepalli S, Diacovo MJ, Baekkeskov S, Jaume JC. Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice.
J. Autoimmun. 33: 50-57 (2009).
-
Elbein SC, Chu WS, Das SK, Yao-Borengasser A, Hasstedt SJ, Wang H, Rasouli N, Kern PA. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent.
Diabetologia 50: 1621-1630 (2007).
*
-
Elbein SC, Das SK, Hallman DM, Hanis CL, Hasstedt SJ. Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (Genetics of NIDDM) study Cohort.
Diabetes 58: 268-274 (2009).
-
Elbelt U, Hahner S, Allolio B. Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy.
Eur. J. Endocrinol. 160: 919-924 (2009).
-
Elder DA, Wooldridge JL, Dolan LM, D'Alessio DA. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes.
J. Pediatr. 151: 653-658 (2007).
*
-
Eldor R, Cohen IR, Raz I. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
Int. Rev. Immunol. 24: 327-339 (2005).
-
Eldor R, Kassem S, Raz I. Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results.
Diabetes Metab. Res. Rev. 25: 316-320 (2009).
-
Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, Klein T, Serup P, Eizirik DL, Melloul D. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.
Proc. Natl. Acad. Sci. U.S.A. 103: 5072-5077 (2006).
*
-
Elefsiniotis IS, Papatsimpas G, Liatsos GD, Tasidou A, Moulakakis A. Atypical autoimmune polyglandular syndrome type 3 overlapped by chronic HCV infection resulting in carcinogenesis and fatal infection.
South. Med. J. 101: 756-758 (2008).
-
Elfaitouri A, Berg AK, Frisk G, Yin H, Tuvemo T, Blomberg J. Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method.
J. Med. Virol. 79: 1861-1867 (2007).
-
Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF. Risk of primary adrenal insufficiency in patients with celiac disease.
J. Clin. Endocrinol. Metab. 92: 3595-3598 (2007).
*
-
Elias D, Avron A, Tamir M, Raz I. DiaPep277(R) preserves endogenous insulin production by immunomodulation in type 1 diabetes.
Ann. N. Y. Acad. Sci. 1079: 340-344 (2006).
*
-
Eller E, Vardi P, Babu SR, Bugawan TL, Erlich HA, Yu L, Fain PR. Celiac disease and HLA in a Bedouin kindred.
Hum. Immunol. 67: 940-950 (2006).
-
Eller E, Vardi P, McFann KK, Babu SR, Yu L, Bugawan TL, Erlich HA, Eisenbarth GS, Fain PR. Differential effects of DRB1(*)0301 and DQA1(*)0501-DQB1(*)0201 on the activation and progression of islet cell autoimmunity.
Genes Immun. 8: 628-633 (2007).
*
-
Ellingsgaard H, Ehses JA, Hammar EB, Van Lommel L, Quintens R, Martens G, Kerr-Conte J, Pattou F, Berney T, Pipeleers D, Halban PA, Schuit FC, Donath MY. Interleukin-6 regulates pancreatic alpha-cell mass expansion.
Proc. Natl. Acad. Sci. U.S.A. 105: 13163-13168 (2008).
*
-
Elliott DE, Summers RW, Weinstock JV. Helminths as governors of immune-mediated inflammation.
Int. J. Parasitol. 37: 457-464 (2007).
*
-
Elliott J, Johnston JA. SOCS: role in inflammation, allergy and homeostasis.
Trends Immunol. 25: 434-440 (2004).
*
-
Elsurer R, Tatar G, Simsek H, Balaban YH, Aydinli M, Sokmensuer C. Celiac disease in the Turkish population.
Dig. Dis. Sci. 50: 136-142 (2005).
*
-
Elwing JE, Gao F, Davidson NO, Early DS. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women.
Am. J. Gastroenterol. 101: 1866-1871 (2006).
*
-
Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, Thiesen A, Shapiro AM. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.
Diabetes 58: 1302-1311 (2009).
-
Emanuelli B, Eberle D, Suzuki R, Kahn CR. Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance.
Proc. Natl. Acad. Sci. U.S.A. 105: 3545-3550 (2008).
*
-
Emre Y, Hurtaud C, Karaca M, Nubel T, Zavala F, Ricquier D. Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes.
Proc. Natl. Acad. Sci. U.S.A. 104: 19085-19090 (2007).
*
-
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Ann. Surg. 248: 84-96 (2008).
-
Endo T, Takizawa S, Tanaka S, Takahashi M, Fujii H, Kamisawa T, Kobayashi T. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes mellitus.
Diabetes 58: 732-737 (2009).
-
Endreffy E, Laszlo, Szabo A, Roman F, Kurti K, Kalman M, Rasko I. Molecular genetic studies in monogenic and polygenic human diseases.
Acta Biol. Hung. 48: 121-128 (1997).
-
Enee E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
J. Immunol. 180: 5430-5438 (2008).
*
-
Engkilde K, Menne T, Johansen JD. Inverse relationship between allergic contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based study.
Diabetologia 49: 644-647 (2006).
*
-
Enoki T, Ohnogi H, Nagamine K, Kudo Y, Sugiyama K, Tanabe M, Kobayashi E, Sagawa H, Kato I. Antidiabetic activities of chalcones isolated from a Japanese herb, Angelica keiskei.
J. Agric. Food Chem. 55: 6013-6017 (2007).
*
-
Enzler T, Gillessen S, Dougan M, Allison JP, Neuberg D, Oble DA, Mihm M, Dranoff G. Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta-cells.
Blood 110: 954-961 (2007).
*
-
Epstein S, Leroith D. Diabetes and fragility fractures - a burgeoning epidemic?
Bone 43: 3-6 (2008).
-
Erdogan M, Karadeniz M, Eroglu Z, Tezcanli B, Selvi N, Yilmaz C. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
Diabetes Res. Clin. Pract. 78: 355-359 (2007).
-
Eriksson JG. The role of genes in growth and later health.
Nestle Nutr. Workshop Ser. Pediatr. Program 61: 69-77 (2008).
-
Erikstrup C, Mortensen OH, Nielsen AR, Fischer CP, Plomgaard P, Petersen AM, Krogh-Madsen R, Lindegaard B, Erhardt JG, Ullum H, Benn CS, Pedersen BK. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes.
Diabetes Obes. Metab. 11: 204-212 (2009).
-
Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S, Nevalainen J, Veijola R, Pekkanen J, Ilonen J, Simell O, Knip M, Virtanen SM. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children.
Clin. Exp. Allergy 39: 875-882 (2009).
-
Erlich H, Bugawan T, Begovich A, Scharf S. Analysis of HLA class II polymorphism using polymerase chain reaction.
Arch. Pathol. Lab. Med. 117: 482-485 (1993).
-
Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P; for the TIDGC. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium Families.
Diabetes 57: 1084-1092 (2008).
*
-
Erlich HA. HLA class II polymorphism and genetic susceptibility to insulin-dependent diabetes mellitus.
Curr. Top. Microbiol. Immunol. 164: 41-55 (1990).
-
Erlich HA. HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus.
Baillieres Clin. Endocrinol. Metab. 5: 395-411 (1991).
-
Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffith RL. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM.
Diabetes 39: 96-103 (1990).
-
Erlich HA, Griffith RL, Bugawan TL, Ziegler R, Alper C, Eisenbarth G. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
Diabetes 40: 478-481 (1991).
-
Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, Beshkov Y, Costin G, Pressman S, Bugawan T, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families.
Nat. Genet. 3: 358-364 (1993).
*
-
Ernestam S, Hafstrom I, Werner S, Carlstrom K, Tengstrand B. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
J. Rheumatol. 34: 1451-1458 (2007).
-
Eroglu Z, Cetinkalp S, Erdogan M, Kosova B, Karadeniz M, Kutukculer A, Gunduz C, Tetik A, Topcuoglu N, Ozgen AG, Tuzun M. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
J. Diabetes Complications 22: 186-190 (2008).
-
Erskine JM, Lingard C, Sontag M. Update on enteral nutrition support for cystic fibrosis.
Nutr. Clin. Pract. 22: 223-232 (2007).
-
Ertas FS, Hasan T, Ozdol C, Gulec S, Atmaca Y, Tulunay C, Karabulut H, Kocum HT, Dincer I, Kose KS, Erol C. Relationship between angiotensin-converting enzyme gene polymorphism and severity of aortic valve calcification.
Mayo Clin. Proc. 82: 944-950 (2007).
*
-
Ertekin V, Ayse Selimoglu M, Doneray H, Orbak Z, Ozkan B. Prevalence of celiac disease in a sample of Turkish children and adolescents with type 1 diabetes mellitus.
J. Clin. Gastroenterol. 40: 655-657 (2006).
-
Erten G, Gurol AO, Deniz G, Satman I, Yilmaz MT. Organ specific autoantibodies in preclinical and early clinical type 1 diabetes in Turkey.
Ups. J. Med. Sci. 112: 231-243 (2007).
*
-
Esensten JH, Lee MR, Glimcher LH, Bluestone JA. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
J. Immunol. Jun 17 [Epub ahead of print] (2009).
-
Espe K, Galler A, Raila J, Kiess W, Schweigert FJ. High-normal C-reactive protein levels do not affect the vitamin A transport complex in serum of children and adolescents with type 1 diabetes.
Pediatr. Res. 62: 741-745 (2007).
*
-
Estall JL, Drucker DJ. Glucagon and glucagon-like peptide receptors as drug targets.
Curr. Pharm. Des. 12: 1731-1750 (2006).
-
Esteghamati A, Ashraf H, Nakhjavani M, Najafian B, Hamidi S, Abbasi M. Insulin resistance is an independent correlate of increased urine albumin excretion: a cross-sectional study in Iranian type 2 diabetic patients.
Diabet. Med. 26: 177-181 (2009).
*
-
Esteves J, Laranjeira AF, Roggia MF, Dalpizol M, Scocco C, Kramer CK, Azevedo MJ, Canani LH. Diabetic retinopathy risk factors.
Arq. Bras. Endocrinol. Metabol. 52: 431-441 (2008).
-
Ettinger RA, Liu AW, Nepom GT, Kwok WW. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus.
J. Immunol. 165: 3232-3238 (2000).
*
-
Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.
J. Mol. Med. 79: 198-204 (2001).
*
-
Evans JL, Lin JJ, Goldfine ID. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
Curr. Diabetes Rev. 1: 299-307 (2005).
-
Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity.
Nat. Med. 10: 355-361 (2004).
*
-
Evans-Molina C, Robbins RD, Kono T, Tersey SA, Vestermark GL, Nunemaker CS, Garmey JC, Deering TG, Keller SR, Maier B, Mirmira RG. PPAR-gamma activation restores islet function in diabetic mice through reduction of ER stress and maintenance of euchromatin structure.
Mol. Cell. Biol. 29: 2053-2067 (2009).
-
Evelson P, Susemihl C, Villarreal I, Llesuy S, Rodriguez R, Peredo H, Lemberg A, Perazzo J, Filinger E. Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats.
Ann. Hepatol. 4: 115-120 (2005).
*
-
Everhart JE. Recent developments in the epidemiology of Helicobacter pylori.
Gastroenterol. Clin. North Am. 29: 559-578 (2000).
-
Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG; the HALT-C TrialGroup. Weight related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Gastroenterology May 12 [Epub ahead of print] (2009).
*
-
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part 2: lower gastrointestinal diseases.
Gastroenterology 136: 741-754 (2009).
*
-
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part 3: liver, biliary tract, and pancreas.
Gastroenterology 136: 1134-1144 (2009).
*
-
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part 1: overall and upper gastrointestinal diseases.
Gastroenterology 136: 376-386 (2009).
*
-
Everson GT, Trouillot T, Wachs M, Bak T, Steinberg T, Kam I, Shrestha R, Stegall M. Early steroid withdrawal in liver transplantation is safe and beneficial.
Liver Transpl. Surg. 5: S48-S57 (1999).
-
Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Diabetes Metab. May 4 [Epub ahead of print] (2009).
-
Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY. Interleukin-10 -592C/A, -819C/T, and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes patients.
Clin. Endocrinol. (Oxf.) 70: 401-407 (2009).
-
Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
J. Diabetes Complications 22: 331-338 (2008).
-
Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
Clin. Endocrinol. (Oxf.) 68: 542-546 (2008).
*
-
Faesch S, Jennane F, Izembart I, Chatenoud L, Taupin P, Martin D, Polak M, Robert JJ. Thyroiditis and gluten intolerance: extrapancreatic auto-immune diseases associated with type 1 diabetes.
Arch. Pediatr. 14: 24-30 (2007).
-
Faideau B, Larger E, Lepault F, Carel JC, Boitard C. Role of beta-cells in type 1 diabetes pathogenesis.
Diabetes 54: S87-S96 (2005).
*
-
Fajardy I, Vambergue A, Stuckens C, Weill J, Danze PM, Fontaine P. CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect.
Eur. J. Immunogenet. 29: 251-257 (2002).
-
Fakler JW, Schmitt-Egenolf M, Vejbaesya S, Boehncke WH, Sterry W, Eiermann TH. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis.
Hum. Immunol. 40: 299-302 (1994).
-
Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes.
Semin. Liver Dis. 21: 17-26 (2001).
-
Falcone M, Facciotti F, Ghidoli N, Monti P, Olivieri S, Zaccagnino L, Bonifacio E, Casorati G, Sanvito F, Sarvetnick N. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
J. Immunol. 172: 5908-5916 (2004).
*
-
Fallahi GH, Ahmadian JH, Rabbani A, Yousefnezhad A, Rezaei N. Screening for celiac disease in diabetic children from Iran.
Indian Pediatr. pii: S097475590800435-2 (2009).
*
-
Falorni A. Immunologic and genetic aspects of latent autoimmune diabetes in the adult.
Minerva Endocrinol. 28: 297-312 (2003).
-
Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Tortoioli C, Luthman H, Brunetti P, Santeusanio F. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.
Clin. Exp. Immunol. 107: 341-346 (1997).
*
-
Falorni A, Laureti S, Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II.
Endocrinol. Metab. Clin. North Am. 31: 369-389, vii (2002).
-
Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China.
J. Hepatol. 50: 204-210 (2009).
*
-
Fan Y, Wang Y, Tang Z, Zhang H, Qin X, Zhu Y, Guan Y, Wang X, Staels B, Chien S, Wang N. Suppression of proinflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells.
Arterioscler. Thromb. Vasc. Biol. 28: 315-321 (2008).
-
Fanciulli G, Meloni G, Locatelli M, Bottazzo GF, Delitala G. Diabetes-related autoantibodies in schoolchildren with celiac disease.
Ann. Endocrinol. (Paris) 68: 212-213 (2007).
-
Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition.
Nutrition 18: 872-879 (2002).
*
-
Fani F, Kamali-Sarvestani E, Yazdanparast R, Monabati A, Rafiei S. T cell tolerance following bacterial glutamic acid decarboxylase (GAD) feeding in streptozotocin-induced diabetes.
Iran. J. Immunol. 3: 169-175 (2006).
-
Fantuzzi G. Adiponectin and inflammation: consensus and controversy.
J. Allergy Clin. Immunol. 121: 326-330 (2008).
*
-
Fareau GG, Maldonado M, Oral E, Balasubramanyam A. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
Metabolism 56: 670-675 (2007).
*
-
Faria AM, Weiner HL. Oral tolerance.
Immunol. Rev. 206: 232-259 (2005).
*
-
Faria AM, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases.
Clin. Dev. Immunol. 13: 143-157 (2006).
*
-
Farid NR, Thompson C. HLA and autoimmune endocrine disease 1985.
Mol. Biol. Med. 3: 85-97 (1986).
-
Farrell FJ, Keeffe EB. Diabetes and the hepatobiliary system.
Clin. Liver Dis. 2: 119-131, vii (1998).
-
Farrell GC. Drugs and steatohepatitis.
Semin. Liver Dis. 22: 185-194 (2002).
-
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Hepatology 43: S99-S112 (2006).
*
-
Fas SC, Fritzsching B, Suri-Payer E, Krammer PH. Death receptor signaling and its function in the immune system.
Curr. Dir. Autoimmun. 9: 1-17 (2006).
-
Fasciano S, Li L. Intervention of Toll-like receptor-mediated human innate immunity and inflammation by synthetic compounds and naturally occurring products.
Curr. Med. Chem. 13: 1389-1395 (2006).
-
Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.
Hepatology 40: 820-826 (2004).
*
-
Fatehi-Hassanabad Z, Chan CB. Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function.
Nutr. Metab. (Lond.) 2: 1 (2005).
*
-
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Gastroenterology 127 (5 Suppl. 2): S35-S50 (2004).
*
-
Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Drugs 45: 953-1040 (1993).
-
Faustman DL. Immunotherapy on trial for new-onset type 1 diabetes.
N. Engl. J. Med. 359: 1956-1958 (2008).
*
-
Faustman DL, Tran SD, Kodama S, Lodde BM, Szalayova I, Key S, Toth ZE, Mezey E. Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice.
Science 314: 1243 (2006).
*
-
Fawaz F, Belding RC. Primary sclerosing cholangitis. A case associated with diabetes mellitus.
W. V. Med. J. 82: 331-332 (1986).
-
Fawwaz S, Nikamo P, Torn C, Landin-Olsson M, Lernmark A, Alarcon-Riquelme M, Kockum I; the Diabetes Incidence in Sweden Study Group. No evidence of association of the PDCD1 gene with type 1 diabetes.
Diabet. Med. 24: 1473-1477 (2007).
*
-
Fazio S, Linton MF. The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy.
Curr. Atheroscler. Rep. 6: 148-157 (2004).
-
Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P, Gonzalez S, Lopez-Larrea C. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis.
Hum. Immunol. 64: 816-822 (2003).
-
Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo JA, Guerrero M, Delgado C, Lopez-Guerrero JA, Alcina A. OAS1 gene haplotype confers susceptibility to multiple sclerosis.
Tissue Antigens 68: 446-449 (2006).
*
-
Fedetz M, Matesanz F, Caro-Maldonado A, Smirnov II, Chvorostinka VN, Moiseenko TA, Alcina A. The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population.
Tissue Antigens 67: 430-433 (2006).
*
-
Fedetz M, Ndagire D, Fernandez O, Leyva L, Guerrero M, Arnal C, Lucas M, Izquierdo G, Delgado C, Alcina A, Matesanz F. Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population.
Tissue Antigens Jun 11 [Epub ahead of print] (2009).
-
Fegan PG, Shore AC, Mawson D, Tooke JE, Macleod KM. Microvascular endothelial function in subjects with type 2 diabetes and the effect of lipid-lowering therapy.
Diabet. Med. 22: 1670-1676 (2005).
*
-
Feghhi M, Nikzamir A, Esteghamati A, Farahi F, Nakhjavani M, Rashidi A. The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative retinopathy in type 2 diabetes.
Diabetes Res. Clin. Pract. 81: e1-e4 (2008).
-
Feher J, Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH).
J. Int. Med. Res. 31: 537-551 (2003).
-
Feillet H, Bach JF. Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden?
Curr. Opin. Gastroenterol. 20: 560-564 (2004).
-
Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, Gavrilyuk V, Russo CD. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
Biochem. Pharmacol. 70: 177-188 (2005).
*
-
Feizy V, Ghobadi A. Atopic dermatitis and systemic autoimmune diseases: a descriptive cross sectional study.
Dermatol. Online J. 12: 3 (2006).
*
-
Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury.
Hepatology 43: S194-S206 (2006).
*
-
Felder TK, Oberkofler H, Weitgasser R, Mackevics V, Krempler F, Paulweber B, Patsch W. The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population.
Int. J. Obes. (Lond.) 31: 1099-1103 (2007).
*
-
Felderbauer P, Karakas E, Fendrich V, Bulut K, Werner I, Dekomien G, Klein W, Bartsch D, Schmidt WE. Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the CASR gene.
Exp. Clin. Endocrinol. Diabetes 115: 527-529 (2007).
-
Feldman PL, Lambert MH, Henke BR. PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?
Curr. Top. Med. Chem. 8: 728-749 (2008).
-
Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, Sole L, Ferreres JC, Condom E. Potassium channels: new targets in cancer therapy.
Cancer Detect. Prev. 30: 375-385 (2006).
-
Felipe F, Bonet ML, Ribot J, Palou A. Modulation of resistin expression by retinoic acid and vitamin A status.
Diabetes 53: 882-889 (2004).
*
-
Fellous TG, Islam S, Tadrous PJ, Elia G, Kocher HM, Bhattacharya S, Mears L, Turnbull DM, Taylor RW, Greaves LC, Chinnery PF, Taylor G, McDonald SA, Wright NA, Alison MR. Locating the stem cell niche and tracing hepatocyte lineages in human liver.
Hepatology 49: 1655-1663 (2009).
-
Fenalti G, Hampe CS, Arafat Y, Law RH, Banga JP, Mackay IR, Whisstock JC, Buckle AM, Rowley MJ. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity.
Diabetes 57: 1293-1301 (2008).
*
-
Feng R, Li Y, Zhao D, Wang C, Niu Y, Sun C. Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis.
Acta Diabetol. Apr 15 [Epub ahead of print] (2009).
-
Feng RN, Li Y, Sun CH. TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis.
Diabetes Res. Clin. Pract. May 26 [Epub ahead of print] (2009).
-
Fennessy M, Metcalfe K, Hitman GA, Niven M, Biro PA, Tuomilehto J, Tuomilehto-Wolf E. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
Diabetologia 37: 937-944 (1994).
-
Fereday J, Macdougall C, Spizzo M, Darbyshire P, Schiller W. "There's nothing I can't do: I just put my mind to it and I can do it": A qualitative analysis of how children with chronic disease and their parents account for and manage physical activity.
BMC Pediatr. 9: 1 (2009).
*
-
Ferguson CA. Disease models of autoimmunity.
Trends Immunol. 26: 557-558 (2005).
*
-
Ferguson LR. Dissecting the nutrigenomics, diabetes, and gastrointestinal disease interface: from risk assessment to health intervention.
OMICS 12: 237-244 (2008).
-
Ferguson LR, Shelling AN, Lauren D, Heyes JA, McNabb WC; Nutrigenomics New Zealand. Nutrigenomics and gut health.
Mutat. Res. 622: 1-6 (2007).
-
Fernandes AP, Pace AE, Zanetti ML, Foss MC, Donadi EA. Immunogenetic factors associated with type 1 diabetes mellitus.
Rev. Lat. Am. Enfermagem. 13: 743-749 (2005).
-
Fernandes G. Progress in nutritional immunology.
Immunol. Res. 40: 244-261 (2008).
*
-
Fernandez A, Maddipati S. A priori inference of cross reactivity for drug-targeted kinases.
J. Med. Chem. 49: 3092-3100 (2006).
*
-
Fernandez AZ. Peroxisome proliferator-activated receptors in the modulation of the immune/inflammatory response in atherosclerosis.
PPAR Res. 2008: 285842 (2008).
*
-
Fernandez AZ. PPARs as targets for the modulation of cardiovascular risk factors associated with the metabolic syndrome.
Curr. Opin. Investig. Drugs 5: 936-940 (2004).
-
Fernandez N, Hitman GA, Festenstein H, Garde L, Labeta M, Walker-Smith JA, Sachs JA. Novel HLA class II-associated structural patterns in coeliac disease and type I diabetes.
Clin. Exp. Immunol. 72: 362-366 (1988).
*
-
Fernandez-Real JM, Broch M, Vendrell J, Ricart W. Insulin resistance, inflammation, and serum fatty acid composition.
Diabetes Care 26: 1362-1368 (2003).
*
-
Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion.
Clin. Chem. 51: 1201-1205 (2005).
*
-
Fernandez-Real JM, Moreno JM, Ricart W. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload.
Diabetes 57: 1918-1925 (2008).
*
-
Fernandez-Veledo S, Nieto-Vazquez I, Rondinone CM, Lorenzo M. Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression.
Diabetologia 49: 3038-3048 (2006).
*
-
Fernandez-Vina M, Ramirez LC, Raskin P, Stastny P. Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans.
Tissue Antigens 41: 57-64 (1993).
-
Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD. Defining the role of the MHC in autoimmunity: a review and pooled analysis.
PLoS Genet. 4: e1000024 (2008).
*
-
Ferrara CT, Wang P, Neto EC, Stevens RD, Bain JR, Wenner BR, Ilkayeva OR, Keller MP, Blasiole DA, Kendziorski C, Yandell BS, Newgard CB, Attie AD. Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling.
PLoS Genet. 4: e1000034 (2008).
*
-
Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.
Diabetes 53 Suppl. 1: S43-S50 (2004).
*
-
Ferrera F, Cava AL, Rizzi M, Hahn BH, Indiveri F, Filaci G. Gene vaccination for the induction of immune tolerance.
Ann. N. Y. Acad. Sci. 1110: 99-111 (2007).
*
-
Fesinmeyer MD, Stanford JL, Brentnall TA, Mandelson MT, Farin FM, Srinouanprachanh S, Afsharinejad Z, Goodman GE, Barnett MJ, Austin MA. Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study.
Pancreas May 11 [Epub ahead of print] (2009).
-
Festen EA, Goyette P, Scott R, Annese V, Zhernakova A, Brant SR, Cho JH, Silverberg MS, Taylor KD, de Jong DJ, Stokkers PC, McGovern D, Palmieri O, Achkar JP, Xavier RJ, Duerr RH, Daly MJ, Wijmenga C, Weersma RK, Rioux JD. Genetic variants in the region harbouring IL2/IL21 associated to ulcerative colitis.
Gut 58: 799-804 (2009).
-
Festenstein H, Awad J, Hitman GA, Cutbush S, Groves AV, Cassell P, Ollier W, Sachs JA. New HLA DNA polymorphisms associated with autoimmune diseases.
Nature 322: 64-67 (1986).
*
-
Feuerer M, Jiang W, Holler PD, Satpathy A, Campbell C, Bogue M, Mathis D, Benoist C. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.
Proc. Natl. Acad. Sci. U.S.A. 104: 18181-18186 (2007).
*
-
Fex M, Mulder H. Lipases in the pancreatic beta-cell: implications for insulin secretion.
Biochem. Soc. Trans. 36: 885-890 (2008).
*
-
Fida S, Myers MA, Whittingham S, Rowley MJ, Ozaki S, Mackay IR. Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases.
J. Autoimmun. 19: 251-257 (2002).
*
-
Fiedler A, Wichers-Rother M, Hoeft A, Putensen C, von Spiegel T, Schroeder S. Schmidt syndrome presenting as acute liver failure.
Exp. Clin. Endocrinol. Diabetes 113: 60-63 (2005).
-
Field LL, Anderson CE, Neiswanger K, Hodge SE, Spence MA, Rotter JI. Interaction of HLA and immunoglobulin antigens in type 1 (insulin-dependent) diabetes.
Diabetologia 27: 504-508 (1984).
-
Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.
Diabetes 54: 1588-1591 (2005).
*
-
Field LL, Goldstein A, Spence MA, Anderson CE, Rimoin DL. No evidence for linkage between an insulin-dependent diabetes mellitus-susceptibility locus and immunoglobulin loci KM or GM.
Genet. Epidemiol. 1: 375-382 (1984).
-
Field LL, Larsen Z, Pociot F, Nerup J, Tobias R, Bonnevie-Nielsen V. Evidence for a locus (IDDM16) in the immunoglobulin heavy chain region on chromosome 14q32.3 producing susceptibility to type 1 diabetes.
Genes Immun. 3: 338-344 (2002).
*
-
Field LL, McArthur RG. The genetics of susceptibility to insulin-dependent diabetes mellitus - possible new markers.
Clin. Invest. Med. 10: 437-443 (1987).
-
Field LL, Tobias R. Unravelling a complex trait: the genetics of insulin-dependent diabetes mellitus.
Clin. Invest. Med. 20: 41-49 (1997).
-
Field LL, Tobias R, Thomson G, Plon S. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31.
Genomics 33: 1-8 (1996).
*
-
Field SF, Nejentsev S, Walker NM, Howson JM, Godfrey LM, Jolley JD, Hardy MP, Todd JA. Sequencing-based genotyping and association analysis of the MICA and MICB genes in type 1 diabetes.
Diabetes 57: 1753-1756 (2008).
*
-
Fievet C, Fruchart JC, Staels B. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.
Curr. Opin. Pharmacol. 6: 606-614 (2006).
-
Fievet C, Staels B. Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery disease.
Curr. Atheroscler. Rep. 11: 281-288 (2009).
-
Fife BT, Griffin MD, Abbas AK, Locksley RM, Bluestone JA. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
J .Clin. Invest. 116: 2252-2261 (2006).
*
-
Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
J. Exp. Med. 203: 2737-2747 (2006).
*
-
Figueira AC, Neto MD, Bernardes A, Dias SM, Craievich AF, Baxter JD, Webb P, Polikarpov I. Low-resolution structures of thyroid hormone receptor dimers and tetramers in solution.
Biochemistry 46: 1273-1283 (2007).
*
-
Filippi C, Bresson D, Herrath M. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.
Int. Rev. Immunol. 24: 341-360 (2005).
-
Filippi C, von Herrath M. How viral infections affect the autoimmune process leading to type 1 diabetes.
Cell. Immunol. 233: 125-132 (2005).
*
-
Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice.
J. Clin. Invest. pii: 38503 (2009).
*
-
Filippi CM, Juedes AE, Oldham JE, Ling E, Togher L, Peng Y, Flavell RA, von Herrath MG. Transforming growth factor-beta suppresses the activation of CD8+ T cells when naive but promotes their survival and function once antigen-experienced: a two-faced impact on autoimmunity.
Diabetes 57: 2684-2692 (2008).
-
Filippi CM, von Herrath MG. Islet beta-cell death - fuel to sustain autoimmunity?
Immunity 27: 183-185 (2007).
*
-
Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, Medras M. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome.
Aging Male 11: 134-139 (2008).
-
Fimmers R, Neugebauer M, Dennert J, Wienker T, Baur MP. Association and sibpair analysis for the HLA, Gm, Km, and insulin polymorphisms in multiplex IDDM families.
Genet. Epidemiol. 6: 107-112 (1989).
-
Finck BN. Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?
Expert Rev. Cardiovasc. Ther. 4: 161-171 (2006).
-
Fine EJ, Lee DE, Hawkins M. Sweet clarity: less invasive measures of hepatic glucose metabolism.
Gastroenterology 132: 794-797 (2007).
*
-
Fink E, Oaklander AL. Small-fiber neuropathy: answering the burning questions.
Sci. Aging Knowledge Environ. 6: pe7 (2006).
-
Finucane FM, O'Connell J, Kinsley BT. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
Ir. J. Med. Sci. 177: 69-71 (2008).
*
-
Fiorina P, Vergani A, Dada S, Jurewicz M, Wong M, Law K, Wu E, Tian Z, Abdi R, Guleria I, Rodig S, Dunussi-Joannopoulos K, Bluestone J, Sayegh MH. Targeting CD22 reprograms B cells and reverses autoimmune diabetes.
Diabetes 57: 3013-3024 (2008).
-
Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L. Targeting farnesoid X receptor for liver and metabolic disorders.
Trends Mol. Med. 13: 298-309 (2007).
*
-
First MR. Tacrolimus based immunosuppression.
J. Nephrol. 17 Suppl. 8: S25-31 (2004).
-
Fischer-Rosinsky A, Fisher E, Kovacs P, Bluher M, Mohlig M, Pfeiffer AF, Boeing H, Spranger J. Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations.
PLoS ONE 3: e3852 (2008).
*
-
Fischler B, Papadogiannakis N, Nemeth A. Aetiological factors in neonatal cholestasis.
Acta Paediatr. 90: 88-92 (2001).
-
Fischman D, Nookala VK. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management.
Endocr. Pract. 14: 1169-1179 (2008).
-
Fisher AH, Lomasky SJ, Fisher MJ, Oppenheim YL. Celiac disease and the endocrinologist: a diagnostic opportunity.
Endocr. Pract. 14: 381-388 (2008).
-
Fisher E, Li Y, Burwinkel B, Kuhr V, Hoffmann K, Mohlig M, Spranger J, Pfeiffer A, Boeing H, Schrezenmeir J, Doring F. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort.
Horm. Metab. Res. 38: 341-345 (2006).
-
Fisman EZ, Adler Y, Tenenbaum A. Biomarkers in cardiovascular diabetology: interleukins and matrixins.
Adv. Cardiol. 45: 44-64 (2008).
-
Fisson S, Djelti F, Trenado A, Billiard F, Liblau R, Klatzmann D, Cohen JL, Salomon BL. Therapeutic potential of self-antigen-specific CD4(+)CD25(+) regulatory T cells selected in vitro from a polyclonal repertoire.
Eur. J. Immunol. 36: 817-827 (2006).
*
-
Fitten LJ, Ortiz F, Fairbanks L, Rosenthal M, Cole GN, Nourhashemi F, Sanchez MA. Depression, diabetes and metabolic-nutritional factors in elderly hispanics.
J. Nutr. Health Aging 12: 634-640 (2008).
-
Fitzpatrick LA. Secondary causes of osteoporosis.
Mayo Clin. Proc. 77: 453-468 (2002).
*
-
Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.
Clin. Sci. (Lond.) 116: 1-16 (2009).
*
-
Flanders KC. Smad3 as a mediator of the fibrotic response.
Int. J. Exp. Pathol. 85: 47-64 (2004).
*
-
Flatt PR, Bailey CJ, Green BD. Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Front. Biosci. 13: 3648-3660 (2008).
-
Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, Hurel SJ, Humphries SE. Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.
Diabetes 54: 582-586 (2005).
*
-
Flavell DM, Pineda Torra I, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller G, Talmud PJ, Staels B, Humphries SE. Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects.
Diabetologia 43: 673-680 (2000).
*
-
Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus.
BMC Med. Genet. 9: 30 (2008).
*
-
Fleming A. What will it take to get therapies approved for type 1 diabetes?
Ann. N. Y. Acad. Sci. 1150: 25-31 (2008).
*
-
Fleming RE, Sly WS. Mechanisms of iron accumulation in hereditary hemochromatosis.
Annu. Rev. Physiol. 64: 663-680 (2002).
*
-
Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH. Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes.
Diabetologia 31: 864-870 (1988).
-
Fletcher MT, Baxter AG. Clinical application of NKT cell biology in type I (autoimmune) diabetes mellitus.
Immunol. Cell Biol. 87: 315-323 (2009).
*
-
Flores YN, Yee HF Jr, Leng M, Escarce JJ, Bastani R, Salmeron J, Morales LS. Risk factors for chronic liver disease in blacks, Mexican Americans, and whites in the United States: results from NHANES IV, 1999-2004.
Am. J. Gastroenterol. 103: 2231-2238 (2008).
*
-
Flores-Calderon J, Gomez-Diaz RA, Rodriguez-Gomez G, Moran-Villota S. Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City.
Ann. Hepatol. 4: 279-283 (2005).
-
Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?
Diabetologia 51: 1100-1110 (2008).
*
-
Florez JC. The new type 2 diabetes gene TCF7L2.
Curr. Opin. Clin. Nutr. Metab. Care 10: 391-396 (2007).
-
Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
N. Engl. J. Med. 355: 241-250 (2006).
*
-
Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
J. Clin. Endocrinol. Metab. 92: 1502-1509 (2007).
*
-
Florez JC, Saxena R, Winckler W, Burtt NP, Almgren P, Bengtsson Bostrom K, Tuomi T, Gaudet D, Ardlie KG, Daly MJ, Altshuler D, Hirschhorn JN, Groop L. The Kruppel-like factor 11 (KLF11) Q62R polymorphism is not associated with type 2 diabetes in 8,676 people.
Diabetes 55: 3620-3624 (2006).
*
-
Florez JC, Sjogren M, Agapakis CM, Burtt NP, Almgren P, Lindblad U, Berglund G, Tuomi T, Gaudet D, Daly MJ, Ardlie KG, Hirschhorn JN, Altshuler D, Groop L. Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes.
Diabetologia 50: 1209-1217 (2007).
*
-
Fodor A, Harel C, Fodor L, Armoni M, Salmon P, Trono D, Karnieli E. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.
Diabetologia 50: 121-130 (2007).
*
-
Fonarow GC. Aggressive treatment of atherosclerosis: the time is now.
Cleve. Clin. J. Med. 70: 431-434, 437438, 440 (2003).
-
Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice.
J. Pediatr. (Rio J.) 83: S192-S203 (2007).
-
Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations.
Am. J. Clin. Nutr. 86: 768-774 (2007).
*
-
Fontaine-Bisson B, Wolever TM, Connelly PW, Corey PN, El-Sohemy A. NF-kappaB -49Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations.
Atherosclerosis 204: 465-470 (2009).
-
Fontana L. The scientific basis of caloric restriction leading to longer life.
Curr. Opin. Gastroenterol. 25: 144-150 (2009).
-
Forbes LV, Brown LJ, Scott RS. HLA-DQ beta typing and non-Asp57 alleles in IDDM and nondiabetic subjects in New Zealand.
Diabetes Care 16: 1179-1183 (1993).
-
Ford McIntyre MS, Young KJ, Gao J, Joe B, Zhang L. Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression.
J. Immunol. 181: 2271-2275 (2008).
-
Ford MS, Chen W, Wong S, Li C, Vanama R, Elford AR, Asa SL, Ohashi PS, Zhang L. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
Eur. J. Immunol. 37: 2234-2241 (2007).
-
Forlani G, Di Bonito P, Mannucci E, Capaldo B, Genovese S, Orrasch M, Scaldaferri L, Di Bartolo P, Melandri P, Dei Cas A, Zavaroni I, Marchesini G. Prevalence of elevated liver enzymes in type 2 diabetes mellitus and its association with the metabolic syndrome.
J. Endocrinol. Invest. 31: 146-152 (2008).
-
Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
Proc. Natl. Acad. Sci. U.S.A. 94: 4312-4317 (1997).
*
-
Forman D, Bulwer BE. Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle.
Curr. Treat. Options Cardiovasc. Med. 8: 47-57 (2006).
-
Formoso G, De Filippis EA, Michetti N, Di Fulvio P, Pandolfi A, Bucciarelli T, Ciabattoni G, Nicolucci A, Davi G, Consoli A. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
Diabetes Metab. Res. Rev. 24: 231-237 (2007).
-
Fornoni A, Lenz O, Striker LJ, Striker GE. Glucose induces clonal selection and reversible dinucleotide repeat expansion in mesangial cells isolated from glomerulosclerosis-prone mice.
Diabetes 52: 2594-2602 (2003).
*
-
Forsythe ME, Love DC, Lazarus BD, Kim EJ, Prinz WA, Ashwell G, Krause MW, Hanover JA. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
Proc. Natl. Acad. Sci. U.S.A. 103: 11952-11957 (2006).
*
-
Foschini MP, Macchia S, Losi L, Dei Tos AP, Pasquinelli G, Di Tommaso L, Del Duca S, Roncaroli F, Dal Monte PR. Identification of mitochondria in liver biopsies. A study by immunohistochemistry, immunogold and Western blot analysis.
Virchows. Arch. 433: 267-273 (1998).
*
-
Foss NT, Foss-Freitas MC, Ferreira MA, Cardili RN, Barbosa CM, Foss MC. Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients.
Diabetes Metab. 33: 439-443 (2007).
-
Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients.
Diabetes Res. Clin. Pract. 82: 329-334 (2008).
-
Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control.
Ann. N. Y. Acad. Sci. 1079: 177-180 (2006).
*
-
Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ, Ayyobi A, Pimstone S, Frohlich J, Ansquer JC, Steiner G; for the DAIS investigators. Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.
Pharmacogenetics 14: 823-829 (2004).
-
Foulis AK. Pancreatic pathology in type 1 diabetes in human.
Novartis Found. Symp. 292: 2-13 (2008).
-
Fourlanos S, Perry C, Stein MS, Stankovich J, Harrison LC, Colman PG. A clinical screening tool identifies autoimmune diabetes in adults.
Diabetes Care 29: 970-975 (2006).
*
-
Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, Harrison LC. The rising incidence of type 1 diabetes is accounted for by cases with lower risk HLA genotypes.
Diabetes Care 31: 1546-1549 (2008).
*
-
Fournier T, Tsatsaris V, Handschuh K, Evain-Brion D. PPARs and the placenta.
Placenta 28: 65-76 (2007).
-
Fourtner SH, Stanley CA, Kelly A. Protein-sensitive hypoglycemia without leucine sensitivity in hyperinsulinism caused by K(ATP) channel mutations.
J. Pediatr. 149: 47-52 (2006).
*
-
Fousteri G, Dave A, Juntti T, von Herrath M. CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes.
J. Autoimmun. 32: 70-77 (2009).
-
Fousteri G, Hayek A, von Herrath M. Stopping diabetes in its tracks: autologous non-myeloablative stem cell transplantation.
Regen. Med. 2: 845-851 (2007).
-
Fowlkes JL, Bunn RC, Liu L, Wahl EC, Coleman HN, Cockrell GE, Perrien DS, Lumpkin CK Jr, Thrailkill KM. Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are downregulated throughout osteogenesis in type 1 diabetes mellitus.
Endocrinology 149: 1697-1704 (2008).
*
-
Fox RI. Sjogren's syndrome.
Curr. Opin. Rheumatol. 7: 409-416 (1995).
-
Frances CP, Conde MC, Saez ME, Diez SF, Rey CM, Ramirez-Armengol JA, Pascual MH, Gonzalez-Perez A, Torres PP, Real LM, Serrano-Rios M, Lopez JL, Ruiz A, Royo JL. Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.
J. Gastroenterol. Hepatol. 22: 2298-2302 (2007).
*
-
Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism.
Annu. Rev. Physiol. 65: 261-311 (2003).
*
-
Francis GA, Li G, Casey R, Wang J, Cao H, Leff T, Hegele RA. Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).
BMC Med. Genet. 7: 3 (2006).
*
-
Francke S, Manraj M, Lacquemant C, Lecoeur C, Leprêtre F, Passa P, Hebe A, Corset L, Yan SL, Lahmidi S, Jankee S, Gunness TK, Ramjuttun US, Balgobin V, Dina C, Froguel P. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27.
Hum. Mol. Genet. 10: 2751-2765 (2001).
*
-
Franks PW, Ekelund U, Brage S, Luan J, Schafer AJ, O'rahilly S, Barroso I, Wareham NJ. PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge.
Diabetologia 50: 569-573 (2007).
*
-
Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC; Diabetes Prevention Program Research Group. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Diabetologia 50: 2451-2460 (2007).
*
-
Franzese A, Valerio G, Buono P, Spagnuolo MI, Sepe A, Mozzillo E, De Simone I, Raia V. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis.
J. Pediatr. Endocrinol. Metab. 21: 109-116 (2008).
-
Franzini L, Ardigo D, Zavaroni I. Dietary antioxidants and glucose metabolism.
Curr. Opin. Clin. Nutr. Metab. Care 11: 471-476 (2008).
-
Fraser A, Ebrahim S, Davey Smith G, Lawlor DA. A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes.
Hepatology 46: 158-165 (2007).
*
-
Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology.
Nat. Rev. Genet. 8: 657-662 (2007).
*
-
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
Science 316: 889-894 (2007).
*
-
Freathy RM, Lonnen KF, Steele AM, Minton JA, Frayling TM, Hattersley AT, Macleod KM. The impact of the angiotensin-converting enzyme insertion/deletion polymorphism on severe hypoglycemia in type 2 diabetes.
Rev. Diabet. Stud. 3: 76-81 (2006).
*
-
Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B, Shields B, Parnell KS, Groves CJ, Ring SM, Pembrey ME, Ben-Shlomo Y, Strachan DP, Power C, Jarvelin MR, McCarthy MI, Davey Smith G, Hattersley AT, Frayling TM. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals.
Am. J. Hum. Genet. 80: 1150-1161 (2007).
*
-
Fredenrich A, Grimaldi P. PPAR delta: an uncompletely known nuclear receptor.
Diabetes Metab. 31: 23-27 (2005).
*
-
Frediani B, Rossini M, Adami S, Bianchi G, Di Munno O, Sinigaglia L, Antonelli M, Minisola G. Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR).
Reumatismo 58: 314-318 (2006).
-
Fredriksson J, Anevski D, Almgren P, Sjogren M, Lyssenko V, Carlson J, Isomaa B, Taskinen MR, Groop L, Orho-Melander M. Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality.
PLoS ONE 2: e285 (2007).
*
-
Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, van der Woude FJ, Bowden DW. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
Nephrol. Dial. Transplant. 22: 1131-1135 (2007).
-
Freeman HJ. Pancreatic endocrine and exocrine changes in celiac disease.
World J. Gastroenterol. 13: 6344-6346 (2007).
*
-
Frelinger JA. Novel epitope begets a novel pathway in type 1 diabetes progression.
J. Clin. Invest. 118: 3268-3271 (2008).
*
-
Friday RP, Trucco M, Pietropaolo M. Genetics of type 1 diabetes mellitus.
Diabetes Nutr. Metab. 12: 3-26 (1999).
-
Fridell JA, Vianna R, Kwo PY, Howenstine M, Sannuti A, Molleston JP, Pescovitz MD, Tector AJ. Simultaneous liver and pancreas transplantation in patients with cystic fibrosis.
Transplant. Proc. 37: 3567-3569 (2005).
*
-
Fridell JA, Wozniak TC, Powelson JA, Reynolds JM. Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis.
Transplant. Proc. 40: 494-497 (2008).
*
-
Friedman E, Blahut RJ, Bender MD. Hepatic abscesses and fungemia from Torulopsis glabrata. Successful treatment with percutaneous drainage and amphotericin B.
J. Clin. Gastroenterol. 9: 711-715 (1987).
-
Friedrich N, Volzke H, Hampe J, Lerch MM, Jorgensen T. Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.
Am. J. Gastroenterol. 104: 89-95 (2009).
*
-
Frigoul A, Lefranc MP. MICA: standardized IMGT allele nomenclature, polymorphisms and diseases.
Recent Res. Devel. Human Genet. 3: 95-145 (2005). *
-
Frisk G, Hansson T, Dahlbom I, Tuvemo T. A unifying hypothesis on the development of type 1 diabetes and celiac disease: gluten consumption may be a shared causative factor.
Med. Hypotheses 70: 1207-1209 (2008).
-
Frohlich-Reiterer EE, Hofer S, Kaspers S, Herbst A, Kordonouri O, Schwarz HP, Schober E, Grabert M, Holl RW; on behalf of the DPV-Wiss Study Group. Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus - data from a German/Austrian multicentre survey.
Pediatr. Diabetes 9: 546-553 (2008).
-
Frostegard J. Atherosclerosis in patients with autoimmune disorders.
Arterioscler. Thromb. Vasc. Biol. 25: 1776-1785 (2005).
*
-
Frostegard J. SLE, atherosclerosis and cardiovascular disease.
J. Intern. Med. 257: 485-495 (2005).
*
-
Fruchart JC. Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease.
Atherosclerosis Mar 20 [Epub ahead of print] (2009).
-
Fruchart JC, Staels B, Duriez P. PPARS, metabolic disease and atherosclerosis.
Pharmacol. Res. 44: 345-352 (2001).
*
-
Frulloni L, Castellani C, Bovo P, Vaona B, Calore B, Liani C, Mastella G, Cavallini G. Natural history of pancreatitis associated with cystic fibrosis gene mutations.
Dig. Liver Dis. 35: 179-185 (2003).
-
Frulloni L, Morana G, Bovo P, Mansueto GC, Vaona B, Di Francesco V, Procacci C, Cavallini G. Salivary gland involvement in patients with chronic pancreatitis.
Pancreas 19: 33-38 (1999).
-
Fu JH, Xie SR, Kong SJ, Wang Y, Wei W, Shan Y, Luo YM. The combination of a high-fat diet and chronic stress aggravates insulin resistance in Wistar male rats.
Exp. Clin. Endocrinol. Diabetes Apr 8 [Epub ahead of print] (2009).
-
Fu Y, Nathan DM, Li F, Li X, Faustman DL. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
J. Clin. Invest. 91: 2301-2307 (1993).
*
-
Fuchtenbusch M, Larger E, Thebault K, Boitard C. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Horm. Metab. Res. 37: 63-67 (2005).
-
Fuchtenbusch M, Vogel A, Achenbach P, Gummer M, Ziegler AG, Albert E, Standl E, Manns MP. Lupus-like panniculitis in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Exp. Clin. Endocrinol. Diabetes 111: 288-293 (2003).
-
Fuchtenbusch M, Ziegler AG, Hummel M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects.
Rev. Diabet. Stud. 1: 39-41 (2004).
*
-
Fueger PT, Schisler JS, Lu D, Babu DA, Mirmira RG, Newgard CB, Hohmeier HE. Trefoil factor 3 stimulates human and rodent pancreatic islet beta-cell replication with retention of function.
Mol. Endocrinol. 22: 1251-1259 (2008).
*
-
Fujii H. Nuclear receptor PPARs and magnesium.
Clin. Calcium 15: 1814-1826 (2005).
-
Fujimura T, Kimura C, Oe T, Takata Y, Sakuma H, Aramori I, Mutoh S. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
J. Pharmacol. Exp. Ther. 318: 863-871 (2006).
*
-
Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.
Clin. Microbiol. Rev. 19: 80-94 (2006).
*
-
Fujisawa T, Ikegami H, Noso S, Yamaji K, Nojima K, Babaya N, Itoi-Babaya M, Hiromine Y, Kobayashi M, Makino S, Ogihara T. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis.
Ann. N. Y. Acad. Sci. 1079: 118-121 (2006).
*
-
Fukushima T, Dong L, Sakai T, Sawaki T, Miki M, Tanaka M, Masaki Y, Hirose Y, Kuwana M, Umehara H. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
Lupus 17: 210-214 (2008).
-
Fuller JM, Bogdani M, Tupling TD, Jensen RA, Pefley R, Manavi S, Cort L, Blankenhorn EP, Mordes JP, Lernmark A, Kwitek AE. Genetic dissection reveals diabetes loci proximal to the Gimap5 lymphopenia gene.
Physiol. Genomics 38: 89-97 (2009).
*
-
Funauchi M, Tamaki C, Yamagata T, Nozaki Y, Sugiyama M, Ikoma S, Kinoshita K. A case of autoimmune polyglandular syndrome type III with a slowly progressive form of type-1 diabetes mellitus that manifested in the course of autoimmune diseases.
Scand. J. Rheumatol. 35: 81-82 (2006).
*
-
Fung E, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, Wicker LS, Todd JA. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus.
Genes Immun. 10: 188-191 (2009).
*
-
Funk C, Ponelle C, Scheuermann G, Pantze M. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Mol. Pharmacol. 59: 627-635 (2001).
*
-
Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Wien. Klin. Wochenschr. 117: 707-710 (2005).
-
Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
Nature 447: 959-965 (2007).
*
-
Furukawa N, Miyamura N, Nishida K, Motoshima H, Taketa K, Araki E. Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome.
Diabetes Res. Clin. Pract. 75: 366-367 (2007).
-
Furuya T, Salstrom JL, McCall-Vining S, Cannon GW, Joe B, Remmers EF, Griffiths MM, Wilder RL. Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci.
Hum. Mol. Genet. 9: 2241-2250 (2000).
*
-
Fux Otta C, Szafryk de Mereshian P, Iraci GS, Ojeda de Pruneda MR. Pregnancies associated with primary adrenal insufficiency.
Fertil. Steril. 90: 1199.e17-e20 (2008).
-
Gaber SA, Mazzola G, Berrino M, Canale L, Cornaglia M, Ghali I, Sergio Curtoni E, Amoroso A. Human leukocyte antigen class II polymorphisms and genetic susceptibility of IDDM in Egyptian children.
Diabetes Care 17: 1341-1344 (1994).
-
Gabory A, Attig L, Junien C. Sexual dimorphism in environmental epigenetic programming.
Mol. Cell. Endocrinol. 304: 8-18 (2009).
-
Gabriely I, Shamoon H. Hypoglycemia in diabetes: common, often unrecognized.
Cleve. Clin. J. Med. 71: 335-342 (2004).
*
-
Gacka M, Adamiec R. Mutations of peroxisome proliferator-activated receptor gamma (PPARgamma): clinical implications.
Postepy. Hig. Med. Dosw. (Online) 58: 483-489 (2004).
-
Gacka M, Bednarska-Chabowska D, Dobosz T, Szymaniec S, Jakobsche U, Lebioda A, Adamiec R. The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma and immunological processes in patients with type 2 diabetes and insulin resistance.
Przegl. Lek. 64: 393-397 (2007).
-
Gaede PH. Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria: rationale and effect on late-diabetic complications.
Dan. Med. Bull. 53: 258-284 (2006).
-
Gaens K, van der Kallen C, van Greevenbroek M, Feskens E, Stehouwer C, Schalkwijk C. Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study.
Ann. N. Y. Acad. Sci. 1126: 162-165 (2008).
*
-
Gagne DJ, Papasavas PK, Dovec EA, Urbandt JE, Caushaj PF. Effect of immunosuppression on patients undergoing bariatric surgery.
Surg. Obes. Relat. Dis. 5: 339-345 (2009).
-
Gahring LC, Rogers SW. Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells.
AAPS J. 7: E885-E894 (2006).
*
-
Gaia E, Salacone P, Gallo M, Promis GG, Brusco A, Bancone C, Carlo A. Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients.
Dig. Dis. Sci. 47: 2416-2421 (2002).
*
-
Galanakis E, Kofteridis D, Stratigi K, Petraki E, Vazgiourakis V, Fragouli E, Mamoulakis D, Boumpas DT, Goulielmos GN. Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population.
Hum. Immunol. 69: 279-283 (2008).
-
Gale EA. A missing link in the hygiene hypothesis?
Diabetologia 45: 588-594 (2002).
*
-
Galera Martinez R, García García E, Gamez Gomez MD, Gomez Llorente JL, Garrido Fernandez P, Bonillo Perales A. Final size attained in type 1 diabetes children.
An. Pediatr. (Barc.) 70: 235-240 (2009).
-
Galgani A, Petrone A, Spoletini M, Hodge A, Del Buono ML, Locatelli M, Buzzetti R; Diabfin Study Group. HLA class II typing in newborns reveals a low frequency of the DRB1*04 allele and a high frequency of DRB1*11 allele in three regions of continental Italy.
Hum. Immunol. 65: 366-372 (2004).
-
Galgani JE, Uauy RD, Aguirre CA, Diaz EO. Effect of the dietary fat quality on insulin sensitivity.
Br. J. Nutr. 100: 471-479 (2008).
*
-
Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: patients with liver disease, families, and populations.
Curr. Gastroenterol. Rep. 6: 44-51 (2004).
-
Gallagher MJ, Ding L, Maheshwari A, Macdonald RL. The GABAA receptor alpha1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation.
Proc. Natl. Acad. Sci. U.S.A. 104: 12999-13004 (2007).
*
-
Gallego O, Ruiz FX, Ardevol A, Dominguez M, Alvarez R, de Lera AR, Rovira C, Farres J, Fita I, Pares X. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.
Proc. Natl. Acad. Sci. U.S.A. 104: 20764-20769 (2007).
*
-
Gallego PH, Craig ME, Duffin AC, Bennetts B, Jenkins AJ, Hofer S, Lam A, Donaghue KC. Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes.
Diabetes Care 31: 1585-1589 (2008).
*
-
Gallegos AM, Bevan MJ. Driven to autoimmunity: the nod mouse.
Cell 117: 149-151 (2004).
*
-
Galli A, Mello T, Ceni E, Surrenti E, Surrenti C. The potential of antidiabetic thiazolidinediones for anticancer therapy.
Expert Opin. Investig. Drugs 15: 1039-1049 (2006).
-
Gallo AP, Silva LB, Franco M, Burdmann EA, Bueno V. Tacrolimus in combination with FTY720 - an analysis of renal and blood parameters.
Int. Immunopharmacol. 6: 1723-1728 (2006).
-
Gallo AP, Silva LB, Franco M, Burdmann EA, Bueno V. Tacrolimus in combination with FTY720 - an analysis of renal and blood parameters.
Int. Immunopharmacol. 6: 1919-1924 (2006).
-
Gallucci F, Russo R, Buono R, Acampora R, Madrid E, Uomo G. Indications and results of videocapillaroscopy in clinical practice.
Adv. Med. Sci. 53: 149-157 (2008).
-
Gambelunghe G, Brozzetti A, Ghaderi M, Candeloro P, Tortoioli C, Falorni A. MICA gene polymorphism in the pathogenesis of type 1 diabetes.
Ann. N. Y. Acad. Sci. 1110: 92-98 (2007).
*
-
Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
Clin. Endocrinol. (Oxf.) 52: 565-573 (2000).
*
-
Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes.
Diabetologia 43: 507-514 (2000).
*
-
Gambelunghe G, Ghaderi M, Tortoioli C, Falorni A, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A; Umbria Type 1 Diabetes Registry. Two distinct MICA gene markers discriminate major autoimmune diabetes types.
J. Clin. Endocrinol. Metab. 86: 3754-3760 (2001).
*
-
Gambelunghe G, Kockum I, Bini V, Giorgi GD, Celi F, Betterle C, Giordano R, Libe R, Falorni A. Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease.
Diabetes 54: 900-905 (2005).
*
-
Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis.
Curr. Opin. Rheumatol. 15: 430-435 (2003).
-
Gammell P, O'Driscoll L, Clynes M. Characterisation of BHK-21 cells engineered to secrete human insulin.
Cytotechnology 41: 11-21 (2003).
*
-
Ganesh R Dr, Arvindkumar R, Vasanthi T. Infantile-onset diabetes mellitus: a 1-year follow-up study.
Clin. Pediatr. (Phila.) 48: 271-274 (2009).
-
Gani OA. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
Cardiovasc. Diabetol. 7: 6 (2008).
*
-
Gao F, Zhang R, Hu C, Fang QC, Wang CR, Ma XJ, Lu JX, Xu J, Jia WP, Xiang KS. Association of -6735T-->C variant of glucokinase-associated dual-specificity phosphatase 12 gene with type 2 diabetes in Chinese.
Zhonghua Yi Xue Za Zhi 88: 2250-2253 (2008).
-
Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB. Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
J. Autoimmun. 26: 90-103 (2006).
-
Gao JX, Xu DL, Shao YH, Lao WY, Lin S, Zhang B. Association of Gly82Ser polymorphism of receptor for advanced glycation end products gene in a type 2 diabetic Chinese population.
Nan Fang Yi Ke Da Xue Xue Bao 27: 219-222 (2007).
-
Gao XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus.
Chin. Med. J. (Engl.) 121: 701-705 (2008).
-
Garcia D, Angel B, Carrasco E, Albala C, Santos JL, Perez-Bravo F. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile.
Diabetes Res. Clin. Pract. 77: 134-140 (2007).
-
Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.
World J. Gastroenterol. 15: 280-288 (2009).
*
-
Garcia-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem.
Ann. Hepatol. 8: 13-20 (2009).
*
-
Gardiner A, Richards KA, Sant AJ, Arneson LS. Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide.
Int. Immunol. 19: 1103-1113 (2007).
-
Gardner JM, Devoss JJ, Friedman RS, Wong DJ, Tan YX, Zhou X, Johannes KP, Su MA, Chang HY, Krummel MF, Anderson MS. Deletional tolerance mediated by extrathymic Aire-expressing cells.
Science 321: 843-847 (2008).
*
-
Garman JH, Mulroney SE, Manigrasso M, Flynn E, Maric C. Omega-3 fatty acid rich diet prevents diabetic renal disease.
Am. J. Physiol. Renal Physiol. 296: F306-F316 (2009).
*
-
Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastroenterology 133: 496-506 (2007).
*
-
Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B; The RISC Investigators. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.
Hepatology 49: 1537-1544 (2009).
-
Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren's syndrome in salivary glands of non-obese diabetic mice.
Arthritis Res. Ther. 11: R24 (2009).
*
-
Gatzka M, Walsh CM. Apoptotic signal transduction and T cell tolerance.
Autoimmunity 40: 442-452 (2007).
-
Gaudel C, Schwartz C, Giordano C, Abumrad NA, Grimaldi P. Pharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle.
Am. J. Physiol. Endocrinol. Metab. 295: E297-E304 (2008).
*
-
Gaulton KJ, Willer CJ, Li Y, Scott LJ, Conneely KN, Jackson AU, Duren WL, Chines PS, Narisu N, Bonnycastle LL, Luo J, Tong M, Sprau AG, Pugh EW, Doheny KF, Valle TT, Abecasis GR, Tuomilehto J, Bergman RN, Collins FS, Boehnke M, Mohlke KL. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes.
Diabetes 57: 3136-3144 (2008).
-
Gaur LK. Nonhuman primate models for islet transplantation in type 1 diabetes research.
ILAR J. 45: 324-333 (2004).
-
Gavanescu I, Benoist C, Mathis D. B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients.
Proc. Natl. Acad. Sci. U.S.A. 105: 13009-13014 (2008).
*
-
Gavanescu I, Kessler B, Ploegh H, Benoist C, Mathis D. Loss of Aire-dependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunity.
Proc. Natl. Acad. Sci. U.S.A. 104: 4583-4587 (2007).
*
-
Gaynor JJ, Moon JI, Kato T, Nishida S, Selvaggi G, Levi DM, Island ER, Pyrsopoulos N, Weppler D, Ganz S, Ruiz P, Tzakis AG. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation.
Transplantation 84: 155-165 (2007).
-
Gazit V, Tasher D, Hanukoglu A, Landau Z, Ben-Yehuda Y, Somekh E, Dalal I. Atopy in children and adolescents with insulin-dependent diabetes mellitus.
Isr. Med. Assoc. J. 10: 858-861 (2008).
*
-
Ge K, Cho YW, Guo H, Hong TB, Guermah M, Ito M, Yu H, Kalkum M, Roeder RG. Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression.
Mol. Cell. Biol. 28: 1081-1091 (2008).
*
-
Gebe JA, Falk B, Unrath K, Nepom GT. Autoreactive T cells in a partially humanized murine model of T1D.
Ann. N. Y. Acad. Sci. 1103: 69-76 (2007).
*
-
Gebe JA, Unrath KA, Yue BB, Miyake T, Falk BA, Nepom GT. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.
J. Autoimmun. 30: 197-206 (2008).
-
Gebe JA, Yue BB, Unrath KA, Falk BA, Nepom GT. Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms.
J. Immunol. Jun 17 [Epub ahead of print] (2009).
-
Gellner V, Kurschel S, Scarpatetti M, Mokry M. Lymphocytic hypophysitis in the pediatric population.
Childs. Nerv. Syst. 24: 785-792 (2008).
-
Gelman L, Feige JN, Desvergne B. Molecular basis of selective PPARgamma modulation for the treatment of type 2 diabetes.
Biochim. Biophys. Acta 1771: 1094-1107 (2007).
*
-
Geluk A, van Meijgaarden KE, Schloot NC, Drijfhout JW, Ottenhoff TH, Roep BO. HLA-DR binding analysis of peptides from islet antigens in IDDM.
Diabetes 47: 1594-1601 (1998).
*
-
Genc S, Genc K, Sercan O, Kizildag S, Gulay Z, Atay T, Dundar B, Sakizli M, Buyukgebiz A. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in patients with type 1 diabetes mellitus in a Turkish population.
J. Pediatr. Endocrinol. Metab. 17: 731-735 (2004).
-
Genini D, Carbone GM, Catapano CV. Multiple interactions between peroxisome proliferators-activated receptors and the ubiquitin-proteasome system and implications for cancer pathogenesis.
PPAR Res. 2008: 195065 (2008).
*
-
Genini D, Catapano CV. Control of peroxisome proliferator-activated receptor fate by the ubiquitin-proteasome system.
J. Recept. Signal Transduct. Res. 26: 679-692 (2006).
-
Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review.
Semin. Arthritis Rheum. 36: 88-98 (2006).
*
-
Geoffrey R, Jia S, Kwitek AE, Woodliff J, Ghosh S, Lernmark A, Wang X, Hessner MJ. Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat.
J. Immunol. 177: 7275-7286 (2006).
*
-
Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors.
J. Hand Surg. [Br.] 29: 423-426 (2004).
-
George J, Liddle C. Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
Mol. Pharm. 5: 49-59 (2008).
*
-
Georgopoulos A, Bloomfield H, Collins D, Brousseau ME, Ordovas JM, O'Connor JJ, Robins SJ, Schaefer EJ. Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the veterans affairs HDL intervention trial (VA-HIT).
Atherosclerosis 194: 169-174 (2007).
-
Geraldes P, Yamagata M, Rook SL, Sassa Y, Ma RC, Clermont A, Gao B, Aiello LP, Feener EP, King GL. Glypican 4, a membrane binding protein for bactericidal/permeability-increasing protein signaling pathways in retinal pigment epithelial cells.
Invest. Ophthalmol. Vis. Sci. 48: 5750-5755 (2007).
*
-
Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U. Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis.
Br. J. Dermatol. 159: 1116-1123 (2008).
*
-
Gerhauser C. Cancer chemopreventive potential of apples, apple juice, and apple components.
Planta Med. 74: 1608-1624 (2008).
-
Gero L. Treatment of nephrotic syndrome in the adult.
Orv. Hetil. 147: 2313-2318 (2006).
-
Gershon ES, Badner JA. Progress toward discovery of susceptibility genes for bipolar manic-depressive illness and schizophrenia.
CNS Spectr. 7: 965-968 (2002).
-
Gershwin LJ. Veterinary autoimmunity: autoimmune diseases in domestic animals.
Ann. N. Y. Acad. Sci. 1109: 109-116 (2007).
*
-
Gersuk VH, Nepom GT. A real-time polymerase chain reaction assay for the rapid identification of the autoimmune disease-associated allele HLA-DQB1*0602.
Tissue Antigens 73: 335-340 (2009).
*
-
Gervois P, Fruchart JC, Staels B. Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARalpha and PPARgamma agonists.
Int. J. Clin. Pract. Suppl. 143: 22-29 (2004).
-
Gervois P, Fruchart JC, Staels B. Drug insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Nat. Clin. Pract. Endocrinol. Metab. 3: 145-156 (2007).
*
-
Gey T, Bergoin C, Just N, Paupard T, Cazals-Hatem D, Xuan KH, Tavernier JY, Wallaert B. Langerhans cell histiocytosis and sclerosing cholangitis in adults.
Rev. Mal. Respir. 21: 997-1000 (2004).
-
Geyeregger R, Zeyda M, Stulnig TM. Liver X receptors in cardiovascular and metabolic disease.
Cell. Mol. Life Sci. 63: 524-539 (2006).
*
-
Ghali P, Lindor KD. Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.
Semin. Liver Dis. 24: 389-397 (2004).
-
Ghanaat-Pour H, Sjoholm A. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Diabetes Metab. Res. Rev. 25: 163-184 (2009).
-
Ghandil P, Chelala C, Dubois-Laforgue D, Senee V, Caillat-Zucman S, Kockum I, Luthman H, Nerup J, Pociot F, Timsit J, Julier C. Crohn's disease associated CARD15 (NOD2) variants are not involved in the susceptibility to type 1 diabetes.
Mol. Genet. Metab. 86: 379-383 (2005).
*
-
Ghany MG, Doo EC. Antiviral resistance and hepatitis B therapy.
Hepatology 49: S174-S184 (2009).
-
Ghoreschi K, Rocken M. Immune deviation strategies in the therapy of psoriasis.
Curr. Drug Targets Inflamm. Allergy 3: 193-198 (2004).
-
Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, Tauber M, Weill J, Froguel P. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
BMC Med. Genet. 6: 11 (2005).
*
-
Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, Muti E, Malavolta M, Costarelli L, Piacenza F, Tesei S, Mocchegiani E. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications.
Mol. Genet. Metab. 94: 98-104 (2008).
*
-
Giacconi R, Cipriano C, Muti E, Costarelli L, Maurizio C, Saba V, Gasparini N, Malavolta M, Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc.
Biogerontology 6: 407-413 (2005).
*
-
Giaginis C, Margeli A, Theocharis S. Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.
Expert Opin. Investig. Drugs 16: 1561-1572 (2007).
-
Giaginis C, Spanopoulou E, Theocharis S. PPAR-gamma signaling pathway in placental development and function: a potential therapeutic target in the treatment of gestational diseases.
Expert Opin. Ther. Targets 12: 1049-1063 (2008).
-
Giaginis C, Theocharis S, Tsantili-Kakoulidou A. Quantitative structure-activity relationships for PPAR-gamma binding and gene transactivation of tyrosine-based agonists using multivariate statistics.
Chem. Biol. Drug Des. 72: 257-264 (2008).
-
Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Fundam. Clin. Pharmacol. 21: 231-244 (2007).
*
-
Giamarellos-Bourboulis EJ, Papadimitriou E, Galanakis N, Antonopoulou A, Tsaganos T, Kanellakopoulou K, Giamarellou H. Multidrug resistance to antimicrobials as a predominant factor influencing patient survival.
Int. J. Antimicrob. Agents 27: 476-481 (2006).
*
-
Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005.
Immunol. Rev. 204: 232-249 (2005).
*
-
Giannoukakis N, Phillips B, Trucco M. Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond.
Pediatr. Diabetes 9: 4-13 (2008).
-
Giannoukakis N, Trucco M. Gene therapy for type 1 diabetes.
Am. J. Ther. 12: 512-528 (2005).
-
Giannoukakis N, Trucco M. Gene therapy for type 1 diabetes: a proposal to move to the next level.
Curr. Opin. Mol. Ther. 7: 467-475 (2005).
-
Giarratana N, Penna G, Adorini L. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse.
Methods Mol. Biol. 380: 285-312 (2007).
-
Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.
J. Immunol. 173: 2280-2287 (2004).
*
-
Gibbons LJ, Thomson W, Zeggini E, Worthington J, Barton A, Eyre S, Donn R, Hinks A. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis.
Rheumatology (Oxford) 44: 1390-1393 (2005).
*
-
Gibbs P, Steel S, McLaughlin S, Jones I, Faragher I, Skinner I, Croxford M, Johns J, Chapman M, Lipton L. Type 2 diabetes mellitus, smoking, and colorectal cancer.
Am. J. Gastroenterol. 102: 909-910 (2007).
*
-
Giboney PT. Mildly elevated liver transaminase levels in the asymptomatic patient.
Am. Fam. Physician 71: 1105-1110 (2005).
*
-
Gibson DL, Vallance BA. Intestinal microbiota are transiently altered during Salmonella-induced gastroenteritis.
Expert Rev. Gastroenterol. Hepatol. 2: 525-529 (2008).
-
Giese LA. Milk thistle and the treatment of hepatitis.
Gastroenterol. Nurs. 24: 95-97 (2001).
-
Gigli G, Caielli S, Cutuli D, Falcone M. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Immunology 122: 409-417 (2007).
*
-
Gil A, Bengmark S. Advanced glycation and lipoxidation end products - amplifiers of inflammation: the role of food.
Nutr. Hosp. 22: 625-640 (2007).
-
Gilde AJ, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors at the crossroads of obesity, diabetes, and cardiovascular disease.
J. Am. Coll. Cardiol. 48: A24-A32 (2006).
-
Giles TD, Sander AG. Effects of thiazolidinediones on blood pressure.
Curr. Hypertens. Rep. 9: 332-337 (2007).
-
Gill H, Prasad J. Probiotics, immunomodulation, and health benefits.
Adv. Exp. Med. Biol. 606: 423-454 (2008).
-
Gillespie KM. Type 1 diabetes: pathogenesis and prevention.
CMAJ 175: 165-170 (2006).
*
-
Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, Gale EA, Shield JP. Islet autoimmunity in children with Down's syndrome.
Diabetes 55: 3185-3188 (2006).
*
-
Gilliam LK, Binder KA, Banga JP, Madec AM, Ortqvist E, Kockum I, Luo D, Hampe CS. Multiplicity of the antibody response to GAD65 in type I diabetes.
Clin. Exp. Immunol. 138: 337-341 (2004).
*
-
Gilliam LK, Liese AD, Bloch CA, Davis C, Snively BM, Curb D, Williams DE, Pihoker C; SEARCH for Diabetes in Youth Study Group. Family history of diabetes, autoimmunity, and risk factors for cardiovascular disease among children with diabetes in the SEARCH for Diabetes in Youth Study.
Pediatr. Diabetes 8: 354-361 (2007).
*
-
Ginanjar E, Sumariyono , Setiati S, Setiyohadi B. Vitamin D and autoimmune disease.
Acta Med. Indones. 39: 133-141 (2007).
-
Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.
Arch. Intern. Med. 168: 1174-1180 (2008).
*
-
Girona J, Guardiola M, Cabre A, Manzanares JM, Heras M, Ribalta J, Masana L. The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients.
Clin. Chem. Lab. Med. 46: 453-457 (2008).
-
Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
Semin. Thromb. Hemost. 35: 313-324 (2009).
-
Gissel T, Rejnmark L, Mosekilde L, Vestergaard P. Intake of vitamin D and risk of breast cancer - a meta-analysis.
J. Steroid Biochem. Mol. Biol. 111: 195-199 (2008).
-
Gizard F, Bruemmer D. Transcriptional control of vascular smooth muscle cell proliferation by peroxisome proliferator-activated receptor-gamma: therapeutic implications for cardiovascular diseases.
PPAR Res. 2008: 429123 (2008).
*
-
Gladman DD, Ang M, Su L, Tom BD, Schentag CT Phd, Farewell VT. Cardiovascular morbidity in psoriatic arthritis (PsA).
Ann. Rheum. Dis. 68: 1131-1135 (2009).
-
Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Goke B, Ochsenkuhn T, Muller-Myhsok B, Brand S. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
Am. J. Gastroenterol. May 19 [Epub ahead of print] (2009).
*
-
| |
